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ABSTRACT 
Sara Bingham Jones: Association of Mid-Life Alcohol with Stroke and Cognitive Decline in the 
Atherosclerosis Risk in Communities Study 
(Under the direction of Wayne D. Rosamond) 
 
 One in three adults will experience stroke or develop dementia in their lifetime, underscoring 
the need to identify modifiable factors to delay or prevent disease.  Alcohol, a common exposure in 
most populations, may confer cardiovascular benefits at light-to-moderate doses.  Its association with 
stroke and cognitive function is uncertain. 
 This dissertation aims to estimate the associations between mid-life alcohol consumption and 
incident stroke and rate of cognitive decline using data from the Atherosclerosis Risk in Communities 
Study, a biracial population-based cohort of 15,792 adults aged 45-64 at baseline with >20 years of 
follow-up.  Alcohol consumption was self-reported as usual drinks per week; categorized as never, 
former, light (≤3), moderate (4-17), and heavier (≥18).  One-third of participants were light drinkers, 
roughly one-fifth each were moderate, never and former drinkers and only 4% reported heavier 
consumption. 
Suspected strokes were obtained through self-report and hospital surveillance, validated using 
medical records, and adjudicated by physician experts.  Light and moderate consumption were not 
strongly associated with ischemic stroke (HR=0.98, 95% CI 0.79-1.21; 1.06, 0.84-1.34) while heavier 
drinking was associated with a 31% increased rate relative to abstention in Cox proportional-hazard 
regression.  Specification of intake with quadratic splines did not support a J-shaped relationship with 
stroke; we noted a roughly linear relative increase across intake.  Moderate-to-heavy, but not light, 
consumption increased hemorrhage rates. 
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Cognitive status was assessed at visits 2, 4, and 5 using three validated tests.  Linear regression 
with generalized estimating equations estimated the difference in 20-year decline by alcohol intake.  We 
used multiple imputation with chained equations to address informative attrition in sensitivity analysis.  
Global 20-year cognitive change did not differ between light drinkers and abstainers (0.019 z-score 
units; 95% CI -0.032, 0.070) and was somewhat faster for heavier drinkers (-0.041; -0.0152, 0.070).  No 
consistent pattern in 20-year change was observed across tests, but effects were somewhat larger on 
tests of verbal fluency and executive function. 
Light-to-moderate consumption at mid-life was not associated with reduced stroke risk or 
slower cognitive decline compared with abstention over 20 years of follow-up in the ARIC study.  
Heavier consumption tended to increase the risk for both outcomes. 
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CHAPTER 1: INTRODUCTION 
 
Brain-related diseases are important targets for public health prevention, particularly given 
the ageing population and expected concomitant increases in disease burden.  Stroke is a leading 
cause of mortality and disability, and dementia prevalence is estimated to be as high as 50% among 
adults aged 85 years and older.7, 8  Approximately 1 in 3 Americans will have a stroke or develop 
dementia in their lifetime, underscoring the need for continued examination of modifiable risk 
factors for these diseases.9  
The association between alcohol and coronary heart disease has been widely studied, with 
relatively consistent findings of a J-shaped relationship such that moderate drinkers have the lowest 
risk of disease.10-14 15  Whether similar dose-response relationships exist between alcohol 
consumption and diseases of the brain, including stroke and cognitive impairment, is less well 
understood.  Previous studies have reported that heavy alcohol consumption is associated with 
increased ischemic and hemorrhagic stroke risk as well as cognitive decline and dementia.2, 6, 16-19   
However, results are conflicting with regard to whether low-to-moderate intake is associated with 
reduced risk of stroke and cognitive decline.1, 14, 18, 20-26  Several of these studies rely on a single 
baseline measure of alcohol intake that in studies of cognitive decline is often temporally close to 
outcome measurement,1, 19-22, 24-35  use few categories of alcohol intake thus limiting assessment of 
dose response, have mixed reference groups,19, 21, 22 21, 28, 29, 31, 32, 35  are limited in availability of 
potential confounders,1, 19, 20, 24-26, 28-32, 34-37 adjust for possible mediators including HDL cholesterol 
and blood pressure,1, 19, 21, 22, 24-27, 30-32, 34, 35  have short (<5 year) follow-up periods,20, 21, 23, 25 1, 21, 27-32, 34  
and lack clinician-based diagnosis of stroke or ideal measurement of cognitive decline.1, 28, 30, 31, 37  
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Furthermore, there are few studies of the effects of alcohol in African-American populations despite 
the fact that African-Americans have a higher incidence of stroke and dementia and higher 
prevalence of problem drinking.7, 38  Some evidence suggests that effects on stroke risk may differ by 
race, but studies are few. 39-41   
Alcohol may exert protective effects for ischemic stroke by increasing high-density 
lipoprotein, apolipoprotein A, insulin sensitivity, and fibrinogen levels as well as by decreasing 
inflammation, thrombotic factors, and platelet activity.6, 42-44  Moderate alcohol consumption may 
reduce the risk of cognitive decline through similar mechanisms, resulting in preserved brain 
vasculature, fewer subclinical infarcts and microbleeds, and less white matter degradation.  In 
addition, moderate alcohol may facilitate learning and memory by increasing acetylcholine, a 
neurotransmitter involved in attention and memory storage, in the hippocampus.8, 18  In contrast, 
high doses of alcohol have clear deleterious effects through direct neurotoxic effects on brain 
structures, elevated blood pressure, reduced cerebral blood flow, and development of atrial 
fibrillation and cardiomyopathy that increase the risk of stroke and cognitive decline.18  The anti-
thrombotic effects of alcohol that may protect against ischemic stroke may increase hemorrhage 
risk.  Heavy drinking can also lead to Wernicke-Korsakoff syndrome, a thiamine deficiency 
characterized by cognitive and memory deficits.  Chronic alcohol abuse indirectly leads to thiamine 
deficiency through malnourishment and directly plays a role by decreasing absorption from the 
gastrointestinal tract, interfering with the conversion of thiamine into its active form.45 Moderate 
alcohol intake may have harmful effects as well.  There is risk of addiction for certain populations 
and studies suggest that moderate intake may be associated with increased stomach, esophageal 
and breast cancer risk.46  Additional risks include disruption of sleep, medication interaction, and 
harm to fetal development.  Because of these hazards, and the inability to predict those sub-groups 
at risk for progression to problem drinking, the American Heart Association does not currently 
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recommend initiation of moderate drinking among abstainers for the purpose of reducing risk of 
heart disease.47  Instead, public health messages focus on reduction of heavy drinking and binge 
drinking episodes and encouragement of current drinkers to consume alcohol in moderation.  The 
risk-benefit tradeoff of moderate drinking versus abstention may differ with age, with benefits 
outweighing risks beginning in middle age.48  Currently, the definition of moderate intake is not 
standardized and U.S. and international guidelines differ.49 There is some evidence that current 
recommendations for moderate drinking among older adults by the National Institute on Alcohol 
Abuse and Alcoholism may be conservative.  Continued research will help to better identify harmful 
and beneficial doses of alcohol. 
Public health recommendations regarding alcohol consumption require integration of 
evidence on many outcomes including injury, cancer, coronary heart disease, and all-cause 
mortality.14  Herein, we propose to contribute further understanding through additional research of 
the association between alcohol consumption and diseases of the brain, conditions for which 
evidence to date has been inconsistent.  There remains a need for further elucidation of the 
complex relationship between alcohol and stroke and cognitive decline and to report these findings 
for both White and African-American populations.  Finally, obtaining estimates of the effect of 
changes in population-level drinking patterns on disease burden will be of use to population 
scientists and policy makers. 
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CHAPTER 2: STUDY OBJECTIVES AND SPECIFIC AIMS 
 
The proposed study seeks to estimate the association between alcohol consumption and 
stroke and cognitive decline in a population-based sample of White and Black participants aged 45-
64 at baseline in the Atherosclerosis Risk in Communities study.  The proposed study will utilize data 
from the 5 study visits of the ARIC study as well as data collected at annual follow-up and through 
surveillance of community hospital discharge lists.  Manuscript 1 will address Specific Aims 1 and 2 
and manuscript 2 will address Specific Aim 3. 
Specific Aim 1:  Estimate the dose-response relationship between alcohol intake over time 
and incident total, ischemic, and hemorrhagic stroke among White and Black participants in the 
Atherosclerosis Risk in Communities (ARIC) Study (Manuscript 1; Chapter 5).  Time-to-event analysis 
will be used to obtain effect estimates for the association of mid-life alcohol consumption with 
incident total, ischemic, and hemorrhagic stroke.  Models will be adjusted for potential confounders, 
and account for the competing risk of death.  We hypothesize that heavy drinking will be associated 
with the highest rate of all stroke types and that light-to-moderate drinking will be associated with 
reduced rate of ischemic, and to a lesser degree hemorrhagic, stroke compared with lifetime 
abstention from drinking.  We will assess modification of these relationships by race and sex given 
the previous findings that effects of alcohol on cardiovascular disease risk may vary by race-ethnicity 
and that the dose-response relationship may differ by sex.   
Specific Aim 2:  Investigate the feasibility of estimating the proportional changes in stroke 
incidence among sex-race groups that could result from population-level shifts in alcohol 
consumption categories (Manuscript 1).  If feasible, the proportional change in total, ischemic, and 
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hemorrhagic stroke events resulting from changes in the distribution of alcohol intake will be 
estimated using generalized impact fraction methods.  Generalized impact fractions will be 
estimated within strata of age, sex, and race using effect estimates obtained from Cox regression 
models in Specific Aim 1.  We will estimate the expected change in stroke incidence that 
corresponds with achievement of the 2020 Healthy People Goals for reductions in heavy drinking.50  
These goals target a ~3% reduction in the prevalence of heavy drinking, defined as consumption of 
>2 drinks per day for men and >1 drink per day for women. 
Specific Aim 3:  Estimate the association between alcohol consumption and rate of cognitive 
decline among the ARIC participants attending Visit 2 (Manuscript 2; Chapter 6).  Linear regression 
with generalized estimating equations will be used to estimate the rates of cognitive decline across 
levels of alcohol consumption.  Inverse-probability weights will be calculated to account for the 
different mechanisms of attrition (drop-out and death) that may induce selection bias.  Alternative 
methods to address attrition will be considered in the event that inverse-probability weights prove 
infeasible.  We hypothesize that moderate consumption of alcohol will be associated with a slower 
rate of decline in cognitive function than lifetime abstention.  Heavy alcohol intake is hypothesized 
to result in the steepest decline in cognitive function.  We will explore modifications of these 
relationships by sex, race, and ApoE ε4 allele status. 
In summary, by utilizing data from a large, racially-diverse population-based cohort we will 
contribute further understanding of the effects of alcohol consumption on vascular-related diseases 
of the brain.  The study strengths include a long duration of follow-up, multiple measurements of 
exposure and confounders, robust stroke ascertainment, and repeated assessment of cognitive 
function.  Results will be interpreted in light of study limitations including possible exposure 
misclassification, selection bias from competing risks and attrition, and residual confounding.  This 
study will contribute additional data on the effects of alcohol consumption for future meta-analyses 
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and for clinicians judging risks and benefits of alcohol consumption for their patients.  In addition, 
results may aid in understanding the thresholds effects of alcohol, and will provide novel estimates 
of the population impact of changes in alcohol consumption on disease burden to assist public 
health practitioners working in areas of lifestyle modification and policy. 
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CHAPTER 3: BACKGROUND AND SIGNIFICANCE 
 
3.1 Public Health Burden of Stroke and Cognitive Impairment 
Stroke and pathological cognitive decline are important targets for public health prevention.  
Both are associated with significant morbidity and heath care costs and are estimated to increase in 
burden over the next few decades due to longer life expectancies and demographic population 
changes.51, 52  Worldwide, dementia contributes to 11.2% of total years lived with disability and 
stroke to 9.5% for adults aged 60 years and older.53  With approximately 1 in 3 Americans estimated 
to have a stroke or develop dementia in their lifetime, there is urgent need for continued 
examination of modifiable risk factors for these diseases.  Cardiovascular (CV) risk factors such as 
high blood pressure, obesity, diabetes, physical inactivity, and smoking have been implicated in 
disease risk.   Identifying additional modifiable factors such as alcohol consumption may provide 
further avenues for preventing or delaying disease.  This is particularly important for cognitive 
decline, as there are no effective pharmaceutical treatments for dementia. 
 
A. Stroke and its Epidemiology 
Stroke has historically been defined using variations of the World Health Organization 
criteria as a “sudden impairment of brain function resulting from the interruption of circulation to 
one or other parts of the brain following either an occlusion (ischemic stroke) or hemorrhage 
(hemorrhagic stroke) of the artery supplying that area”.54  A more recent definition has been 
established that incorporates both clinical and tissue-based criteria.55  Under these new definitions, 
ischemic stroke is defined as “an episode of neurological dysfunction caused by focal cerebral, spinal 
or retinal infarction” that requires either objective evidence of ischemic injury or clinical evidence of 
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injury based on symptoms lasting more than 24 hours.  Intracerebral hemorrhage is defined as 
“rapidly developing clinical signs of neurological dysfunction attributable to focal collection of blood 
within the brain parenchyma or ventricular system that is not caused by trauma”.  Subarachnoid 
hemorrhage is defined as “rapidly developing signs of neurological dysfunction and/or headache 
because of bleeding into the subarachnoid space (between the arachnoid membrane and the pia 
mater)”. 
Despite its sudden onset, many 
strokes are the result of an atherosclerotic 
disease process that begins decades earlier.  
Atherosclerosis is an inflammatory disease 
of the arterial wall that can result in 
weakening of the vessel wall and protrusion 
of atherosclerotic plaques into the lumen.56  
This narrowing can lead to restriction or 
cessation of blood flow to the brain (ischemia) and subsequent infarction.  In the U.S., strokes of 
ischemic etiology are common and account for 87% of all strokes.7  Ischemic events may occur by 
way of thrombosis, wherein a blood clot forms around an atherosclerotic lesion, or embolism, 
wherein clots that develop in the heart or break off from a thrombus become lodged in circulation 
and obstruct blood flow to the brain.57  Large artery stenoses result from occlusion of one of the 
large arteries that supplies the brain such as the internal carotids, cerebral, and basilar arteries 
(Figure 158).  Lacunar infarctions occur in the deep penetrating arteries of the brain with resultant 
lesions often seen in the putamen, thalamus, and pons.  Cardioembolic strokes result from arterial 
occlusions (often in the middle or posterior cerebral artery) from emboli of a cardiac source. 
Intracerebral and subarachnoid hemorrhages account for the remaining 10% and 3%, 
  Figure 1. Types of ischemic stroke
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respectively, of strokes in the U.S.7  Their etiology is not atherosclerotic in nature, but can still result 
from many years of exposure to CV risk factors, particularly the damaging effects of high blood 
pressure, cigarette smoking, and other harmful lifestyle habits.  Hemorrhagic events result from 
rupture of a blood vessel and bleeding in the brain, either in the deep portions of the cerebral 
hemisphere in the case of ICH or in the subarachnoid spaces in the case of SAH.57  Rupture may 
result from weakening of the vessel wall, as from sustained elevated blood pressure, or from 
malformation in the vessel as in arteriovenous malformations.  Brain damage from hemorrhagic 
strokes results from the increased pressure of blood on surrounding tissue and the direct toxic 
effects of blood on brain tissue.57 
Stroke is the 4th leading cause of death in the United States, accounting for 1 in 19 deaths, 
and is a leading cause of disability.  There are 610,000 new and 185,000 recurrent strokes each year 
in the U.S.  Since 1950, death rates from stroke have declined.54  Despite this, the number of deaths 
attributed to stroke are projected to increase from 5.7 million currently to 7.8 million in 2030 and 
the number of first-ever strokes will increase from 16 to 23 million worldwide.  Overall prevalence is 
2.8% in the U.S. and is projected to increase to 3.4% by 2030.7  Prevalence rates increase with age 
and reach 13-17% in adults aged ≥80 years.54  The burden of stroke is higher among African 
Americans compared with whites (age-adjusted incidence per 100,000 person-years: white men 
150, white women 130, black men 300, black women 300).54  Lifetime risk of stroke at age 65 is 
20.6% for women and 16.8% for men, with 5-year survival averaging approximately 40%.54 Direct 
and indirect costs exceed $38 billion annually and the lifetime cost of stroke to an individual 
averages more than $140,000.7  
Elevated blood pressure is a strong risk factor for both ischemic and hemorrhagic stroke.7  
Other risk factors include diabetes mellitus, atrial fibrillation, physical inactivity, low social support, 
and family history of stroke.7  Smokers have 2-4 times the risk of stroke as nonsmokers; however, 
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data are inconsistent as to whether smoking increases the risk of ICH.  High cholesterol levels 
increase the risk for stroke in some studies, but effects are smaller than those observed for heart 
disease and are absent in some studies.  Finally, there are risk factors specific to women that include 
pregnancy, hormone use, and age at menopause.  Several of these risk factors are also associated 
with alcohol intake including low social support, HDL-C, smoking, and physical activity. 
 
B. Cognitive Decline and its Epidemiology 
Cognitive function, defined as “the mental processes that are required to receive, analyze, 
and act on information from the environment”, is classified into cognitive domains including, among 
others, reception, memory and learning, attention, visuoperception and visual reasoning, language, 
construction, motor ability, decision making, and executive control (Table 1).51, 59  Declines in 
function over time are common with aging, but a complete understanding of ‘normal’ cognitive 
aging is lacking.60  On average, most aspects of cognition decline with age including working memory 
and processing speed.59  Other functions, for example expert knowledge and vocabulary, remain 
stable or even increase with age.  Declines exist on a continuum from normal aging to pathological 
declines.  The latter may hinder independent living, social relationships, and quality of life.  The 
definition of pathological declines is somewhat arbitrary and studying declines that have yet to 
reach the threshold for clinical diagnosis will improve our understanding of modifiable factors that 
affect the entire disease process.  Cognitive aging is not uniform across the population; some 
individuals experience very little decline well into their 80s while others exhibit declines beginning in 
their 60s.59  This variation in degree and rate of decline is of interest to researchers, particularly if it 
can be leveraged to identify modifiable risk factors.  Alcohol consumption is one such putative factor 
with mechanistic support. 
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Table 1. Description of selected cognitive domains 
Cognitive function Description Task 
Orientation Awareness of self in relation to one’s surroundings, 
including time, place, and person. Requires 
integration of attention, perception, and memory 
Knowledge of today’s date 
Attention and 
concentration 
Ability to sustain and focus thoughts and behavior Symbol substitution 
Mental tracking Hold information in memory while performing a 
mental operation 
Repeat numbers in reverse 
order 
Memory Capacity to retain information and utilize it for 
adaptive purposes 
Short-term word recall 
Language Ability to comprehend and produce speech Verbal fluency – name as 
many words as possible 
beginning with ‘F’ 
Construction Combined perception and motor response.   Draw a clock face 
Reasoning Thinking with a conscious intent to reach a 
conclusion 
Arithmetic calculations, 
organize pictures in logical 
temporal order 
Psychomotor speed Amount of time it takes to process information, plan 
a response, and carry out a physical movement; 
combines decision time and motor components 
Digit symbol substitution 
Executive function Ability to respond in an adaptive manner to novel 
situations. Comprised of several other functions 
including planning, organization, coordination, 
implementation, and evaluation. 
Route finding task 
 
Cognitive declines that have progressed to a certain degree of severity are defined clinically 
as mild cognitive impairment (MCI) and dementia.  MCI is an intermediate state of cognitive 
function between normal cognition and dementia that generally does not impair daily life.51  MCI 
can be thought of as a sub-clinical impairment and is a risk factor for development of dementia later 
in life.60  Not all individuals with MCI appear to develop dementia and some even show 
improvements in cognitive function.  Dementia is a “clinical syndrome caused by neurodegeneration 
and characterized by inexorably progressive deterioration in cognitive ability and capacity for 
independent living”.  Common pathologies include Alzheimer’s disease (AD), vascular dementia, and 
Lewy body dementia.52  A relatively new definition of vascular cognitive impairment has been 
developed and includes impairments ranging from mild to severe affecting at least 1 cognitive 
domain and with evidence of clinical stroke or subclinical vascular brain injury.61 
Many different disease processes underlie changes in brain structure and function that 
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manifest themselves as declines in one or more domains of cognition.  These include, among others, 
vascular disease, degenerative diseases, traumatic brain injury, and toxicity.  Alcohol has the most 
direct effects through neurotoxicity and alterations in vascular risk factors, but also can be an 
upstream contributor to traumatic brain injury.  The latter, however, is beyond the scope of this 
dissertation. 
Vascular and neurodegenerative processes occur over the life course, are multi-factorial, 
and incompletely understood.  Neurodegenerative and vascular-related pathologies overlap 
considerably and share several risk factors including alcohol consumption.  Alzheimer’s disease, one 
of the more common neurodegenerative dementias, is characterized by accumulation of amyloid 
plaques and neurofibrillary tangles as well as neuronal loss.  Mixed pathology is seen in 25-80% of 
dementias and there is some evidence that cerebrovascular and AD lesions may act synergistically in 
the development of dementia.62  Vascular dementia is the end result of vascular lesions in the brain 
that impair its function.  Because the brain relies on a constant supply of blood for proper 
functioning, interruption of blood flow results in tissue death.61  Important factors in the likelihood 
of developing dementia are the volume of brain damage, the number of lesions, and their location; 
however, the types of lesions that result in dementia are quite heterogeneous. 
Contributors to vascular-related cognitive impairment include clinical stroke (likely reflecting 
both tissue damage from the event itself and the presence of CV risk factors such as high blood 
pressure that contribute to additional brain damage), microbleeds, white matter lesions, and silent 
brain infarctions.  Silent brain infarctions are 5 times as prevalent as clinical strokes in the 
population, with prevalence estimates ranging from 8-28%.55, 59  These, along with white matter 
lesions, are common and may increase the risk of impairment for some individuals.  Even transient 
ischemic attacks, once thought not to result in permanent damage, are associated with mild 
cognitive deficits.59  Measures of both atherosclerosis (e.g. carotid intima-media thickness) and 
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arteriosclerosis are associated with impairment.  Atherosclerosis of medium and large arteries 
contributes to cognitive impairment through emboli that arise from carotid plaques and thrombotic 
occlusion of large vessels that result in cerebral hypoperfusion and subsequent brain damage.  Small 
vessel disease, similar to atherosclerotic changes but without calcification, can result in 
hemorrhages, microinfarcts and microbleeds, white matter hyperintensities, as well as lacunar 
infarcts.62  Finally, cerebral amyloid angiopathy in which amyloid β-protein is deposited in vessel 
walls, may lead to disturbances in blood flow, microinfarcts and microbleeds, white matter lesions, 
and hemorrhages.  Collectively, atherosclerosis, small vessel disease, and cerebral amyloid 
angiopathy can lead to cerebrovascular lesions and subsequent cognitive decline. 
 Cardiovascular risk factors that are associated with cognitive decline include diabetes (via 
damaging effects of elevated insulin and glucose) and hypertension, which is associated with MCI 
even in the absence of lesions.59  Randomized controlled trials have largely been unable to show a 
beneficial effect of glucose and blood pressure modification on later development of dementia.  
However, trials are few in number given the long-term follow-up required, have had somewhat 
inconsistent results, and are subject to methodological limitations.61  In addition to the CV risk 
factors discussed above, age, race, education, obesity, hypercholesterolemia, physical inactivity, 
smoking, dietary factors, depression, and social isolation have been implicated in cognitive 
decline.35, 51 Alcohol consumption is one of the dietary factors that has received attention from 
researchers as both a protective and harmful factor, though its putative causal relationship with 
cognitive decline has not been rigorously evaluated and evidence to date is weak.33, 63  Assessing this 
association in a study with long-term follow-up and multiple measures of cognitive function will 
contribute to this literature. 
Data on the epidemiology of mild cognitive impairment (MCI) and dementia are highly 
variable due to large differences in study methods (e.g. diagnostic criteria, measurement tools, and 
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sampling).64  The prevalence of MCI is reported at 2-20%, and is thought to be 13% among adults 
≥65 years of age representing 5.4 million adults.64, 65  Data from the Aging, Demographics, and 
Memory Study of adults aged over 70 years reported 13.7% prevalence of dementia (10.8% in men 
and 15.5% in women), with 70% attributed to AD and 17% to vascular dementia.66  Prevalence of 
non-dementia cognitive impairment was 22%.  Global prevalence is estimated to triple within 40 
years and in the U.S. prevalence will rise to 11-16 million by 2050.51  The incidence of AD and 
dementia increase with age, doubling roughly every 5 years after age 65.  Age-adjusted incidence of 
dementia ranges from 2.4 per 1000 person-years in the age group 65-69 to 27.5 per 1000 p-y in the 
age group 85-89 and ranges from 9-26 per 1000 person-years for ‘pre-dementia syndromes’.65, 66  
Healthcare costs totaled $183 billion dollars in 2011 and the cost of informal care in the U.S. was an 
additional $18 billion per year.53  Persons with dementia have higher annual health care costs than 
similarly-aged persons without dementia ($42,072 versus $13,515).  Finally, dementia confers 
significant costs to care givers, who can experience high levels of stress, depression, financial 
difficulties, and adverse health outcomes.  In summary, the prevalence of dementia is high and will 
continue to increase over time given the sharp increase in incidence associated with aging coupled 
with expected demographic shifts and individuals attaining older ages. 
 
C. Summary 
Stroke and cognitive impairment represent a significant health burden nationwide and 
globally.  The prevalence of these conditions is projected to increase dramatically as the population 
demographic shifts to a greater proportion of older adults and people experience increased 
longevity.  Identifying modifiable risk factors to prevent or delay disease - such as the consumption 
of alcoholic beverages - is necessary to reduce disease burden, its high economic cost, and negative 
impact on quality of life. Given its plausible mechanisms of effect through reduction of CV risk 
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factors and vascular disease, alcohol represents a viable target for intervention. 
 
3.2 Alcohol Consumption Patterns in the U.S. 
Several national surveys collect data on alcohol consumption including the National Health 
and Nutrition Examination Survey (NHANES), the Behavioral Risk Factor Surveillance System (BRFSS), 
the National Health Interview Surveys (NHIS), and the National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC) conducted by the National Institute on Alcohol Abuse and Alcoholism 
(NIAAA). 
NHANES is a cross-sectional, nationally representative survey of US civilian, non-
institutionalized persons and includes an in-person home interview and health examination.  Alcohol 
consumption information was collected on adults aged 20-85 years in two 2-year waves from 1999 
to 2002 (Figure 2).67  Overall, 
70% of adults were current 
drinkers, 17% were former 
drinkers, and 13% were 
lifetime abstainers.  Binge 
drinking, defined as 
consumption of 5 or more 
drinks in 1 day at least once in the past year was reported by 42% of white males, 18% of white 
females, 27% of black males, and 10% of black females. 
The BRFSS is a state-based, cross-sectional telephone survey of non-institutionalized, civilian 
U.S. adults aged 18 years or older.  Questions on alcohol in this survey include one on frequency of 
drinking (days per week), quantity of drinking (average drinks per occasion), and frequency of binge 
drinking (occasions in the past 30 days during which at least 5 (for men) or 4 (for women) drinks 
Figure 2. Prevalence of alcohol consumption levels by sex and age, 
NHANES 1999-2002 
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were consumed).  A report from the 2006 survey cross-classified individuals according to average 
consumption (calculated by multiplying frequency x quantity) and binge drinking.68  Nearly 70% of 
current drinkers were both non-binge and non-heavy drinkers.  Table 2 shows the frequency of the 
four drinking patterns according to socio-demographic characteristics.  Consistent with other survey 
findings, both heavy and binge drinking were more prevalent among younger compared with older 
adults, in men compared with women, and among Whites compared with Blacks.  Assessment of 
drinking patterns is important to the study of alcohol consumption because average consumption 
measures may under-represent harmful drinking patterns such as infrequent episodes of excessive 
drinking. 
Table 2. Prevalence of heavy and binge drinking by sociodemographic characteristics, BRFSS 2006 
  
Binge/Heavy % 
(95% CI) 
Binge/Non-Heavy % 
(95% CI) 
Non-
Binge/Heavy % 
(95% CI) 
Non-Binge/ 
Non-Heavy % 
(95% CI) 
Total (N=157,914) 7.6 (7.3–7.9) 21.8 (21.3–22.3) 1.7 (1.6–1.8) 69 (68.4–69.5) 
Age (years) 
           18–24 15 (13.5–16.7) 35.9 (33.7–38.2) 0.3 (0.2–0.6) 48.8 (46.4–51.1) 
   25–39 7.6 (7.1–8.2) 29.5 (28.5–30.4) 0.6 (0.5–0.8) 62.2 (61.2–63.2) 
   40–54 7.4 (6.9–7.8) 19.3 (18.6–20.0) 1.6 (1.4–1.8) 71.8 (71.0–72.5) 
   55+ 4.2 (3.9–4.5) 9.1 (8.6–9.7) 3.5 (3.2–3.8) 83.1 (82.5–83.8) 
Race or ethnicity 
           White 7.7 (7.4–8.1) 20.9 (20.4–21.4) 1.9 (1.8–2.0) 69.5 (69.0–70.1) 
   Black 5.7 (4.7–6.8) 19.9 (18.1–21.7) 1.3 (0.9–1.8) 73.1 (71.1–75.0) 
   Hispanic 8.5 (7.2–10.0) 29.7 (27.3–32.2) 0.5 (0.3–0.8) 61.3 (58.8–63.8) 
   Other 5.7 (4.4–7.2) 22.3 (19.4–25.5) 0.7 (0.4–1.3) 71.3 (68.0–74.4) 
Gender 
           Male 8.4 (7.9–8.8) 27.2 (26.4–27.9) 0.8 (0.7–0.9) 63.7 (62.8–64.5) 
   Female 6.7 (6.3–7.1) 15.5 (14.9–16.0) 2.6 (2.4–2.8) 75.2 (74.6–75.9) 
Marital status 
           Married 5.5 (5.2–5.8) 18.8 (18.3–19.3) 1.6 (1.5–1.8) 74.1 (73.5–74.6) 
   Previously married 8.6 (7.8–9.3) 17.8 (16.9–18.8) 2.8 (2.5–3.2) 70.8 (69.7–71.9) 
   Never married 12.5 (11.6–13.5) 32.4 (31.0–33.8) 0.9 (0.7–1.1) 54.2 (52.8–55.7) 
Education 
           <High school 13 (11.2–15.0) 31.7 (29.1–34.4) 1 (0.7–1.4) 54.4 (51.6–57.1) 
   High school 
graduate 9.2 (8.6–9.9) 25.4 (24.3–26.4) 1.4 (1.2–1.6) 64 (62.8–65.1) 
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   Some college 8.4 (7.7–9.0) 22.3 (21.4–23.3) 1.4 (1.3–1.6) 67.9 (66.8–68.9) 
   College graduate 5.3 (5.0–5.7) 18 (17.3–18.7) 2 (1.8–2.2) 74.7 (74.0–75.4) 
Income, $ 
           <20,000 10.3 (9.1–11.6) 27.3 (25.3–29.4) 1.4 (1.0–1.7) 61 (58.9–63.1) 
   20,000–34,999 8.8 (7.9–9.8) 23.2 (21.9–24.7) 1.5 (1.3–1.8) 66.4 (64.9–67.9) 
   35,000–49,999 7.8 (7.1–8.6) 22.7 (21.5–24.0) 1.8 (1.5–2.1) 67.7 (66.3–69.0) 
   50,000–75,000 6.9 (6.2–7.5) 22 (20.9–23.0) 1.4 (1.2–1.6) 69.8 (68.7–71.0) 
   >75,000 7 (6.5–7.6) 19.9 (19.1–20.7) 1.8 (1.6–2.0) 71.2 (70.4–72.1) 
* Binge drinking was defined as consuming ≥5 drinks on an occasion for men and ≥4 drinks for women. 
Heavy drinking was defined as consuming on average >2 drinks/day for men and >1 drink/ day for women. 
  
Another analysis of the BRFSS assessed time trends in binge drinking according to 
demographic characteristics from 1993 to 2001.69  Binge-drinking episodes increased slightly among 
men from 10.8 per person per year to 12.5 and remained stable among women (2.2 to 2.7).  
Younger aged adults consistently had higher rates of binge drinking; among 35-54 year-olds binge-
drinking episodes increased from 5.4 to 6.7 and among adults 55 and older changed little from 2.5 
to 2.7.  Finally, Blacks had lower binge drinking rates than Whites, increasing from 4.2 to 5.4, while 
Whites increased from 6.6 to 7.4.  In summary, these data suggest that the heaviest drinking occurs 
in young white males and that this group has experienced the largest increase in consumption from 
the early 1990s to 2000s. 
The National Health Interview Surveys from 5 years (1997-2001) were pooled to assess 
drinking patterns in adults over the age of 60.70  These interviews represented 15,811 men and 
24,745 women.  Alcohol was measured in terms of quantity (average drinks per occasion), frequency 
(number of drinking days per year), and episodes of heavy episodic drinking (number of days on 
which 5 or more drinks were consumed).  The majority (57% of men and 77% of women) reported 
less than 1 drink per day on average.  One to two drinks per day was reported by 26% of men and 
20% of women.  No episodes of heavy episodic drinking were reported by 80% of men and 95% of 
women.  If these results are generalizable to the ARIC population, it would suggest that heavy 
drinking episodes are not prevalent in our population, reducing concerns for strong confounding of 
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average volume estimates by different drinking patterns.  It also highlights the importance of 
studying alcohol exposures in mid-life, which are more variable than in older adults, and that may 
reflect relevant exposure window. 
Sales data support many of 
the conclusions above from self-
reports regarding secular trends in 
alcohol consumption.  Sales data 
have the advantage of being 
objective, but may not represent 
total alcohol actually consumed 
because of waste or home 
production.  A recent analysis from NIAAA reports that while alcohol sales have decreased 
substantially from the mid-1970s, there has been a steady increase since the late 1990s (Figure 3).4  
This increase is largely due to wine and spirits which offset the continued decline in beer sales.  
Finally, while longitudinal reports are less common than repeated, cross-sectional surveys, they 
support that on average individuals reduce their average consumption over the life-course.  Peak 
consumption generally occurs in the late teens and early twenties followed by a sharp decline and 
stabilization in the 30-50s, with declines again in older age (~60s).  Trajectories of alcohol 
consumption vary by individual, and according to socioeconomic and demographic factors. 69, 71 
 
A. Summary 
The consumption of alcohol is relatively common in the United States and has increased 
over the past decade.  Abstention increases with age and is higher in subgroups such as women and 
individuals of higher SES.  While drinking in excess decreases with age, there remains a significant 
Figure 3. Per capita ethanol consumption by beverage type, 
United States, 1977-20094 
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portion of adults that consume more than the recommended average intake (e.g. 20% of men aged 
60 and older consume 3+ drinks per day according to the NHIS).  Given the high prevalence of 
alcohol consumption in the US, examining potential health benefits and risks associated with this 
exposure may inform population scientists about the extent of disease that is attributable to alcohol 
exposure.  The persistence of heavy drinking, particularly among certain sub-groups, suggests that 
there is potential reduction in disease burden that may be achieved through population 
interventions to reduce heavy drinking.  Reducing the proportion of persons engaging in binge and 
excessive drinking is part of the Healthy People 2020 goals, has been identified as a high priority 
health issue, and is a Leading Health Indicator.50  Estimates from 2008 for the proportion of adults 
that engage in binge and excessive drinking are 27.1% and 28.2%, respectively.  Targets were set for 
each at 24.4% and 25.4%, a reduction of roughly 3% by 2020.  These targets will inform Aim 2 and 
provide reasonable intervention goals for population shifts in alcohol consumption.  We will 
estimate what effect achievement of these goals will have on stroke burden.  Finally, a greater 
understanding of the benefits and risks of alcohol consumption may inform individual and clinician 
decision-making regarding risk factor modification. 
 
3.3 Mechanisms Linking Alcohol with Stroke and Cognitive Impairment 
 The primary component of alcohol is ethanol (C2H5OH), which is an energy-yielding 
molecule.  It may be partially metabolized (~2%) in the stomach by gastric alcohol dehydrogenase 
(ADH).  Remaining alcohol then diffuses across the stomach and intestine and enters portal 
circulation where it is further metabolized in the liver at a rate of roughly 15 grams per hour.  
Ethanol can also be biotransformed in Phase I reactions in the smooth endoplasmic reticulum by 
way of the microsomal ethanol-oxidizing system (MEOS; Figure 4).  The bioavailability of alcohol 
varies by sex and age.  Men have more gastric ADH and therefore reduced bioavailability of alcohol 
 20 
 
than women.  In addition, body composition changes as 
people age and percentage body water declines.  This water 
loss slows ethanol distribution and results in higher blood 
alcohol content.49 Women tend to have a lower percentage 
of water, which is another reason for their greater alcohol 
bioavailability relative to men.  In addition to ethanol, some 
alcoholic beverages, notably red wine, contain antioxidant 
polyphenol compounds of the flavonoid and stilbene 
classes.  These components have been hypothesized to 
confer health benefits in addition to ethanol and may have 
unique cardioprotective properties.72 Red wine has the highest concentration of polyphenolic 
compounds, with white wine and beer containing 10-20% the amount in red wine depending on 
cultivar and age.73, 74 
 
A. Alcohol as a Risk Factor for Stroke and Cognitive Decline- Effects of Heavy Alcohol Consumption 
High doses of alcohol have clear deleterious effects on health that accumulate over time.  
There is a direct neurotoxic effect on brain structures as well as indirect health effects through 
elevated blood pressure, increased reactive oxygen species, reduced cerebral blood flow, and 
development of atrial fibrillation and cardiomyopathy.18, 75  Heavy drinking can also have negative 
health effects in combination with nutritional deficiencies.  One example is Wernicke-Korsakoff 
syndrome, a thiamine deficiency characterized by cognitive and memory deficits.  Chronic alcohol 
abuse indirectly leads to thiamine deficiency through malnourishment and directly plays a role by 
interfering with the conversion of thiamine into its active form and decreasing its absorption in the 
intestines.45  Other nutrient deficiencies such as pellagra nicotinic acid deficiency can cause memory 
Figure 4. Metabolism of ethanol into 
acetaldehyde by alcohol 
dehydrogenase and the MEOS pathway 
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impairment and lead to dementia; these symptoms typically reverse upon treatment with nicotinic 
acid.76 
Direct neurotoxic effects of chronic heavy alcohol use can lead to cognitive deficits in the 
absence of nutritional deficiencies, i.e. in uncomplicated alcoholics.76  Heavy drinking results in 
structural brain changes including ventricular enlargement and brain shrinkage.  There is atrophy of 
both the white and grey matter, although evidence suggests that white matter is more severely 
affected.77  These structural changes are a hallmark of one form of dementia known as alcoholic 
dementia, a progressive multi-domain cognitive impairment.  Human studies have also shown that 
heavy alcohol intake can result in changes to dendrite receptors, neurotransmitters, and neuronal 
loss in several brain areas, most commonly the superior frontal association cortex, hypothalamus, 
and cerebellum.78  Damage to these areas can result in deficiencies in the areas of planning, 
organization, problem solving, and disinhibition.  The associations of alcohol with brain 
abnormalities including brain atrophy, subclinical infarcts, and white matter disease were assessed 
in the Cardiovascular Health Study.77  Drinking was associated with increased risk of brain atrophy 
with no apparent threshold, whereas the relationship between alcohol consumption and white 
matter disease was U-shaped. 
 Mechanisms underlying alcohol’s neurotoxicity are not fully understood, but could occur by 
several pathways.  These include glutamate excitotoxicity (a process through which excessive 
stimulation of receptors leads to neuronal cell death), oxidative stress, hyperhomocysteinemia, 
reduced availability of brain-neurotrophic factor and nerve growth factor, and DNA damage.  Acute 
ethanol exposure inhibits N-methyl-D-aspartate (NMDA) receptor activity.  However, chronic 
exposure leads to compensatory upregulation of NMDA glutamate receptors and glutamate binding 
sites in the frontal cortex.79, 80  During withdrawal, inhibition of glutamate activity is removed and 
there is potential for elevated activity and glutamate-mediated excitotoxicity.  Excess glutamate 
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binds to the over-expressed 
receptors and leads to 
excitotoxicity.80  In this way, 
chronic alcohol exposure results in 
increased sensitivity of neurons to 
excitotoxicity.  Upregulation of 
NMDA receptors leads to 
generation of free radicals that 
contribute to oxidative damage.  
Homocysteine, often present at unusually high concentration in the plasma of heavy drinkers, can 
also contribute to excitotoxicity.  It is an excitatory amino acid and is able to function as an agonist 
at glutamate binding sites on NMDA receptors.  Upon binding of the NDMA receptor, there is a 
prolonged influx of calcium ions that enter the cell.  This leads to a cascade of events that damage 
cell structures and DNA and ultimately results in neuronal apoptosis (Figure 5).79 
Other mechanisms may explain the neurotoxic effects of alcohol beyond those mediated 
through NMDA receptors.78  First, chronic ethanol exposure reduces the availability of brain-derived 
neurotrophic factor and receptors for nerve growth factor.  These changes can impair intracellular 
signaling pathways contributing to neuronal cell death and malfunctioning of neural circuits.  
Second, the oxidative stress brought on by alcohol intake can result in DNA strand breaks and cell 
death.  Third, damaging acetaldehyde protein adduct formation, derived from the highly reactive 
byproduct of ethanol metabolism, has been observed in white matter and neurons in the frontal 
cortex.  Taken together, the neurotoxicity of alcohol may play a key role in the development of 
cognitive impairment through direct damage to the brain’s structure and function.  These effects are 
likely cumulative, highlighting the importance of understanding long-term, cumulative alcohol 
  Figure 5. Effect of ethanol on NMDA receptors and excitotoxicity 
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exposure when studying cognitive changes over time. 
 In addition to the direct neurotoxic effects described above, heavy alcohol intake has 
indirect effects on the brain through elevated blood pressure, atrial fibrillation and cardiomyopathy, 
reactive oxygen species, endothelial dysfunction, inflammation, glucose intolerance and insulin 
insensitivity, and reduced cerebral blood flow.  These effects can increase the risk of stroke and 
dementia and also result in microinfarctions and lesions that contribute to cognitive decline.  
Alcohol intake has a dose-dependent effect on blood pressure, with consistent findings of increased 
blood pressure at high doses (usually more than 2 drinks per day,77, 81 but other studies have found 
thresholds below and above this level).82  The blood pressure response to alcohol is biphasic.  Within 
several hours of consumption, blood pressure is lowered due to vasodilation and then 11-13 hours 
later rises higher than baseline levels.83  A meta-analysis of randomized controlled trials reported a 
mean decrease in systolic blood pressure of -3.31 mm/Hg and in diastolic blood pressure of -2.04 
mm/Hg associated with interventions to reduce drinking by 67% from a baseline consumption of 3-6 
drinks per day.84  Mechanisms through which alcohol affects blood pressure are not completely 
understood, but could include stimulation of the sympathetic nervous and the renin-angiotensin-
aldosterone systems, increases in endothelin (a potent vasoconstrictor), and changes in cortisol and 
intracellular calcium.81, 82  Elevated blood pressure is a well-established and strong risk factor for 
both ischemic and hemorrhagic stroke and has been shown in some, but not all, randomized 
controlled trials to reduce risk of dementia.7, 61 
 Alcohol intake is associated with increased risk for atrial fibrillation and cardiomyopathy.  
Although the precise dose-response relationship between alcohol and atrial fibrillation is debated, 
findings for increased risk with heavy drinking are relatively consistent.  Authors of a recent meta-
analysis report a relative risk of 1.22 (95% CI: 1.02-1.46) in consumers of more than 3-4 drinks per 
day compared with abstainers.85  Alcohol may alter atrial structure, trigger fibrillation, have 
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proarrhythmic effects (QT interval elongation, impaired vagal heart rate control, and 
hyperadrenergic activity), and enhance persistence of otherwise asymptomatic episodes.85-88  Atrial 
fibrillation is a known risk factor for stroke and is associated with vascular dementia.7, 61  
Cardiomyopathy may develop as a result of heavy alcohol consumption and is associated with 
reduced ejection fraction and stroke volume and can lead to heart failure. 89, 90  Cardiomyopathy in 
turn can increase the risk of embolic stroke and dementia.91, 92 A common form of cardiomyopathy 
identified in chronic heavy drinkers is dilated cardiomyopathy in which the heart is enlarged, 
weakened and contracts poorly.93  Evidence suggests that even in the absence of clinically manifest 
cardiomyopathy, heavy alcohol intake has a negative inotropic effect and decreases left ventricular 
ejection fraction.90 
 Alcohol increases oxidative stress which has been shown to promote endothelial 
dysfunction and inflammatory responses.83  Alcohol may negatively impact endothelial function 
through changes in adhesion molecules, interleukin-6, and C-reactive protein, and also has 
prothrombotic effects through decreased fibrinolytic ability, elevations in factor VII, fibrinogen, and 
plasma viscosity.77, 83, 94  Inflammation and endothelial dysfunction are hallmarks of the atherogenic 
process56 and together with impaired hemostatic function contribute to reduced cerebral blood flow 
and increased susceptibility of the brain to injury. 61  Some studies have demonstrated that binge 
drinkers have more rapid progression of atherosclerosis in carotid arteries compared with moderate 
and non-drinkers.  Atherosclerosis of the carotid artery can lead to cerebral hypoperfusion or 
infarction by way of emboli from carotid plaque or thrombotic occlusion of the vessel.  Measures of 
carotid intimal-medial thickness, a marker for atherosclerosis, are associated with both stroke and 
cognitive decline.7, 61  Finally, heavy alcohol consumption is associated with insulin resistance, 
glucose intolerance, and diabetes, 77, 83 which in turn are associated with stroke risk and cognitive 
decline.7, 95-97   
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B. Alcohol as a Protective Factor for Stroke and Cognitive Decline – Effects of Low-to-Moderate 
Consumption 
 There are a number of plausible mechanisms through which alcohol may protect against 
stroke and cognitive decline.72  Low-to-moderate alcohol intake modulates several vascular risk 
factors and is associated with increased high-density lipoprotein cholesterol, decreased fibrinogen 
and platelet aggregation, and improvements in inflammatory markers and insulin sensitivity.6, 42-44  
These factors contribute to the formation of atherosclerosis and thrombosis, which when present in 
the carotid or cerebral arteries, contributes to ischemic stroke risk.  Moderate alcohol consumption 
may reduce the risk of cognitive impairment through similar atherothrombotic mechanisms, 
resulting in preserved brain vasculature and fewer subclinical infarcts.  Finally, there is evidence that 
alcohol consumption increases acetylcholine in the hippocampus, a neurotransmitter that facilitates 
learning and memory.8, 18, 98 
Experimental study designs and randomized feeding trials have been used to understand 
mechanisms of alcohol action.  In these studies, participants are randomized to short-term alcohol 
consumption and their effects on biomarkers can be measured with minimal confounding.  
However, attributing disease causality to alcohol as mediated through changes in biomarkers 
requires the assumption that short-term changes in biomarkers reflect a long-term reduction in 
disease risk assuming these biomarker levels are sustained.99   
 Numerous trials have reported changes in biomarkers according to alcohol consumption.  
One of the strongest and most consistent findings is an increase in HDL cholesterol.  A meta-analysis 
of trials with mean duration of 4 weeks reported a 4.0 mg/dl increase in HDL-C associated with 
intake of 30 grams of ethanol per day (the equivalent of roughly 2 standard drinks of beer (12-oz), 
wine (5-oz), or liquor (1.5oz)). 13  In addition, apolipoprotein A1 increased by 8.8 mg/dl and 
triglyceride by 5.7 mg/dl (Figure 6).  No significant changes in thrombolytic factors were found.  The 
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authors extrapolated the effect of changes in 
biomarkers on disease risk and report a 
predicted relative reduction in heart disease risk 
of 25%.13 
A more recent meta-analysis, published 
over a decade after the earlier report by Rimm 
et al., found dose-dependent increases in HDL-C 
of 2.8, 4.0, and 5.5 mg/dl for 1-2, 2-4, and ≥5 
drinks per day, respectively, and no change in LDL.100  For a similar 30-g dose as assessed in the 
previous meta-analysis, HDL increased 3.7 mg/dl and apolipoprotein AI increased 8.7 mg/dL, quite 
similar to the results of Rimm et al.  In contrast to the earlier results, the authors reported significant 
decreases in fibrinogen (-0.2 g/L) and no change in triglyceride levels except at very high doses of 
alcohol (>60 g/day was associated with a 24.3 mg/dL increase).  Finally, adiponectin increased 0.56 
mg/L with alcohol consumption, which is hypothesized to result in improved insulin sensitivity.  
Results were inconsistent with regard to changes in endothelial and hemostatic factors other than 
fibrinogen, with some studies reporting cardioprotective changes in these factors and others 
reporting no change.  Put in a clinical context, these findings suggest alcohol produces meaningful 
changes in biomarkers.  Moderate alcohol intake appears to increase HDL-C more than single 
pharmacological interventions, which increase HDL-C levels roughly 2.6 mg/dl.101  Furthermore, a 1 
gram/L increase in fibrinogen may double the risk of heart disease and stroke based on pooled 
cohort data.102 
Alcohol is postulated to increase HDL-C through a variety of pathways, but the precise 
pathways remains unknown.  Potential mechanisms include increased lipoprotein transport and 
lipase activity.100  HDL-C is responsible for removing LDL particles from vessel walls and therefore 
Figure 6. Percent change in biomarkers associated 
with intake of 30g (~2 drinks) of alcohol per day 
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contributes to reduced plaque build-up and atherosclerosis.  Apolipoprotein A1 is a component of 
the HDL complex, helping to clear cholesterol from white blood cells in artery walls, and may be 
involved in anticlotting activity.  Fibrinogen is an important factor in thrombosis, contributing to 
platelet aggregation, fibrin formation, and plasma viscosity and therefore is a risk factor for 
atherothrombotic disease.103  In addition to reducing fibrinogen concentration, alcohol may also 
affect its conformation and stability.100  Other studies have reported that ethanol prevents platelet 
aggregation, opposes thrombin activity, and reduces inflammatory cytokines.  These effects have 
greater inconsistencies across studies than those of HDL-C and fibrinogen, but remain potential 
mechanisms through which alcohol may impact risk of stroke and cognitive decline. 
Elevated blood pressure is a risk factor for stroke and cognitive decline and there is evidence 
that light-to-moderate alcohol intake may reduce the risk for hypertension.104  Results are variable, 
with some suggesting a J-shaped association in women but not men93 and others findings increased 
risk in black men with only moderate intake. 
  Metabolic abnormalities including impaired glucose tolerance, metabolic syndrome, and 
diabetes have been associated with stroke risk and cognitive decline.7, 95, 96  Light to moderate 
drinkers have lower insulin levels, greater insulin sensitivity, and reduced risk of type II diabetes 
mellitus.93  Postmenopausal women who were randomized to consume 30 grams of alcohol per day 
had lower insulin concentrations and higher insulin sensitivity than the comparison group 
consuming 0 grams of alcohol.105  These studies suggest that improved metabolic factors may 
mediate part of the relationship between alcohol and stroke and cognitive decline. 
 Finally, there has been research to determine if effects of alcohol on CV risk factors are the 
result of ethanol per se or if they differ by beverage type.  The meta-analysis results of Brien et al. 
were consistent across beverage types (wine, beer, spirits).  While some evidence suggests that 
there are additional benefits of polyphenols, the observed effects of alcohol on biomarkers were 
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most likely the result of ethanol rather than other components found in red wine.  It is possible that 
the added benefit of polyphenols was not detectable in this analysis on top of the effect of ethanol.  
There is evidence supporting an additional role for resveratrol, a polyphenolic antioxidant found at 
highest concentration in red wine, and other phenolic compounds on disease risk.73 74, 90, 106  
Experimental evidence in animal models, cell culture, and clinical studies suggests that polyphenols 
in red wine (e.g. resveratrol, catechin, kaempferol, and tannic acid) can have anti-atherosclerotic, 
anti-inflammatory, and antithrombotic effects.74, 106  Namely, they improve endothelial function, 
reduce susceptibility of LDL to oxidation, reduce oxidative stress by scavenging for free radicals and 
interfering with free radical-producing systems, and reduce platelet aggregation.74, 76, 90, 106 A 
randomized trial testing the effects of red wine, ethanol, and dealcoholized red wine found both 
ethanol and polyphenols had anti-inflammatory effects (most of these were non-additive), but that 
only polyphenols modulated leukocyte adhesion molecules and only ethanol increased interleukin-
10.107  The most likely mode of benefit from polyphenols may come from prevention of LDL 
oxidation, which has been demonstrated in vitro as well as in some, but not all, human studies.108 
 
C. Summary 
The effect of alcohol on risk of stroke and cognitive decline is dose dependent.  There is 
convincing and well-established mechanistic support for a negative effect of heavy drinking on these 
endpoints resulting from direct neurotoxic effects, increases in blood pressure, and adverse effects 
on other CV risk factors.  The precise threshold for negative effects is not well established, however.  
Alcohol in moderate doses is a plausible beneficial factor for stroke and cognitive decline through its 
well-established effect on CV biomarkers such as HDL, fibrinogen, and insulin.  Effects of low-dose 
alcohol on endothelial factors and blood pressure are less well-established, however.  Whether the 
effect of low-dose alcohol on biomarkers translates to improved clinical event rates is not fully 
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understood and warrants further research.  The goal of this dissertation is to examine the dose-
dependent effects of alcohol on stroke and cognitive decline and to quantify the disease burden 
attributable to heavy intake. 
 
3.4 Measurement of Alcohol Consumption 
A. Measurement Tools in Epidemiologic Research 
Several measurement tools are available to research scientists to assess alcohol 
consumption (Table 3).109  The choice of which to use depends on its feasibility, cost, performance 
characteristics, and the research goal (i.e. ranking individuals in categories of exposure vs. 
estimating absolute levels of intake).  Measurement tools may be subjective self-reports or objective 
measures.  Subjective measures are further classified as assessing 1) customary or ‘usual’ drinking, 
in which the participant is required to average intake over a defined recall period; or 2) recent 
drinking, which estimates both intake and within-person variability.  Usual drinking measurement 
tools are retrospective and subject to recall errors and reporting errors.  Recent drinking approaches 
can be either retrospective or concurrent, the latter being subject to measurement-induced 
behavior change as well as reporting error. 
Table 3. Tools for the measurement of alcohol consumption 
Measurement Tool 
Subjective 
vs. 
Objective 
Type of 
drinking 
assessed Timing Primary Limitations 
Single-item frequency Self-report Summary Retrospective Confounds Q and F and 
does not detect infrequent 
heavy drinking episodes 
Quantity-frequency (QF) Self-report Summary Retrospective Does not capture heavy 
episodic drinking or 
beverage specific 
consumption 
Indexed QF Self-report Summary Retrospective May over-estimate intake 
depending on algorithm 
Extended QF Self-report Summary Retrospective May over-estimate intake if 
categories overlap 
Graduated frequency Self-report Summary Retrospective May over-estimate intake if 
categories overlap 
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Most recent drinking 
occasion(s) 
Self-report Daily Retrospective Biased for irregular 
drinkers, may over-estimate 
frequency 
Survey period recall Self-report Daily Retrospective Biased for irregular 
drinkers, may over-estimate 
abstention 
Diaries Self-report Daily Retrospective 
or Concurrent 
High respondent burden; 
potential for behavior 
change 
Blood alcohol content 
(serum, breath, urine, 
transdermal) 
Objective Recent 
exposure 
Retrospective Expensive; may not reflect 
usual drinking 
Other biomarkers (e.g. 
GGT, CDT) 
Objective Recent (past 
1-8 weeks) 
Retrospective Detects only chronic, heavy 
drinking; sensitivity may 
differ by gender 
 
By far the most common measurement tools used in epidemiological studies are 
retrospective, self-reports to assess customary drinking habits.  Modes of administration for these 
questionnaires include interviewer-administered (in person or over the telephone) and self-
administered.  A variety of measurement tools are available within this category including single-
item frequency-based consumption measures, quantity-frequency (QF) measures, and graduated 
QF.109-112  
In single-item frequency-based alcohol measures, respondents are asked to report the 
frequency (i.e. number of drinking days in a defined period) of alcohol consumption and are 
provided with response categories consisting of, for example, ‘less than monthly’, ‘once per week’, 
and ‘one drink per day’.  These questions are simple and rapidly administered, but are limited in that 
the response categories confound quantity and volume.  Daily drinkers consuming large amounts 
would be captured as heavy drinkers, but not infrequent drinkers of large quantity.  These questions 
thus differentiate better at the higher end of intake (i.e. with response options for once per day, 
twice per day, thrice per day, etc.), but are unable to differentiate between one drink once per week 
and 5 drinks once per week, because both would be categorized as drinking ‘once per week’.109 
QF measures, by far the most common in research, assess usual intake in 2 dimensions - 
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drinking frequency (number of drinking days over a reference period) and quantity (usual number of 
drinks per occasion).  Quantity and frequency are often collapsed into a 1-dimensional measure, 
average volume, by multiplying QF responses.  QF methods are simple to administer and easy to 
compute, but can underestimate heavy drinking occasions.  When compared with alcohol sales data, 
QF methods have been shown to underestimate 23-77% of predicted intake.113  Methods that 
incorporate additional questions on binge drinking into standard QF measures yield higher levels of 
reported intake.  Reasons for underestimation from standard QF measures are two-fold.  First, 
respondents are typically not given enough time (or do not take enough time) to accurately 
calculate average quantity per drinking occasion.  Second, respondents are likely to misinterpret the 
question as referring to the modal quantity or frequency and not the arithmetic mean.  Because 
individual intake distributions are typically right-skewed, the mode will underestimate the mean.  As 
a result of the underestimation of simple QF measures, the NIAAA Task Force recommends that 
epidemiological research include at least 3 questions to measure alcohol intake: usual quantity, 
usual frequency, and a third item for frequency of heavy drinking, referred to as binge drinking or 
heavy episodic drinking.  The latter question type typically asks the respondent for the number of 
days over a reference period that he/she has consumed 5 or more drinks (a value of 4 or more is 
sometimes used for women).  Questions on heavy drinking enable researchers to measure drinking 
patterns and may also be used to adjust average volume measures through an algorithm known as 
indexing.  Indexing methods adjust the average number of drinks per day based on the number of 
reported heavy drinking days and the quantity consumed on these occasions.  Standard QF 
measures were compared with indexed QF methods in an analysis of 2003 BRFSS data.113  The 
authors reported that prevalence estimates of heavy drinking in the U.S. are higher when indexing 
methods are used (6.8% vs. 8.1%) as is the average number of drinks per day (0.49 vs. 0.43).  
Differences between these two calculation methods were larger for men and younger adults aged 
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18-34 years, groups in which heavy drinking is most common.  Finally, extended QF measures have 
been developed that capture drinking frequencies for different beverage types, in different 
locations, or in different situations.  These measures provide additional detail to researchers and 
also are intended to reduce the respondent burden of averaging over different situations, reducing 
variability. 
A third measure is a derivative of the standard QF known as the graduated frequency (GF) 
measure.  This assesses the usual frequency of drinking at various quantity levels or ‘bands’.  The 
first step is to establish the maximum number of drinks consumed in any day within the reference 
period (usually chosen to be 1 year). Next, frequencies of drinking in the maximum band are 
assessed; this process is repeated successively in lower quantity bands.  The respondent burden of 
averaging quantities is no longer required, but instead the respondent must accurately distribute 
drinking days into categories of quantity.  These question types are able to provide greater detail on 
consumption, but are more time consuming for the respondent and therefore are infrequently used 
in epidemiologic studies.  In addition, because of their complexity, this measure typically collapses 
all beverage types whereas QF methods are more easily able to incorporate separate questions on 
beverage types such as wine, beer, and spirits. 109, 110, 112 
The second broad category of self-reported measurement tools are those that assess recent 
drinking either retrospectively or prospectively.  These include assessment of most recent drinking 
occasion(s), fixed survey period recalls, and diaries.  Most recent drinking occasion questionnaires 
ask respondents to list all alcohol consumed on the last drinking occasion.  Often the questionnaire 
asks for the last two to four occasions to improve the measurement, but this method is still subject 
to serious limitations.  This technique tends to overestimate drinking frequency, particularly among 
irregular drinkers, and therefore has differential validity according to drinking pattern.109, 110, 112  
The survey period approach asks respondents to list all drinking occasions and quantities 
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consumed over a specified period, often one week in length.  The advantage of this tool is that the 
researcher may estimate within-person variability.  Frequency is estimated based on the number of 
drinking days in the reference period and quantity by averaging across all occasions.  As with the 
fixed-occasions assessment, this method is best used for populations with regular drinking 
patterns.109, 110, 112 
Finally, diaries can be used to capture recent drinking history or concurrent consumption.  
These enable detailed data capture on type and quantity, but have high respondent burden and are 
therefore best suited for short periods of time.  A common method for measuring variability is to 
use a series of 24-hour recalls.  Concurrent records are subject to the respondent changing intake 
behavior because of social desirability or to reduce recording burden.  Advantages are that these 
methods are likely subject to less reporting error from forgetting and averaging, and they provide 
estimates of within-person variability.109-112, 114    
 Objective measures of alcohol consumption exist, though they have serious limitations for 
use in large population-based studies.109, 115, 116  Blood alcohol content is accurate and relatively 
easily measured in breath, serum, urine or transdermally, but only reflects very recent intake and is 
therefore not useful for assessing usual intake.109  Gamma-glutamyl transferase (GGT) is one of the 
most commonly used biomarkers for alcohol consumption and is elevated in the blood with chronic, 
heavy consumption, typically 4 or more drinks per day for 4-8 weeks.  Some evidence also suggests 
that GGT is associated with moderate self-reported drinking.117  Carbohydrate-deficient transferrin 
(CDT) is a second blood protein that is elevated with heavy consumption and usually is detectible 
prior to GGT (after 1-2 weeks of exposure).  While elevated CDT has high specificity, the sensitivity is 
lower than GGT and there is evidence that it performs less well among women.  Interestingly, 
elevations in GGT and CDT may indicate different drinking patterns.  A study of outpatient alcoholics 
found that among men, CDT was elevated more by drinking frequency (i.e. number of drinking days) 
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and GGT by drinking intensity (i.e. drinks per drinking day) while among women, both markers were 
more influenced by drinking intensity.116  Numerous other biomarkers exist, but have similar 
limitations with low sensitivity, many sources of false positives including cardiovascular disease, 
diabetes, hypertension and obesity, and utility primarily for the detection of very heavy drinking 
(>40-60 grams per day).118  While biomarkers may be useful in clinical practice to monitor a patient’s 
adherence to treatment, they are impractical in large epidemiologic studies because of their high 
cost and ability to identify only recent drinking and those individuals who are chronic, heavy 
drinkers (a small proportion of most samples).  However, these biomarkers may have utility for 
validation of self-reported heavy drinking (although this author is unaware of their use for this 
purpose in any longitudinal population-based study).   
Epidemiologic studies usually measure alcohol consumption as part of food-frequency or 
diet history questionnaire.  Most use a standard QF technique and many use extended QF measures, 
incorporating questions on heavy drinking episodes to capture additional detail.  Some studies also 
include a series of 24-hour recalls or weighed food diaries in either the whole or often a sub-sample 
for validation purposes.   
In the ARIC study, alcohol was measured using a single tool, precluding regression 
calibration correction for measurement error.  The ARIC study does have multiple measures over 
time, however, which allows estimation of cumulative average and time-varying exposure with the 
caveat that measurement changes over time may also reflect measurement error .  The QF 
measurement is vulnerable to under-reporting of heavy drinking episodes, as discussed above.  
However, separate questions for average quantity and frequency were included in questionnaires at 
visits 3-5, allowing for separate analysis of quantity and frequency (i.e. drinking pattern) in 
secondary analysis.  Possible under-reporting of intake is a limitation of the measurement tool used 
in ARIC.  While the degree of bias is unknown, simulation can be used to estimate this bias under 
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plausible misclassification scenarios. 
 
B. Measurement Error and Validation Studies 
 The estimation of alcohol consumption is subject to measurement error that can be related 
to the instrument itself or to the individual.  Instrument-related errors include collection mode, 
administration, question format, and reference period length.109  Mode of data collection 
(telephone, mailed questionnaires, in-person) does not appear to affect measurement, although 
there is a tendency for response rates to be lower with mailed questionnaires.119  Modes of 
administration include self- and interviewer-administered.  Some evidence suggests that self-
administered questionnaires yield higher alcohol intakes, purportedly because of increased sense of 
privacy and confidentiality relative to interviewer-administered surveys.109, 120  Responses to self-
administered questionnaires yielded higher alcohol levels than in telephone surveys likely because 
of reduced social desirability and interviewer effects.119  However, interviewer administered surveys 
can result in high data quality because of greater control over data recording.114  The question 
format can also be an important factor in alcohol measurement.  Research indicates that open-
ended questions elicit higher responses than closed-ended questions as does providing the 
respondent with a wide range of categories to reduce social desirability bias.  Finally, the length of 
the reference period can impact measurement error.  Shorter periods tend to over-estimate 
abstainers, while longer periods are subject to more forgetting error, particularly if drinking patterns 
are irregular.  Longer recall periods, therefore, are theoretically less biased in estimating rank-order 
and distributions of drinking, but more subject to biases from forgetting.  The better ranking in long 
versus short reference periods assumes that errors are linearly related to intake, i.e. that bias is 
similar across levels of intake.  While no gold standard measure exists, the best administration mode 
is likely self-administration of a questionnaire that asks participants to report long-term 
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consumption and provides a wide range of response categories. 
 Individual related errors arise from recall errors of calculation, forgetting, and concealing.  
As discussed in the previous section, an individual’s distributions of drinking frequency and quantity 
are highly right-skewed.  When asked for the ‘usual’ value, respondents generally calculate the most 
common value, i.e. the mode.  The mode will underestimate the mean of a right-skewed 
distribution.  Some evidence suggests that the opposite effect can occur for reporting of frequency.  
For respondents with infrequent, periodic drinking, there may be a tendency to over-report 
frequency.  Furthermore, because there is more individual variability in frequency than quantity, 
extended QF measures that ask about QF for different beverage types yield more valid estimates of 
average quantity.  These methods minimize bias because the variability is decreased by asking 
separate questions on strata that account for individual variation in frequency, i.e. beverage type, 
location, etc.  Many researchers collapse average quantity and frequency into average volume for 
analysis.  The error in volume is directly related to errors in Q and F.  While errors are compounded 
in the calculation of volume, rank order is maintained assuming that errors in Q and F are 
independent, i.e. that, for example, frequent drinkers do not have more bias in reporting quantity 
than infrequent drinkers.  While some studies have found that frequent drinkers underestimate 
consumption and others that they overestimate consumption,114 there is little convincing empirical 
support for dependent errors.  For this reason, researchers assume that independence is 
achieved.109  Finally, non-response bias in exposure measurement may result in selection bias, for 
example, if heavy drinkers are less likely to respond to alcohol consumption questionnaires than 
other drinkers.  Interestingly, however, there is only mixed evidence in support of this hypothesis, 
with several studies reporting that heavy drinkers were equally likely to participate.109, 112  The 
greater selection bias appears to arise from defining the sampling frame for study.  Many sub-
populations including institutionalized individuals, the homeless, and people without telephones are 
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not included in sampling frames for population-based studies and have a higher prevalence of heavy 
drinking than those living in households. 
The above section summarized the mechanisms that can give rise to error in the estimation 
of alcohol consumption.  Many studies have attempted to measure the magnitude of these errors 
and validate measurement tools.  Validation of alcohol consumption is challenging given the lack of 
gold standard measurement and researchers have instead relied on relative validity studies that 
compare two or more different tools.109, 112, 120  Relative validity studies have limitations, but are 
thought to be informative because the measurement errors between instruments are often 
independent and high correlations reflect stability of rank order.121  Whether this is the case for 
alcohol is not fully understood.  Validation studies have used a variety of designs to compare reports 
including collateral reports, official records, alcohol purchase and sales data, direct observations, 
self-report records, and biomarkers.  Several of these designs are used in the clinical setting, namely 
collateral reports, official records, direct observation, and biomarkers, but are less useful for large 
epidemiologic settings.  Below we will consider validation studies of alcohol in population-based 
studies, which typically compare self-reports (e.g. food frequency questionnaire [FFQ] and 24-hour 
recalls) and biomarkers. 
Because there is no gold standard for measurement, validation studies tend to follow the 
assumption that greater reported consumption reflects higher instrument validity.  One reason for 
this theory is that self-reports from national surveys vastly under-report consumption compared 
with sales data – to a degree beyond estimates of waste and sampling error.  Another reason is that 
the ‘more is better’ philosophy aligns with the psychological mechanisms purported to underlie 
reporting errors.  Forgetting drinking occasions and underreporting frequency and quantity because 
of social desirability would both lead to lower reported intake.  However, there are situations that 
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can lead to over-reporting that should be considered when comparing instruments.  These include 
double counting consumption in GF methods and potential overlap in extended QF measures.109, 120 
A review of 33 relative validity studies, primarily from the U.S. and Europe, found that 
beverage-specific QF yielded 19% higher intake than other methods.  After accounting for inclusion 
of beverage-specific questions, the type of measurement tool was associated with reported intake; 
retrospective diaries yielded intakes ~20% lower than QF and prospective diaries. Reference period 
length and mode of administration were not predictors of intake level.   The authors also compared 
mean intakes across measurement tools according to reported intake.  There was some evidence for 
non-proportional underreporting.  Differences across measures were larger among individuals 
reporting high intake (10 drinks per week) compared with individuals reporting low intake (4 drinks 
per week).  Finally, the authors assessed ranking of individual intake across the 33 studies using 
relative validity and test-retest correlations (Table 4).  Overall, the repeatability and relative validity 
were good, particularly for QF methods.  Test-retest correlations for volume of alcohol intake using 
the extended QF method was 0.88 (range across studies from 0.83-0.98) and correlations between 
extended QF methods and diaries were 0.66 and 0.73 (range of 0.57-0.89 across studies).122  These 
high correlations suggest that ranking of individuals is relatively accurate, although the possibility 
that there is similar under-reporting in both instruments cannot be ruled out.  True validity cannot 
be assessed in the absence of gold standard measurements. 
Table 4. Ranking of individuals according to alcohol intake: weighted averages of correlations (range across 
studies)122 
Method QF Extended QF 
Retrospective 
Diary Prospective Diary 
QF 0.88 (0.75-0.99)    
Extended QF 0.63 (0.59-0.90) 0.88 (0.83-0.98)   
Retrospective Diary 0.67 (0.66-0.74) 0.66 (0.66) -  
Prospective Diary 0.71 (0.61-0.90) 0.73 (0.57-0.89) 0.65 (0.51-0.65) 0.84 (0.84) 
24-hour Recalls 0.68 (0.32-0.90) - - - 
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A validation study was conducted in the Nurses’ Health and Health Professional Follow-up 
Studies that reported high correlation coefficients between 2 FFQs and multiple 1-week diet records 
for total alcohol; correlations ranged from 0.86-0.90 for women and 0.83-0.86 for men.123  The 
correlation between 2 FFQs administered 1 year apart was 0.90 for women and 0.92 for men 
suggesting stability in reported consumption over a 1-year period.  Correlations were not different 
for specific beverage types.  Classification of individuals was also very similar between methods, 
with over 90% of individuals classified by FFQ within 1 quintile of their classification using diet 
records.  Finally, the authors compared self-reported alcohol intake with serum HDL cholesterol 
levels.  The relationships were roughly linear and consistent with controlled alcohol feeding studies, 
providing construct validity.  Correlations ranged from 0.33-0.40 and were similar between diet 
records and FFQs.  The primary source of potential correlated error between diet records and FFQ is 
intentional under-reporting of intake due to social desirability.  This is most likely to affect heavy 
drinkers, as moderate drinking is not socially undesirable in U.S. culture.  It is hypothesized, 
however, that heavy drinkers who are willing to participate in studies are also unlikely to conceal 
drinking.  Differences in reported intake between frequency questionnaire and interview were 
unrelated to mean intake for beer, wine, and spirits in men and women in the Danish MONICA 
study.124  In contrast, a study of 58 men in Finland found that, on a single drinking occasion, heavy 
drinkers (12-16 drinks) under-reported drinking compared with observation by an average 1.65 
drinks (20%) compared with light drinkers (7-11 drinks) who under-reported drinking by 0.35 drinks 
(14%).125 
  More recent studies have found similar results to those described above.  Women in 
Norway enrolled in the Norwegian Women and Cancer Study completed 2 FFQs 3 months apart.  
Test-retest correlation for alcoholic beverages was 0.76 and average within person difference was -
9.1 (-11.5, -6.7) grams per day.126  Regression calibration corrected results were away from the null 
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relative to naïve estimates.  This suggested that, in their study, random error in measurement of 
alcohol biased results toward the null.  An analysis of FFQ versus 12 days of weighed food records 
completed by Australian adults reported a Spearman correlation of 0.85 for alcohol intake.  
Differences in the two measurement instruments were not related to participant characteristics of 
age, sex, BMI, or occupation nor according to the level of alcohol intake (i.e. errors were relatively 
proportional across alcohol intake).127  A study of male and female German adults participating in 
the European Prospective Investigation into Cancer and Nutrition Study compared relative validity of 
3 24-hour recalls with a FFQ.128  The mean difference was 0.9 grams, with the FFQ being slightly 
lower.  Correlations were highest of any nutrient, 0.86-0.88, and classification of individuals within 1 
quintile of each other occurred in 87% of participants.  Finally, while population-based studies have 
not used biomarkers to validate alcohol intake, results from clinical populations suggest that self-
reports and biomarkers have modest agreement, but the generalizability of these results to non-
clinical populations is unknown.120 
 
C. Challenges in the Operational Definition of Alcohol Exposure 
Epidemiologic studies vary in how alcohol intake is represented in analysis and their ability 
to differentiate effects of the components of intake.  Alcohol consumption may be operationalized 
in terms of average frequency, average quantity, average volume (‘drinks’ or grams of ethanol per 
unit time), drinking patterns (e.g. number of binge drinking episodes), or combinations of these 
components.  By far the most common analytic approach is to calculate average volume and 
estimate effects across categories.  Operationally defining alcohol consumption in terms of volume 
confounds effects of frequency and quantity.129  This results in loss of information on drinking 
pattern.  Some researchers choose to separately estimate effects of frequency and quantity or to 
estimate effects of drinking patterns on disease risk.  In addition to choosing how to specify alcohol 
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consumption, researchers must also consider ethanol content, definition of cut-points for 
categorical analysis, and selection of reference group. 
 Error may be introduced in the calculation of average quantity or volume resulting from the 
variation in ethanol content according to beverage type, brand/manufacturer, glass size and shape, 
and percent alcohol.77  Questionnaires ask about the number of drinks consumed and usually supply 
guidelines for the size of a typical drink (e.g. a 5-ounce glass of wine).  However, respondents are 
likely to report in terms of the drink size they usually consume even if a quantity for typical drinks is 
provided as a reference.110  Because drink size is the largest source of variation in ethanol content, 
some studies have provided individuals with pictures, observed pouring, and mailed standard size 
glasses with marks to more accurately measure quantity.  These methods are less feasible for large 
population-based studies.  When average volume is expressed as grams per unit time, there is an 
advantage of increased comparability across studies, particularly with international populations in 
which a ‘drink’ may be defined differently that in the U.S.  Content of a ‘standard’ drink ranges from 
8 grams in the United Kingdom to almost 20 grams in Japan (Figure 7A).3  The standard drink 
measure used in the U.S. contains approximately 14 grams of ethanol and corresponds to 12 ounces 
of beer, 5 ounces of wine, and 1.5 ounces of distilled spirits or liquor (Figure 7B).130 
  
Figure 7. Standard drink sizes in international populations3 (A) and in the United States (B)5 
  
A. Ethanol content of standard drinks by country            B. Ethanol content of US standard drinks by type 
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Selection of cut-points used for categorical analysis also varies greatly across studies, 
limiting their comparability.  Current studies typically include categories for never drinkers, former 
drinkers, and current drinkers divided according to volume, e.g. <1/week, 1-7/week, etc.93  There is 
some evidence that effects of drinking may differ by age, sex, or other individual-level factors.  
Categories need to be narrow enough to capture this potential modification so that definitions of 
‘moderate drinking’ are sensitive to heterogeneity.  Furthermore, care must also be used when 
estimating thresholds because the assessment of absolute intake is sensitive to measurement error.  
For example, if heavy drinkers underreport drinking, then the threshold of harm will be artificially 
elevated.93 
 Choice of reference group is also important for analysis.  Many studies, particularly older 
ones, combined former, never, and occasional drinkers into the ‘nondrinker’ category and used this 
for reference group.131, 132  Several authors have postulated that this categorization, known as 
‘abstainer error’ or ‘health selection’, has biased effects of moderate drinking away from the null.  
Because sickness and old age are associated with reductions in drinking as well as with poor health, 
inclusion of these ‘sick quitters’ in the abstainer category would increase the risk in this group and 
therefore bias estimates of moderate vs. no drinking toward a protective effect.  Inclusion of 
occasional drinkers in the abstainer category can also lead to error.129, 132 For this reason, the use of 
a ‘former drinker’ and ‘never drinker’ category is preferred to a ‘nondrinker’ and ‘occasional drinker’ 
category.  Researchers may also exclude early outcome events from analysis in case these were the 
result of pre-existing illness that had altered alcohol consumption.  Finally, in their operational 
definitions of alcohol, researchers may choose to stratify by beverage type and consider the time-
varying nature of alcohol consumption. 
 The measurement tool used by ARIC was similar to those used by many other population-
based studies.  The primary disadvantage is the absence of a second measurement tool such as 24-
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hour recalls.  There are several advantages, however.  Questions were included on drinking history 
that allow for differentiate of never and former drinkers.  Response categories were narrow, 
reducing reporting errors, enabling categorization of participants into groups with homogenous 
disease risk, as well as generating categories similar to other research in order to compare study 
results.  Importantly, ARIC included questions on both frequency and volume (allowing for 
calculation of quantity) for later study visits which may be useful in sensitivity analysis.  
 
3.5 Outcome Measurement 
A. Ascertainment and Definition of Stroke Events 
 Validity of stroke outcome measurement depends on the completeness of case 
ascertainment, the accuracy of diagnosis, and correct differentiation between stroke types (i.e. 
ischemic vs. hemorrhagic).  Ascertainment of stroke events can be accomplished using a variety of 
methods.  Recommendations for stroke incidence studies were published by Malmgren133 and later 
refined by Sudlow and Warlow to incorporate more widely available imaging technologies.134  
Recommended methods include self-reports; hospital and emergency department admission logs; 
local physicians and outpatient clinic referrals; mortality databases and death certificates; follow-up 
of TIA cases; and brain, carotid, and cerebral vascular imaging logs (Table 5).   
Table 5. Methods of stroke case ascertainment recommended for use in community-based studies134 
• General practitioners or primary healthcare physicians 
• Other primary healthcare workers, e.g., district nurses, community physiotherapists, and 
occupational therapists 
• Emergency services, e.g., ambulance coordination centers 
• Nursing, residential, and rest homes 
• Hospital admission lists, including patients presenting to casualty/emergency departments using a 
broad range of diagnostic labels 
• Hospital discharge lists 
• Computer-linked records systems 
• Regular ward checks for cases occurring in patients already in the hospital 
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• Referrals to radiology departments for CT or MRI scans, carotid duplex studies, and cerebral 
angiography 
• Death certificates 
• Newspapers, e.g., news, obituaries, death announcements 
 
Ascertainment is broadly classified as being passive (cold pursuit) or active (hot pursuit).134, 
135  In passive surveillance, cases are identified by searching hospital discharge lists or mortality 
databases for stroke-related discharge codes (often ICD-9 430-438 with some exclusions based on 
poor validity of individual codes).  These are cost-effective and resource-conservative methods, but 
only capture hospitalized cases (which may be more severe) and rely on the accuracy of discharge 
diagnosis codes.  Some studies adjudicate diagnosis with medical record review; this improves 
validity but does depend on record completeness and accuracy.  In active surveillance, cases are 
identified by screening a variety of sources such as ED logs, out-of-hospital facilities, medical wards, 
and imaging centers.  The advantage of this method is that non-hospitalized community cases are 
captured, but this method is time consuming and resource intensive.  A relatively broad set of key 
diagnostic terms such as “dizziness”, “visual disturbance”, vertigo”, “cerebrovascular accident”, and 
“stroke” are used for screening.135  Accuracy of active methods depends on several factors including 
the breadth of screening terms, the position and sets of ICD-9 codes used for identification, and 
completeness and accuracy of medical records.  Much of the difference in case finding between 
active and passive surveillance is likely attributable to minor strokes that may not present to the 
hospital, may not be hospitalized, or may be incorrectly diagnosed as TIA.  Routine clinical coding is 
known to underestimate the incidence of minor stroke because of misclassification as TIA.136 
 Several studies have compared ascertainment methods.  Whether findings on the relative 
strengths of case ascertainment methods are generalizable across populations is unknown, given 
that populations differ with regard to healthcare systems, individual healthcare-seeking behavior, 
and access to care.  For example, the proportion of stroke patients admitted to the hospital varies 
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widely across populations - from 40% in the Oxford Vascular Study to 95% in a Swedish cohort.  
Hospitalization rates also vary within the United States.  Out-of-hospital stroke cases (fatal and 
nonfatal) comprised roughly 17% of all cases among Whites and 8% among Blacks in the Greater 
Cincinnati/Northern Kentucky Stroke Study (GCNKSS) from 1993-2005 and 14% of strokes in the 
Rochester Stroke Registry from 1970-1989.137, 138  Below are described the findings from 3 different 
population-based studies that compared ascertainment of stroke events with different methods.  
They support the general conclusion of previous researchers that advocate for the use of multiple, 
overlapping methods. 
 The Oxford Vascular Study authors defined a ‘core’ group of ascertainment methods that 
included physician referral, hospital admission, ED, and discharge lists, case notes of in-hospital 
deaths and acute medical wards, contact and case review of patients attending local clinics, and the 
national death register. 134, 139  ‘Supplemental’ methods were follow-up of TIA patients and review of 
referrals for brain carotid, or cerebral vascular imaging.  ‘Additional’ methods included follow-up of 
patients with any stroke-related discharge code in electronic medical records and follow-up of high-
risk patients (i.e. those hospitalized for cardiovascular disease in the past 6 months).  ‘Supplemental’ 
methods identified 15% more cases than core methods alone.  Most of these cases were initially 
identified as TIA by core methods, but were determined to be minor strokes.  ‘Additional’ methods 
of ascertainment identified only 2 additional cases, suggesting they have minimal benefit. 
The Brain Attack Surveillance in Corpus Christi (BASIC) project is a population-based stroke 
surveillance study in the U.S. that also used a combination of active and passive ascertainment 
methods.  Through active surveillance, researchers identified strokes that were admitted to the 
hospital (82% of all validated cases), presented to the ED without hospital admission (16%), and 
other out-of-hospital cases (2%; Figure 8).135  Roughly half of the ED and out-of-hospital cases 
identified only by active surveillance were TIAs.  Passive surveillance alone identified 7% of cases 
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and failed to identify 11% of 
hospitalized cases, half of 
which were ischemic 
strokes.  Overall, passive 
surveillance failed to 
capture 26% of cases, 46% 
of which were TIAs.  If only 
active surveillance had been 
used, 7% of cases would have been missed.  This study indicates that active surveillance was 
superior to passive surveillance alone for case ascertainment, but that an ideal study would use 
overlapping methods to capture stroke cases in the community as neither method by itself captured 
100% of cases.    
In the Cardiovascular Health Study (CHS), 3.5% of strokes and 0% of TIAs were ascertained 
using Medicare hospitalization data only, i.e. cases were not additionally identified through CHS 
assessment that included telephone calls, clinic visit interviews, and self-reports.  In contrast, 15.5% 
of strokes and 30% of TIAs were identified by CHS ascertainment but not hospitalization data.140  
These study results support the need for supplementation of hospitalization records with other case 
ascertainment methods to identify non-hospitalized events and suggests that self-reports without 
passive surveillance of hospital logs does not capture a high proportion of cases. 
 In addition to missing cases, hospitalization and death certificates are subject false positives.  
The accuracy of death certificate cause of death (COD) was assessed in the Minnesota Heart Study 
compared with adjudicated cause of death from medical record review of in-hospital deaths.  The 
positive predictive value (PPV), sensitivity (Se), and specificity (Sp) for ICH were 82%, 76%, and 95% 
and for non-hemorrhagic stroke were 97%, 58%, and 98%.141 Analyses from the Framingham Study 
  Figure 8. Sources of case identification in the BASIC project 
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were similar, with 78% sensitivity and 94% specificity for total stroke.142  A study in Finland assessed 
the accuracy of ICD-9 codes listed in mortality records with physician review based on clinical signs 
and symptoms, neuroradiological findings, surgery, and autopsy.  The proportions of correct 
diagnoses were 95% for SAH, 91% for ICH, 92% for IS.  These values suggest reasonably high 
accuracy of codes; however, the generalizability of these findings is unknown particularly as the 
autopsy rate was high (39%).143  Cardiovascular Health Study researchers compared death certificate 
cause of death with adjudicated cause of death and only 42% of true stroke deaths had a stroke-
related COD and 62% of death certificates that listed stroke as the COD were adjudicated as stroke 
by the events committee.140  In summary, death certificates have modest validity and it may be 
lower in the US than in Europe.  Reliance only on death certificates will likely result in significant 
measurement error from missed cases and inclusion of non-strokes.  Ideally, studies that include 
death certificates in case finding would include a validation step to remove false positives. 
 Accuracy of discharge codes is similar to death coding and varies widely depending on code 
groups used.  The sensitivity of codes for stroke ranged from 72%-90% across several studies in the 
U.S. and Canada and PPV ranged from 47%-82%.135 137 138 140 143, 144 The percentage of total correct 
code-based diagnoses have been reported as up to 90% in Canada and ~80% for SAH/ICH. 143 144   
Taken together, there is clear need for adjudication of cases that are identified using ICD codes to 
reduce outcome misclassification.  Accuracy of diagnosis codes varies by their position and the code 
groups used, but is not adequate in any combination for identifying stroke events without bias.   
 Self-reported stroke had moderate positive predictive value in the British Heart Study when 
compared with medical record review (PPV=75%; Se=89%).145  Most false positives were the result 
of TIA diagnosis that the patient reported as stroke, although there were cases of stroke-like 
symptoms being attributed to stroke by the patient.  False positive rates of patient recall compared 
with medical record review from Norway, the Nurses’ Health Study, and studies in the UK range 
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from 34-37% and false negative rates range from 5-66% suggesting that self-reports alone are not an 
adequate measure of stroke events.  
 Stroke diagnosis in epidemiological studies has typically been based on clinical presentation, 
with most studies using the World Health Organization definition of “rapidly developing clinical signs 
of focal (at times global) disturbance of cerebral function, lasting more than 24 hours or leading to 
death with no apparent cause other than that of vascular origin”.146  As discussed above, this 
definition is considered obsolete in favor of revised tissue-based criteria that also excludes global 
ischemia in stroke definition.55  Table 6 shows minimal recommendations for diagnosis of stroke 
types that were common in the era during which most of the observational studies included in this 
proposal were designed and conducted. All depend on the availability of brain imaging for definite 
diagnosis.93, 147   
Table 6. Standard definitions for comparing pathological types of stroke148 
Definite Cerebral Infarction (CI) 
• WHO-defined stroke and 
• CT scan within 30 days of stroke (or MRI scan) shows infarct or no relevant lesion and/or 
• Autopsy shows CI 
Definite Primary Intracerebral Hemorrhage (PICH) 
• WHO-defined stroke and 
• CT (or MRI) scan shows PICH and/or 
• Autopsy shows PICH 
Definite Subarachnoid Hemorrhage (SAH) 
• Appropriate clinical history and 
• CT head scan shows subarachnoid blood and/or 
• Lumbar puncture shows subarachnoid blood and/or 
• Cerebral angiography shows source of subarachnoid bleeding and/or 
• Necropsy shows SAH ± source 
Probable CI 
• WHO-defined stroke and 
• Validated clinical score (Guy’s Hospital Stroke Diagnosis Score or Siriraj Score) gives >90% likelihood 
of infarction 
Probable PICH 
• WHO-defined stroke and 
• Validated clinical score gives >90% likelihood of hemorrhage 
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Undetermined pathological type 
• WHO-defined stroke but not fulfilling above criteria for CI, PICH, or SAH 
 
Researchers have developed a variety of clinical scores to differentiate ischemic and 
hemorrhagic subtypes in the absence of brain imaging.  These utilize patient signs, symptoms, and 
medical history and in general have been found to have moderate accuracy.  A study assessed the 
Guys’ Hospital Stroke score and the Siriraj Hospital Stroke score compared with computed 
tomography (CT) and autopsy diagnosis.  The Guys’ Hospital Stroke (or Allen) Score diagnosis of 
hemorrhage had Se, Sp, and PPV values of 31%, 95%, and 73% and ischemic stroke of 78%, 70%, and 
86%, respectively.147  The Se, So, and PPV of the Siriraj score for hemorrhage were 48%, 85%, and 
59%, and for ischemic stroke were 61%, 74%, and 84%.  Other studies have reported similar poor 
accuracy of clinical scoring systems.149  While these scores may be useful in estimating burden of 
disease provided corrections are made for measurement error, they are inadequate for defining 
stroke types and could result in considerable bias in etiologic studies.   
 Accurate classification of ischemic stroke, ICH, and SAH requires brain imaging results.  Two 
imaging modalities commonly used for diagnosis are CT and magnetic resonance imaging (MRI).  CT 
is more common than MRI diagnosis because it is less expensive, more widely available, and fast.  It 
is the standard for stroke detection and is useful for ruling out hemorrhage; however, it has limited 
sensitivity for detection of early ischemia and can yield inconclusive results.150, 151  The inter-rater 
reliability is higher for MRI compared with CT in some studies, but lower in others.150, 152  The 
sensitivity of MRI compared with final clinical diagnosis for detecting acute ischemic stroke is higher 
than for CT (83% vs. 16%), but the specificities were similar (96% vs. 98%) and the detection of 
hemorrhages was similar.150, 151  A third imaging technique, transcranial color-coded duplex 
sonography, is widely available and is reasonably accurate in differentiating ischemic from 
hemorrhagic stroke when compared with CT (Se=94%; Sp=95%).151  This modality may offer an 
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alternative to CT/MRI when neither is available as it is easy to perform, mobile, and non-invasive.  
Choice of imaging technique used for stroke diagnosis is not likely to result in misclassification when 
final clinical diagnosis also takes into consideration additional diagnostic tests and patient 
symptoms.  Finally, there is some evidence that the physician specialty is important for diagnostic 
accuracy.  Emergency department physicians in the BASIC study missed 11% of stroke cases 
compared with neurologist-validated diagnosis (Se=92%; PPV=89%).153  As described in detail above, 
discharge codes and death certificates have limited ability to accurately identify strokes and to 
correctly distinguish subtype.  For example, ICD-9 diagnosis of stroke type in the BASIC study was 
accurate for only 84.5% of hospitalized cases.154 Ischemic strokes can be further classified according 
to their etiology and a common system was developed by the Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) for this purpose.  Subtypes include large-artery atherosclerosis, cardioembolism, 
small-artery-occlusion, and ‘other’ cause. 
 
B. Summary 
 Epidemiologic studies wishing to study etiology of stroke need to include CT/MRI findings, 
when available, as part of case definition, and should not rely solely on administrative data for 
stroke ascertainment or diagnosis of stroke type.  The ARIC study uses multiple, overlapping 
ascertainment methods and stroke events are validated by algorithm and physician review.  
Information used for validation is abstracted from medical records and includes evidence from brain 
imaging studies.  Classification of events is based on the National Survey of Stroke criteria (Appendix 
1), which were developed several decades ago and are currently dated compared with more recent 
classification systems such as TOAST and the AHA updated definitions.  This is a potential limitation; 
however, the impact of using this outdated scheme is likely not significant because the criteria are 
roughly similar to more recent classification for the broad classification of ischemic stroke vs. 
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hemorrhage. 
 
C. Measurement of Cognitive Function 
 Numerous neuropsychological assessment tools have been developed, standardized, and 
validated to assess cognitive function.  These include both global and domain-specific tests and have 
varying applications to the clinical setting and in large research studies.  Important considerations of 
test selection include the domain(s) of interest, floor and ceiling effects, and validity in the 
population of interest.  Floor and ceiling effects occur when cognitive performance being assessed is 
outside the test range are therefore not measurable.  Epidemiologic studies often utilize global 
cognitive tests as screening tools for dementia as well as domain-specific tests that are sensitive to 
changes at the higher end of cognitive function.  For our study, which aims to estimate cognitive 
declines from mid-life into older age in a population with relatively high cognitive function at 
baseline, the best assessment tools will be reliable and valid tests in a bi-racial population, able to 
detect small changes over a broad range of cognition (i.e. without strong ceiling effects), and 
without strong practice effects because of their repeated administration over follow-up.  In addition, 
practical considerations of administration time and cost are important for a large-scale study.  Below 
are reviewed the most common neuropsychological assessments used in epidemiologic studies on 
cognitive decline, including those that are used by the ARIC study (see Appendix 3). 
 The Mini-Mental State Examination (MMSE)155 was initially designed as a brief 11-item 
screening tool for cognitive loss in elderly patients and is now one of the most widely used screening 
tools for dementia.  The test measures global cognition and captures several domains including 
orientation to space and time, language and comprehension, memory, attention, calculation, and 
praxis.  Scores range from 0 to 30.  Normal declines in MMSE reportedly range from 0.1-0.3 points 
per year for cohorts younger than 85 years of age.60 Reliability of change estimates increases with 
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increasing duration of follow-up and time in between measurements.60  Cut-points used for 
MCI/dementia screening are often 23/24 or 24/25 and may vary by education level to minimize 
misclassification.  Sex-based differences are not seen for the MMSE, but age, race, and education 
seem to affect scores.  Reliability, both test-retest and inter-rater , is high (>0.8) in most reports.156  
Content validity and concurrent validity (comparison with other global tests of cognition) are both 
high, with correlations generally ranging from 0.6-0.8.  Most research in MMSE validity has focused 
on its ability to classify individuals with dementia, for which sensitivities and specificities are >80%.  
Ability to classify patients correctly differs by education and in some studies age and race.  
Advantages of the MMSE are that it can be administered by trained non-specialists, is brief in 
duration, and has relatively high validity for detecting clinical impairments.  Limitations include floor 
and ceiling effects, low sensitivity to mild cognitive deficits when used as a screening tool, and poor 
discrimination among degrees of dementia.156 Of particular concern for population-based studies 
that aim to detect changes across a wide range of cognition, including the higher end, is the strong 
ceiling effect.157  The MMSE is not an ideal tool for our aims. 
 The Telephone Interview for Cognitive Status (TICS-m)158 is a 13-item telephone-
administered test similar to the MMSE with scores ranging from 0 to 51.59  It was later modified to 
include an immediate and delayed recall of a 10-item word list.  Telephone administration of the 
test correlates well with face-to-face administration modes (r=0.85) and has high validity for 
distinguishing dementia.  In addition, research supports the absence of ceiling and learning effects 
for the modified version.159  The TICS-m, in contrast to the MMSE, may also be useful for 
distinguishing MCI.159  The primary advantages of the TICS-m are its administrative ease in large 
population-based studies, lower concern for ceiling effects compared with the MMSE, good 
performance as a screening tool, and enhanced assessment of memory compared with the MMSE.  
Because of these factors it is better able to discriminate individuals with high levels of cognition.  
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Limitations include difficultly administering over the phone to individuals with hearing impairments 
and reliance on one primary domain (memory) to discriminate at higher levels of cognition.  The 
memory component accounts for at least 50% of the variation in scores in a healthy adult 
population and therefore this test may detect declines in different cognitive domains (memory at 
higher end and global aspects at lower end). 
 The Modified Mini-Mental State Test (3MS)160 assesses multiple domains including 
attention, concentration, orientation to time and space, memory, language ability, and abstract 
thinking.  It contains the same items as the MMSE plus 4 additional items and adjusted scoring, 
which ranges from 0 to 100.  Test-retest and inter-rater reliability are very high (>0.9) and the 
validity compared with other tests and as a screening tool for dementia are high.156  Compared with 
the MMSE, the 3MS offers superior validity, covers more cognitive domains (i.e. verbal fluency and 
reasoning/judgment), has reduced floor and ceiling effects, and a larger scoring range.  There is little 
added administration time and some increased complexity of scoring.  Because of these factors the 
3MS may offer a better assessment of cognition than the MMSE in a population of generally healthy 
adults. 
 The Digit Symbol Substitution Test (DSST)161 measures 2 domains of cognition, attention 
and psychomotor speed, and is a component of the revised Wechsler Adult Intelligence Scale.  
Participants are given 90 seconds to fill in numbered blanks with corresponding symbols using a 
numeric key that links numbers 1 to 9 with a symbol.  Scores can range from 0 to 93 and reliability is 
high (0.82-0.88).59  Factors important for performance are motor persistence, attention, response 
speed, and visuomotor coordination.  There is no apparent effect of intellectual ability, learning, or 
memory domains on scores.  The test in insensitive to location of brain injury and thus is a good 
assessment for nonspecific brain dysfunction.  Education accounts for roughly 30% of the variation 
in scores and age an additional 14%, though use of age and education norms are debated.  A major 
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advantage to this test is that it does not display a ceiling effect (likely because of the speed 
component of the test) and the relationship between the test score and its underlying construct is 
linear for moderate to high cognition.  Because of these properties, the DSST is very sensitive to 
changes at high levels of cognition and is one of the first tests to show declines in dementia.  In 
contrast, at the impaired end of the spectrum, this test is nonlinear and is unable to detect changes 
(i.e. has a strong floor effect).157  For clinical use in measuring progression of dementia, this test 
would not be very useful, but for our purposes is a good choice for neuropsychological assessment 
of attention and speed.  Another advantage for use in a study with repeated measures is the 
apparent lack of practice effects.  Limitations of this test include possible bias in test scores for 
elderly individuals with physical impairments that limit speed and floor effects.   
 The Delayed Word Recall Test assesses verbal learning and short-term memory.162  
Respondents are given a 10-word list and after a 5-minute interval are given 60 seconds to recall 
these words.  Scores range from 0 to 10 and the test has demonstrated high test-retest reliability 
(r=0.75) in elderly individuals.162  Age and sex appear to influence responses to word recall tests and 
there is evidence of practice effects up to a year and beyond.  The primary limitation of this test is 
that 10 words is too low a ceiling for many participants of normal cognition.59  Error types in this test 
may help distinguish dementia types, with Alzheimer’s and alcohol-related dementia patients 
making the most false positive recognitions and forgetting the most words, and patients with 
vascular dementia  having fewer false positive recognitions and more repetitions. 
 The Word Fluency Test (WFT) is used as part of the Multilingual Aphasia Examination.59  It 
assesses language skills and short-term memory (to maintain the list of words already generated).  
Participants are asked to record as many words as possible within a 60-second time interval that 
begin with the letters ‘F’.  This is repeated for letters ‘A’ and ‘S’.  Scores are calculated as the total 
number of words recorded for each trial.  Scores are influenced by age, sex, and education and test-
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retest reliability is high (r=0.82).163  Individuals with ability to organize verbal output into meaningful 
clusters, for example words that start with the same phonological cluster such as ‘con’, are more 
successful.  Verbal fluency impairments are seen with frontal lobe damage, particularly the left 
lateral front lobe.  An advantage of this test is its sensitivity to early declines in cognitive functioning 
in older adults and a limitation is that it does not distinguish patients with depression and 
dementia.59 
 Operationally, many researchers will standardize raw test scores into z scores to make them 
comparable across tests or sub-groups.59  The reasoning behind this approach is that the same raw 
score achieved by two individuals may not represent the same level of the underlying construct 
because of group-level differences in test performance (or norms).  The z-score represents the raw 
score’s placement on a standard normal curve with a mean of zero and a standard deviation of 1.  
There is debate in the literature as to what the standard population should be, but many 
researchers use some stratification of age, sex, race, or education.  Education appears to influence 
performance on all tests while demonstration of race differences are mixed.59  Use of standard 
scores is debated because when population means differ, for example by race, it is often difficult to 
determine if this is because of cultural preference of the testing instrument or a true difference due 
to differing prevalence of risk factors, underlying disease process, and genetic or biological factors.  
We will not use race-specific standard scores in primary analysis because there is no strong support 
for a racial difference and using different standards would bias estimates toward the null. 
 
D. Summary 
The best assessment of cognitive function is a standardized, reliable, and valid test that is 
tailored to its intended use and population.  For our aim of studying changes over a long period from 
mid-life through older age, it is important to choose a test that is sensitive to early changes in 
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cognitive function and is not subject to strong practice effects.  Tests without ceiling effects such as 
the DSST will be better able to discriminate early changes than tests with skewed distributions such 
as the MMSE.  While there may be some practice effect for the DWRT and WFT, these are not likely 
to be strong in our study, which had visits separated by 3 and 14 years. 
 
3.6 Studies Assessing the Relationship Between Alcohol and Stroke 
A. Overview 
The association between alcohol intake and stroke has been intensely studied for decades.  
Unlike in the area of coronary heart disease where there is a high degree of consistency in findings 
of a cardioprotective effect associated with moderate drinking, research in the area of stroke has 
been inconsistent.  Early studies dating back to the 1980s often produced ‘null’ results and tended 
to have significant limitations.  Many studies combined ischemic and hemorrhagic stroke types as an 
outcome, the etiologies of which differ as does the role of alcohol on disease risk.  Combining a 
putative protective effect on ischemic stroke and harmful effect on hemorrhagic stroke could yield 
an overall lack of association depending on the magnitude of association and the proportion of each 
stroke type.  Later studies that separated out stroke types in analysis tended to find a J-shaped 
relationship with ischemic stroke, but not for hemorrhagic stroke.   
 Stroke ascertainment may be incomplete in studies that relied on self-reports only or on 
administrative data.  Methodological issues of exposure measurement have also plagued some 
cohort studies and could have yielded biased results.  Several of these early studies used crude 
measures of alcohol consumption, sometimes categorizing individuals into broad categories of 
‘drinkers’ and ‘nondrinkers’.  The chosen referent group sometimes was a combination of former 
and current non-drinkers as well as occasional drinkers, groups that are not likely to have 
homogeneous disease risk.  While early studies suggested a particular beneficial effect of red wine 
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on atherothrombotic diseases, the majority of observational studies find reduced risk with all 
alcohol types.  Many authors have concluded that there is currently no strong and convincing 
evidence that beverage type differentially affects risk, 93 while others maintain that there is good 
reason to recommend red wine consumption over other forms of alcohol for prevention of stroke 
and dementia.72 
 In this author’s opinion, while there is reasonable biologic plausibility for independent 
effects of polyphenols above those of ethanol alone, the body of evidence from observational 
studies is not strong enough, nor consistent enough, to recommend red wine consumption in 
particular over other types of alcohol for the reduction of stroke risk.  Additional limitations of prior 
studies include adjustment for possible causal intermediates such as blood pressure, lack of 
adjustment for confounding variables, and inability to account for time-varying exposure or patterns 
of alcohol consumption. 
 Below are summarized the findings from seven representative studies that assessed the 
alcohol-stroke relationship as well as three meta-analyses on the subject.  The studies are arranged 
chronologically and were selected in part because they represent the state of the field at the time of 
their publication and because they have comparably robust methods.  In general, there was an 
improvement in methods over time, with increasing attention paid to separating subtypes of stroke 
in analysis, validating exposure measurement, incorporating more sophistication in analysis (i.e. by 
adjusting for time-varying confounding and estimating effects for cumulative and time-varying 
exposure), increasing control for confounding bias, and assessment of population burden measures 
in addition to relative risk estimation.  Appendix 2 summarizes these and other studies in terms of 
their study population and design, methods of exposure and outcome measurement, and results. 
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B. Description of Seven Key Studies 
Key Study 1 – Physician’s Health Study164 
The Physicians Health Study was a randomized controlled trial of regular aspirin use among 
21,071 male physicians aged 40-84 years at baseline in 1982.164  Alcohol was assessed in terms of 
frequency (number of times per week) by mailed questionnaire at baseline, “How often do you 
usually consume alcoholic beverages?”.  Strokes were ascertained by self-report in annual follow-up 
questionnaires and adjudicated using medical records.  Deaths were ascertained from family reports 
and postal authorities and stroke was assigned as the cause of death based on information from 
medical records, death certificates, and eye witness accounts.   Cox proportional hazards models 
adjusted for age, systolic blood pressure, smoking, BMI, exercise, history or diabetes, current 
treatment for hypertension, and randomization group. 
 Over an average 12.2 years of follow-up there were 679 strokes, 557 ischemic, 88 
hemorrhagic and 34 unknown type.  Much of the analysis focused on total stroke and the authors 
report a reduced risk of all drinking frequencies compared with less than once per week.  Stroke 
type specific analyses show similar results.  The protective effect is relatively similar across drinking 
frequencies for ischemic and hemorrhagic stroke (Table 7). 
Table 7. Relative risk of subtypes of stroke according to alcohol consumption164 
  Ischemic Stroke Hemorrhagic Stroke 
Alcohol 
Consumption Cases RR (95% CI) 
p-
value Cases RR (95% CI) p-value 
<1 drink/wk 168 1.00 0.10† 26 1.00 0.67† 
1 drink/wk 54 0.73 (0.52-1.00) 13 1.17 (0.58-2.40) 
 2-4 drinks/wk 91 0.74 (0.56-0.98) 14 0.70 (0.33-1.46) 
 5-6 drinks/wk 68 0.81 (0.59-1.12) 11 1.00 (0.46-2.23) 
 1+ drinks/d 176 0.79 (0.62-1.00) 24 0.90 (0.48-1.69)   
* Values are adjusted for age (in years), randomized treatment assignment (aspirin, yes or no; beta 
carotene, yes or no), systolic blood pressure (continuous variable), current treatment for hypertension, 
smoking (four categories), history of diabetes (yes or no), body-mass index (in quartiles), drink per week 
served as the reference category. 
 † P-values are for linear trend across all categories of alcohol consumption. 
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A limitation of this study was the author’s interpretation of their results given how alcohol 
was measured.  The questionnaire assessed drinking frequency not quantity, but the authors 
interpreted these questions as reflecting average volume.  As in other studies that rely on self-
reported stroke, there is the potential for missed events.  However, this bias is likely minimal given 
that the population consists entirely of physicians.  Estimates were adjusted for the potential causal 
intermediate of blood pressure and dose-response was only assessed in category-by-category 
comparisons instead of in analysis that estimates the dose-response relationship.  Category-by-
category comparisons are sensitive to the choice of referent category and not ideal for estimation of 
dose-response.  The referent category used in this study could contain a mixture of occasional, 
never, and former drinkers, the risks of which could differ.  Exposure was measured only at baseline 
and potential confounders such as social support and exercise were not included.  Finally, these 
results reflect a population of high-SES, male, nearly all-White physicians and included only a small 
number of hemorrhagic stroke events.  Overall, this study design and methodology were not strong 
and several sources of bias exist.  Effect estimates are likely biased, but the direction is unknown.  
 
Key Study 2 – Northern Manhattan Stroke Study39 
The Northern Manhattan Stroke Study (NOMASS) is a multiethnic population-based study 
among residents of northern Manhattan New York aged 40 years and older.  A case-control study 
was conducted in this population the data of which were used to examine the alcohol-stroke 
relationship.39  Stroke cases were identified from community surveillance in 1993-1997 from local 
hospital admission, discharge and neuroimaging logs; contact with local physicians; self-referral; and 
random-digit dialing.  Strokes were adjudicated and subtyped using data from medical records; 
nearly all records (99%) included CT or MRI imaging.  Controls were selected by random digit dialing 
of households in the study areas and were eligible if they had never had a stroke and were over age 
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40 years; the participation rate was 70%.  Cases and controls were interviewed in person and 
underwent physical and neurological exams.  Alcohol consumption was measured using a beverage-
specific FFQ.  Binge drinking and alcoholism (CAGE questionnaire) were also assessed.  Alcohol was 
operationally defined as categories of average drinks per unit time: no drinks in the past year, 
moderate: >0-2 drinks/day, intermediate: >2-4 drinks/day, heavy: 5+ drinks/day.  Covariates 
included hypertension, cardiac disease, current smoking, education and BMI.  There were 677 cases 
of ischemic stroke included in analysis.  Moderate and intermediate alcohol consumption were 
associated with reduced odds of stroke (Table 8). 
 
There were no significant interactions with sex, age, or race and results were similar by 
beverage type.  Effects appeared stronger in women 
compared with men, but the confidence intervals were 
wide and overlapped considerably.  Heavy intake of ≥5 
drinks per day was associated with increased risk of 
stroke among all subgroups.  In continuous analysis, the 
lowest odds of stroke was observed at roughly 2-3 
drinks per day, with increased odds beginning after 5 
drinks per day (Figure 9). 
Table 8. Adjusted odds for ischemic stroke stratified by sex, age, and race/ethnicity. 
 
Figure 9. Dose response relationship 
between alcohol and ischemic stroke 
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There were several strengths of this study.  First, the authors assessed the reliability of 
alcohol measurement with test-retest methods and construct validity by comparing FFQ responses 
to the CAGE questionnaire.  Other unique strengths include inclusion of minority populations (Blacks 
and Hispanics) and assessment of heavy drinking episodes (in sensitivity analysis former binge 
drinkers did not have an increased risk of stroke).  Finally, the authors assessed potential bias that 
may have resulted from differential selection of control with respect to alcohol consumption.  Bias-
corrected estimates were similar for moderate and heavy drinking and slightly attenuated for 
intermediate drinking.  Limitations include no adjustment for some potential confounders (diet, 
exercise, social support), adjustment for a potential causal intermediate (hypertension), and small 
numbers for subgroup analyses.  Recall bias is possible among cases as is recall error due to stroke-
related cognitive impairment.  The temporality of alcohol exposure (i.e. the year prior to stroke) may 
not represent the period of effect.  Finally, while the authors did attempt to address control 
selection bias, there remains potential for error, particularly if those heavy drinkers that participated 
are different from those that did not (i.e. were not adequate stand-ins for non-responding heavy 
drinkers).  This study provides somewhat strong evidence for a relationship and is one of the most 
methodologically sophisticated studies of the alcohol-stroke relationship, limited primarily by its 
exposure measurement and selection bias as a consequence of the case-control design.  White there 
were unaddressed methodological issues that may have biased the results, the authors performed 
several sensitivity analyses and were able to address many limitations of previous studies. 
 
Key Study 3 – Framingham Study165 
 The Framingham study is a population-based cohort commenced in 1948.  This analysis used 
data from the 5,209 participants in the original cohort who were re-examined biennially.165  The 
average weekly number of drinks was collected at exams 2, 7, 9, 12, 15, and 17 and a standard drink 
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was defined as 360 mL of beer, 120 mL of wine or 37.5 mL of spirits.  Exam 2 data were used to 
identify former drinkers (nondrinker at exam 7 and a drinker at exam 2) and therefore follow-up 
began at exam 7.  In order to account for changes in alcohol consumption over time, the authors 
divided the risk period into 3, 10-year periods in which alcohol was measured at each baseline 
(examinations 7, 12, and 17).  Alcohol consumption was categorized as never, 0.1-11, 12-23, ≥24 
g/d, and former drinking of 0.1-11 and ≥12 g/d.  Stroke events were detected at study examinations, 
by daily surveillance of admissions to local hospitals, and outside hospital records.  Adjudication of 
strokes used information from medical records, radiographic images, medical history, and physical 
examination findings.  Because of the small numbers of hemorrhagic events, this analysis includes 
only ischemic strokes.  Cox proportional hazards models were run on the pooled 10-year risk sets 
and adjusted for age, diabetes mellitus, and smoking. 
Over the 30-year follow-up period, there were 441 ischemic strokes.  There was a small 
decreased risk of ischemic stroke for all current drinking categories relative to never drinking (Table 
9).  Results were largely similar for men and women.   
 
Table 9. Risk and hazard ratio of IS according to total ethanol intake among 
participants of the Framingham Study 
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When authors stratified by age group (50-59, 60-69, and ≥70 y), there was a protective 
effect of current drinking at any level only among 60-69 year-olds.  There is no convincing biological 
explanation for these age-specific results, but they could be due to chance or to different drinking 
patterns by age.  Finally, no large differences in effect were seen by beverage type in analyses that 
compared current drinking with nondrinkers of each type.  Relative risks were 0.8 (95% CI 0.6-1.0) 
for wine, 1.0 (0.8-1.4) for beer, and 0.9 (0.7-1.2) for spirits. 
Ascertainment of strokes in this study was robust and the authors incorporated multiple 
exposure measurements into their analysis which are strengths relative to many other studies.  
Limitations include inability to assess drinking patterns, limited control of confounding, and a 
homogenous study population of primarily White individuals from a single geographic area.  The 
effect estimates are likely biased from residual confounding and are imprecise due to low event 
numbers, limiting the strength of this study in assessing the relationship between alcohol and 
stroke. 
 
Key Study 4 – Cardiovascular Health Study166 
 The Cardiovascular Health Study is a prospective study of 5,888 men and women aged 65 
years and over from 4 U.S. communities starting in 1989.  For the analysis of alcohol and stroke, 
1,437 (24%) participants were excluded due to missing alcohol or pre-existing cardiovascular disease 
(MI, angina, TIA, stroke).166  Alcohol consumption was measured at baseline and each subsequent 
year through 1999 using a beverage-specific quantity frequency questionnaire.  Participants also 
reported whether they had recently changed drinking habits and whether they regularly consume 5 
or more drinks per day.  Incident ischemic strokes were ascertained by telephone calls and clinic 
visits that occurred every other 6 months over an average 9.2 years of follow-up.  A panel of 
neurologists diagnosed stroke based on hospital medical records, test results, and imaging studies 
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using a definition of either a neurological deficit lasting at least 24 hours or imaging showing 
presence of a lesion. 
 In statistical analyses, alcohol was expressed as categories of drinks per week using long-
term abstainers as the reference group.  Models estimated relative risks of stroke in yearly 
increments using the previous alcohol exposure, thus allowing for changing drinking patterns over 
time.  However, this approach assumes that the latency between consumption and stroke is one 
year in duration, which may not be appropriate.  Models assessed individual effects of beverage 
types, modification by ApoE, and were adjusted for age, sex, race, marital status, smoking, 
depression, aspirin use, and BMI. 
 Light-to-moderate drinking was associated with reduced risk of ischemic stroke; heavy 
drinking was not associated with elevated risk (Table 10).  Results were largely unchanged when 
assessing baseline alcohol consumption compared with updated alcohol exposure or across 
different beverage types.  This suggests that changes in alcohol exposure late in life – after age 65 – 
are not contributing much to event risk and that the more important exposure period is mid-life. 
Table 10. Relative risk of ischemic stroke according to usual alcohol consumption among CHS participants 
  
Weekly Number of Drinks 
None Former <1 1–6 7–13 ≥14 P Value‡ 
Updated alcohol use        
Cases 179 90 68 45 22 30  
Person years 14 311 7950 7155 6030 2515 2795  
Basic model* 1 0.86 0.8 0.66 0.72 0.95 0.17 (0.02) 
95% CI … 0.66–1.11 0.60–1.06 0.47–0.92 0.45–1.13 0.63–1.43  
Full model† 1 0.87 0.85 0.75 0.82 1.03 0.52 (0.06) 
95% CI … 0.67–1.15 0.63–1.13 0.53–1.06 0.51–1.30 0.68–1.57  
Baseline alcohol use        
Cases 202 32 74 58 30 38  
Person years 16 409 3069 8017 7343 2540 3378  
Full model† 1 0.83 0.88 0.75 1.13 1.1 0.90 (0.05) 
95% CI … 0.55–1.25 0.66–1.16 0.55–1.03 0.74–1.72 0.76–1.61   
*The basic model adjusted for age, sex, race, education, marital status, and smoking; 
† The full model adjusted for the covariates in the basic model and exercise intensity, depression score, 
frequent aspirin use, body mass index, and diabetes at baseline. 
‡P values are derived from tests of linear (quadratic) trend. 
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ApoE genotype may be a modifier of the relationship between alcohol and stroke, with 
hazard ratios below the null among ApoE4 negative individuals, but over the null for higher levels of 
drinking among ApoE4 positive individuals (Figure 10).  Results were highly imprecise and not 
greatly different in magnitude except for the high drinking categories.  No significant interactions 
were found for sex, age, aspirin use, baseline hypertension, and atrial fibrillation. 
Selection bias may be a concern in this 
study given the substantial portion of the 
cohort, almost one-quarter, that was excluded 
because of missing exposure or outcome data 
and from selection into the cohort (survival to 
age 65), which is likely related to both alcohol 
consumption and stroke risk.  Another 
limitation was that exposure was assessed later 
in life (age 65 or older) and may not represent the time period during which alcohol impacts risk.  
Finally, the prevalence of heavy drinking (2+ drinks/day) was low at 7%.  In our proposed analysis of 
the ARIC study, missing data is much lower and alcohol is assessed at earlier ages; however, the 
prevalence of heavy drinking is similarly low (7.5%).  Despite these limitations, this study provides 
supportive evidence for beneficial effects of moderate drinking but must be interpreted in light of 
the possibly large selection bias. 
 
Key Study 5 – Health Professionals Follow-Up Study167 
The Health Professionals Follow-up Study (HPFS) is a prospective cohort of 51,529 male 
health professionals aged 40-75 years at baseline in 1986.167  Food frequency questionnaires 
captured beverage-specific alcohol quantity and frequency at baseline and at 3 additional occasions 
Figure 10.Risk of ischemic stroke according to 
baseline alcohol intake and ApoE genotype 
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roughly 4 years apart.  A strength of the study was the assessment of the relative validity of FFQ self-
reported alcohol compared with diet records and HDL-C.  These validation results were discussed 
above in section 3.4.2; briefly, correlations were high for FFQ and diet records (0.79) and were as 
expected for HDL-C (0.31-0.35).   Non-fatal strokes were self-reported during follow-up 
questionnaires and confirmed by physician medical record review.  Fatal strokes were ascertained 
from family reports and the National Death Index and confirmed with medical record review (84%), 
autopsy (2%), or using a combination of death certificate cause of death coding plus medical history 
and family reports (14%).  Statistical analysis included a large number of potential confounders, 
updated as necessary over time, and included alcohol as a time-varying exposure.  Potential causal 
intermediates such as blood pressure and HDL-C were not adjusted for in primary analyses.  
 There were 412 ischemic stroke events over 14 years of follow-up.  Adjusted relative risks 
relative to no drinking were as follows: light drinking corresponding to ~<1 drink/day, RR=0.92, 95% 
CI 0.67-1.28; moderate drinking of roughly 1-2 drinks/day, RR=1.15, 0.82-1.61); heavy drinking ~2+ 
drinks/day, RR=1.22, 0.83-1.79).  There was a slight trend for increased risk in the heavier drinking 
category; this was likely due to the wide range of drinking that comprised the heavy drinking 
category.  There was no strong evidence that moderate drinking was associated with reduced risk of 
ischemic stroke.  A second strength of this study design was the use of multiple measures of alcohol 
exposure.  Interestingly, when results of updated alcohol analysis were compared with baseline only 
alcohol, there was an attenuation of the effect of heavy drinking, possibly because of averaging 
previous heavy drinking with later reductions in intake. 
A third strength of the study methodology was the assessment of drinking pattern, which 
few studies have examined.  Regular, moderate drinking defined as consumption of 1-2 drinks per 
day on 3-4 days per week was associated with a reduced risk of ischemic stroke (RR=0.68, 0.44-1.05) 
whereas drinking the same frequency, but more than 2 drinks per day was associated with an 
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increased risk (RR=1.47, 0.94-2.32; Table 11). 
Table 11. Risk for ischemic stroke according to baseline frequency and quantity of alcohol consumption among 
38,156 male health professionals.167 
  Drinking Days per Week 
 
0 1-2 3-4 ≥5 
Cases, n 93 101 57 161 
Person years 123710 153326 83303 145564 
Relative risk 
(95% CI) 
1.00 0.87 (0.66–1.15)  0.87 (0.62–1.21)  1.14 (0.88–1.47) 
Multivariate-
adjusted RR 
(95% CI) 
1.00 0.93 (0.70–1.24)  0.94 (0.66–1.32)  1.20 (0.91–1.58) 
  Average Alcohol Use per Drinking Day 
 
0 < 30 g/d ≥30 g/d < 30 g/d ≥30 g/d < 30 g/d ≥30 g/d 
Cases, n 93 67 34 30 27 80 81 
Relative risk 
(95% CI) 
  0.89 
(0.65–1.22) 
 0.82 
(0.55–1.21) 
 0.63 
(0.42–0.96) 
 1.40 
(0.91–2.16) 
 1.05 
(0.77–1.42) 
 1.18 
(0.87–1.60) 
Multivariate-
adjusted RR 
(95% CI) 
  0.95 
(0.69–1.30) 
 0.89 
(0.60–1.33) 
 0.72 
(0.48–1.10) 
 1.47 
(0.94–2.32) 
 1.17 
(0.86–1.61) 
 1.25 
(0.90–1.74) 
* Relative risks are adjusted for age and smoking. Multivariate-adjusted relative risks are adjusted for age; 
smoking; body mass index; geographic region; parental history of myocardial infarction; physical activity; 
hypercholesterolemia; aspirin use; diabetes; and intake of vitamin E, folate, energy, saturated fat, trans fats, 
potassium, magnesium, omega-3 fatty acids, and dietary fiber. 
 
The authors reported a somewhat stronger protective effect for red wine than for other 
beverage types.  However, this analysis compared only 3 levels of drinking: none, <1 drink/day, and 
1+ drinks per day.  The apparent stronger effect of wine over other beverage types could reflect that 
the 1+ drinking category for wine contained fewer heavy drinkers than for other beverage types 
(because wine drinkers tend to be more moderate drinkers).  Use of an open-ended category that 
could include both moderate and heavier drinkers severely limits the strength of these findings 
regarding beverage types. 
Additional limitations of the study design and analysis include potential missed stroke cases 
that were not self-reported or correctly identified as the underlying cause of death on death 
certificates.  While many potential confounders were available to the researchers, there was no 
adjustment for social support, which is associated with moderate alcohol consumption and 
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decreased stroke risk.  Finally, there was no analysis of hemorrhagic strokes, low power for 
subgroup analysis, only a minority of men were heavy drinkers (3.5% of men consumed >50 g/day), 
and the results reflect a primarily white, high-SES population.  Despite these limitations, this study is 
one of the strongest published with careful attention to operational definition of the exposure and 
analytic methods. 
 
Key Study 6 – Nurses’ Health Study & Health Professional Follow-Up168 
The Nurses’ Health Study (NHS) was established in 1976 as a prospective cohort of primarily 
White women.  Diet and alcohol intake were assessed at baseline and every 4 years thereafter 
through 2002.  This analysis was a pooled study using both the Nurses’ Health Study and the Health 
Professional Follow-Up Study, described above in 3.6.5.168  Ascertainment of stroke in the NHS was 
similar to the HPFS.  Non-fatal events were ascertained from self-reports during follow-up and 
confirmed with medical record review.  Fatal cases were ascertained from next of kin, postal 
authorities, and the National Death Index and confirmed using medical records, autopsy reports, 
and death certificates with stroke listed as the underlying cause of death.  The aim of this study was 
to estimate effects of a low-risk lifestyle on incident stroke.  ‘Low-risk’ for alcohol intake was defined 
as consumption of 5-15 g/d of alcohol for women and 5-30 g/d for men.  Additional stroke risk 
factors included in analysis were smoking, exercise, healthy diet score, and BMI.  Analyses were 
adjusted for parental history of MI, regular aspirin use, vitamin E supplementation, and hormone 
replacement therapy 
 Over follow-up there were 1,559 cases of stroke among women (853 IS, 278 HS, 428 
unknown) and 994 among men (600 IS, 161 HS, 233 unknown).  There was a protective effect of 
light and moderate amounts of drinking for both ischemic and hemorrhagic stroke (Table 12).  
Consumption over 30 grams per day (roughly 2 drinks) was associated with an increased risk of both 
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stroke types, except hemorrhagic events in men.  These estimates must be interpreted with caution, 
however, as they are unadjusted for smoking, a strong confounder.  Authors did conduct additional 
analyses for alcohol that were adjusted for smoking, BMI, diet, and daily exercise, but they report 
only relative effects of moderate drinking compared with other alcohol consumption levels.  Slight 
reductions in the risk of ischemic stroke were found (RR=0.91, 95% CI 0.76-1.09 for women; 
RR=0.92, 0.77-1.09 for men).  While analyses for the association of alcohol and stroke in this study 
were not as robust as other studies, the novel aspect of this study was the estimation of the 
population attributable fraction for low-risk lifestyle factors.  More than half of ischemic strokes 
(54% in women and 52% in men) and a large portion of total strokes (47% in women and 35% in 
men) would have been prevented had all individuals in the population been shifted to the low-risk 
group that included not smoking, optimal BMI, daily exercise of at least 30 minutes per day, optimal 
diet score, and moderate alcohol intake. 
 
Table 12. RR (95% CIs)* of Stroke by Categories of Alcohol Consumption (g/d) in Women and Men168 
  Percent 
Ischemic Stroke Hemorrhagic Stroke Total Stroke 
Cases RR (95% CI) Cases RR (95% CI) Cases RR (95% CI) 
Women        
0 39 398 1.0 (Ref) 125 1.0 (Ref) 745 1.0 (Ref) 
0.1–4.9 32 208 0.77 (0.65–0.92) 76 0.83 (0.62–1.10) 390 0.78 (0.68–0.88) 
5–14.9 19 142 0.82 (0.68–1.00) 45 0.76 (0.54–1.06) 247 0.77 (0.66–0.89) 
15–29.9 6 49 0.86 (0.64–1.16) 13 0.69 (0.39–1.23) 82 0.79 (0.63–0.99) 
≥30 4 56 1.41 (1.07–1.88) 19 1.40 (0.86–2.28) 95 1.30 (1.04–1.61) 
Men 
       0 14 160 1.0 (Ref) 49 1.0 (Ref) 281 1.0 (Ref) 
0.1–4.9 27 137 0.84 (0.67–1.06) 30 0.65 (0.41–1.03) 222 0.81 (0.68–0.97) 
5–14.9 27 144 0.93 (0.74–1.17) 39 0.85 (0.55–1.30) 231 0.86 (0.72–1.03) 
15–29.9 12 57 0.81 (0.60–1.10) 24 1.29 (0.78–2.13) 109 0.91 (0.73-1.15) 
≥30 10 102 1.39 (1.08–1.79) 19 0.99 (0.58–1.71) 151 1.21 (0.99–1.49) 
*RRs were estimated from Cox proportional-hazards models adjusted for age, calendar year, parental history 
of myocardial infarction at <60 years of age, regular aspirin use, and vitamin E supplementation, plus use of 
hormone therapy in women. 
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Possible sources of bias in exposure and outcome measurement are similar to those 
described for the HPFS above.  Importantly, it appears that the risk estimates for alcohol 
consumption were unadjusted for other risk factors, i.e. smoking, physical activity, and diet, except 
in simple binary analysis of moderate intake vs. other intake.  Finally, the population attributable 
fraction method used by the authors estimated a reduction in the event rate of strokes assuming a 
100% shift in the population risk factor level to low-risk.  Given that only 2% of women and 4% of 
men were classified as low-risk, this seems like an infeasible intervention.  In the study population of 
NHS and HPFS, 19% of women and 38% of men were classified as moderate alcohol consumers, and 
therefore ‘low-risk’.  Furthermore, the intervention being considered was a shift in a combination of 
5 risk factors and did not estimate effects of changing only alcohol consumption.  For alcohol, 
assuming a 100% shift to moderate intake is improbable given that there are segments of the 
population that abstain for health-related or religious reasons or because of concerns of alcohol 
dependency.  This study is not particularly useful in providing an unbiased estimate given the 
confounding bias, but is one of the few large cohort studies to publish recent analyses of 
attributable burden.  The assumption of a complete elimination of harmful drinking is a major 
limitation to this methodology, however.  Aim 2 of this proposal will extend these findings by using 
an approach to estimate effects of more moderate, achievable shifts in exposure. 
 
Key Study 7 – Nurses’ Health Study169 
 A recent publication on the association between alcohol and stroke is a re-analysis of the 
Nurses’ Health Study.169  The study population and methods of alcohol and stroke measurement 
were described above.  This analysis improved on many of the limitations of that previous study.  
There were 2,171 strokes (1,206 ischemic, 363 hemorrhagic, and 602 probable strokes of unknown 
subtype) over a 26-year follow-up.  Both baseline alcohol consumption and the cumulative average 
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exposure over follow-up were assessed.  For the cumulative average exposure, alcohol was not 
updated after development of disease.  The authors adjusted for many confounders, particularly 
those that few studies have considered such as diet scores, SES, and marital status (as a rough proxy 
for social support).  Finally, in addition to traditional categorical analysis, the authors estimated 
dose-response relationships using nonparametric spline models. 
 There was a J-shaped relationship between alcohol and total stroke with minimal risk at 
roughly 13 g/d and a threshold for harm beginning at approximately 30 g/d.  Because of the low 
drinking in this cohort, however, estimates at upper intakes are highly extrapolated and confidence 
intervals are very wide.  There was a reduced risk of ischemic and hemorrhagic stroke associated 
with low-to-moderate intake compared with no intake (Table 13).  No differences in effect estimates 
were identified by beverage type. 
 
 
The primary limitation of this study was the very low level of heavier drinking (65% of 
women drank <½ glass/d and only 1% drank >45 g/d).  Stroke ascertainment was from self-report or 
Table 13. Multivariable association between alcohol and incidence of total, ischemic and hemorrhagic 
stroke 
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death certificates, which are subject to error.  Finally, there were few hemorrhagic stroke events, 
minority individuals, and no assessment of drinking patterns.  These limitations are relatively minor 
compared with other studies and many are similar to those of other cohorts (low prevalence of 
heavy drinking and few hemorrhagic events).  While possibly not generalizable to all populations, 
this paper was one of the stronger contributions to the literature when considering internal validity.  
The authors paid careful attention to confounder selection, inclusion of multiple exposure 
measurements, and assessment of dose-response.  Our proposed study builds on these results by 
including a bi-racial population of men and women thereby broadening its generalizability. 
 
C. Meta-Analyses of the Association between Alcohol and Stroke2, 6, 14 
 A meta-analysis on the topic of alcohol and stroke was published by Reynolds et al. in 2003 
and included all published English language papers from 1966 through April 2002 with relative risk 
estimates comparing levels of alcohol consumption on the risk of total, ischemic, or hemorrhagic 
stroke.6  The authors identified 35 observational studies, 19 cohort and 16 case-control in design, 
with sample sizes ranging from 1,621 to 107,137 and 89 to 677, respectively.  Alcohol consumption 
was standardized across studies and categorized as none, light (<12 g/d or <1 drink), light-to-
moderate (12-23 g/d or 1-2 drinks), moderate-to-heavy (24-60 g/d or 2-5 drinks), and heavy drinking 
(60+ g/d or more than 5 drinks).  Results are summarized in Table 14 and indicate that light-to-
moderate drinking was associated with lower risk of ischemic and hemorrhagic stroke relative to no 
drinking while heavy drinking was associated with increased risk.  Estimates for heavy drinking were 
stronger for hemorrhagic than for ischemic stroke.  Gender differences were noted, with women 
experiencing stronger effects of both light and heavy drinking than did men for risk of total stroke. 
The authors did not identify whether this gender difference in total stroke was present for both 
ischemic and hemorrhagic strokes, nor were they able to assess race differences. 
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There was an apparent J-shaped curve for ischemic stroke, but a roughly linear association 
for hemorrhagic stroke in dose-response analysis (Figure 11).  The J-shaped relationship between 
alcohol and total stroke was more pronounced for women than for men. 
 
Results of this meta-analysis have limitations.  The dose-response curve was highly 
extrapolated at higher alcohol consumption levels.  The authors did not assess the separate effects 
of beverage type or drinking pattern on disease risk.  There was no assessment of modification by 
Table 14. Overall relative risk (95% confidence interval) of stroke associated with alcohol consumption 
and test for trend6 
 
 
Figure 11. Scatterplot of log-RR and meta-regression curve of stroke associated with alcohol 
consumption by stroke subtype (top panel) and sex (bottom panel) 
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race-ethnicity and the analysis included point estimates that were adjusted for potential mediators 
as well as those whose referent groups included former drinkers.  The authors did assess whether 
results were sensitive to the robustness of outcome ascertainment and adjustment for important 
confounders.  Results were largely unchanged when restricted to studies using CT diagnosis of 
stroke, those controlling for important risk factors, and those excluding prevalent strokes at 
baseline.  Finally, the authors found no evidence of publication bias in their analysis. 
 A second, more recent meta-analysis was published in 2010 by Patra et al. to assess the 
effect of alcohol on stroke subtypes and included 17 cohort and 9 case-control studies published 
from 1980 through June 2009.2  All languages were included, but studies with fewer than 3 
categories of alcohol consumption were excluded as were reports on total stroke only.  Alcohol 
consumption was standardized across studies using country-specific ethanol content for standard 
drinks to convert results presented only as ‘drinks per day’.  Moderate alcohol intake was slightly 
protective for ischemic stroke for women and men while less so or not at all for hemorrhagic stroke 
(Figure 12).  There was a tendency for light drinking of up to 3 drinks per day to reduce hemorrhagic 
stroke risk for women.  Heavy drinking was associated with increased risk for both stroke types in 
men and women.  There was suggestion that effects were stronger in women, but must be 
interpreted with caution as they are imprecise.  The primary limitation of this meta-analysis is that 
many studies classified stroke type using death certificates or death registries as opposed to CT-
based diagnosis.  This could lead to considerable misclassification; however, the authors state that 
excluding these studies did not largely alter their results.  The authors corrected for bias in the 
reference group (i.e., to have a uniform reference group of never drinkers) using statistical 
adjustment.  This method corrected estimates with mixed reference groups based on results from 
effects among ex-drinkers compared with never drinkers and therefore may by subject to error. 
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The most current meta-analysis was published by Ronksley et al. and included all 
prospective studies published from 1950 through September 2009 on the incidence and mortality 
from stroke.14  There were a total of 10 studies of stroke mortality (sample size range from 286 to 
89,299) and 17 of stroke incidence (N=427 to 128,934).  Alcohol consumption was assessed 
according to average daily consumption, calculating grams as necessary using alcohol content in 
standard US drink portions.  The pooled relative risk of incident stroke from 17 studies shows a 
reduced risk for light-to-moderate intake, with significant elevated risk evident at 60+ grams per 
day.  For stroke mortality, a U-shape relationship was observed; the lowest risk occurred at 2.5-14.9 
grams per day and was increased for 60+ grams per day (Table 15). The authors reported results by 
stroke type, but only comparing current drinkers with non-drinkers.  For IS, the pooled relative risk 
(N=12 studies) was 1.14 (95% confidence interval 0.97-1.34) and for HS (N=8) was 0.92 (0.85-1.00).  
The primary limitation of this meta-analysis was that dose-response was assessed only for total 
Figure 12. Meta-analytic results of ischemic and hemorrhagic stroke incidence and 
mortality in women (panels A & C) and men (panels B & D)2 
 
A. Risk of Ischemic Stroke Among Women B. Risk of Ischemic Stroke Among Men
C. Risk of Hemorrhagic Stroke Among Women D. Risk of Hemorrhagic Stroke Among Men
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stroke and that the referent category of ‘none’ included studies that had combined never and 
former drinkers.  Similar to the previous meta-analysis, the authors were unable to assess drinking 
pattern and beverage type and did not assess modification of the dose-response relationship 
between alcohol and stroke by sex or race. 
Table 15. Stratified analyses of pooled relative risks (95% CI) for stroke outcomes.14 
 
Incident Stroke 
(n=17 studies;  
458,811 subjects) 
Stroke Mortality 
(n=10 studies; 
723,571 subjects) 
Active drinkers v lifetime abstainers 0.93 (0.85 to 1.02)  1.29 (1.09 to 1.53)  
Former drinkers v non-drinkers 0.87 (0.72 to 1.07)  Not reported  
Alcohol intake (g/day) v none   
 <2.5 0.81 (0.74 to 0.89)  1.00 (0.75 to 1.34) 
 2.5–14.9 0.80 (0.74 to 0.87)  0.86 (0.75 to 0.99)  
 15–29.9 0.92 (0.82 to 1.04)  1.15 (0.86 to 1.54)  
 30–60 1.15 (0.98 to 1.35)  1.10 (0.85 to 1.45)  
 >60 1.62 (1.32 to 1.98)  1.44 (0.99 to 2.10)  
Any current drinking v none   
 Men 1.02 (0.92 to 1.13)  1.07 (0.89 to 1.28)  
 Women 0.87 (0.75 to 1.01)  0.81 (0.67 to 0.98)  
 Weak adjustment for confounding  factors* 0.99 (0.86 to 1.13)  1.30 (1.11 to 1.52)  
 Strong adjustment for confounding  factors 0.99 (0.89 to 1.09)  0.96 (0.81 to 1.14)  
 Short follow-up time† 0.98 (0.90 to 1.07)  1.01 (0.82 to 1.24)  
 Long follow-up time† 1.00 (0.88 to 1.13)  1.18 (1.02 to 1.37)  
*Adjustment for confounding factors was dichotomized as weak (<median value) or strong (≥median 
value). Cut points: ≥5 for stroke mortality, ≥7 for incident stroke. 
†Total follow-up time was dichotomized as short (<median value) or long (≥median value). Cut points: 
≥12 for incident stroke, ≥14 for stroke mortality. 
 
D. Gaps and Challenges for Future Research 
 While the meta-analyses above are able to address some limitations of previous individual 
studies, most notably small sample sizes and low power, they remain a summary of studies are 
subject to their same biases.  Meta-analysis is particularly useful for obtaining more precise 
estimates of effect among heavy drinkers, a small proportion of most study cohorts, and for 
identifying potential sources of heterogeneity.  It does not, however, ameliorate sources of bias in 
the parent studies.  Some of the meta-analyses included older studies, which had more bias and 
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reflect experiences of populations that may have different drinking patterns from later cohorts.  
Overall, the literature supports an increased risk of hemorrhagic stroke with heavy drinking, but 
varies as to the consumption level at which this increased risk begins.  A J-shaped relationship 
between alcohol and ischemic stroke was found in many, but not all, studies.  These inconsistencies 
may reflect heterogeneity in study populations, measurement of alcohol, ascertainment and 
validation of stroke events, and analytic methods. 
 Gaps in our knowledge and challenges in studying the alcohol-stroke relationship remain.  
Study designs to date have been observational cohort and case-control studies.  While a randomized 
controlled trial would reduce the probability of confounding by design, it is infeasible for numerous 
reasons including ethical concerns of assigning individuals to alcohol consumption, lack of long-term 
compliance, and prohibitively long intervention and follow-up periods.  Many cohorts in which the 
alcohol stroke relationship has been assessed include relatively high-SES, primarily White 
populations, with insufficient numbers of minorities.  There is some evidence that effects may differ 
by race, particularly for Asian populations compared with Europeans;170, 171 few studies exist to 
compare effects in U.S. Whites and African Americans and have had mixed findings.39-41, 172  Selection 
bias is another concern of cohort studies.  Heavy drinkers may be unlikely to be included in cohort 
sampling frames and to participate.  It is uncertain if the heavy drinkers who do participate are 
representative of heavy drinkers overall and therefore whether the findings among heavy drinkers 
are generalizable.131 
 A primary limitation of all studies is exposure measurement error.  Virtually all studies have 
used self-reported frequency and quantity measures as part of a food-frequency questionnaire.  
These are subject to reporting bias, particularly under-reporting by heavy drinkers, and do not 
adequately capture drinking patterns without supplemental questions.  Under-reporting of heavy 
drinking may change the shape of the dose-response curve and suggest a lower threshold for safety 
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than is actually true (by moving higher-risk individuals to lower exposure levels and artificially 
elevating this group’s risk).  Biomarkers for validation of self-reports have limitations, but may be 
useful for validating heavy drinking in future studies.  Validation studies to date rely primarily on 
instruments that may not have independent errors and therefore development of measures with 
independent errors would allow greater confidence in estimation of error.  Assessment of drinking 
pattern (i.e. regular vs. episodic) is important for future studies and very few to date have examined 
consumption as anything other than average exposure.167, 173, 174  Fewer still consider the time-
varying nature of alcohol consumption.  Drinking patterns and quantities change over the life course 
for many individuals. 69, 71  As such, a single measurement may not accurately reflect long-term 
exposure depending on the timing of measurement, i.e. if measured in older age as compared with 
mid-life.  This is a particularly important consideration given that the biological mechanisms suggest 
many of the effects of alcohol on stroke risk accumulate over many years.  Analysis of the effects of 
different beverage types was carried out by a fair number of studies.165-167, 169, 175, 176  These analyses 
were under-powered and complicated by additional confounding; for example, wine drinkers tend 
to be healthier, non-smoking, female, and of higher SES and have different drinking patterns from 
beer drinkers.131  Outcome measurement errors may be present in studies that had incomplete 
ascertainment (e.g. missing non-hospitalized cases), misclassification of diagnosis, and errors in 
classification of stroke type.  These errors are particularly a concern for studies that use non-
overlapping methods of ascertainment, do not adjudicate events, or rely solely on administrative 
data to ascertain events and determine stroke subtype.  Separation of ischemic and hemorrhagic 
types in analyses is important given their different etiologies; however, many studies estimated 
effects of alcohol on total stroke.174, 177-185   
 Several analytic limitations exist among previous studies.  Few have addressed the time-
varying nature of alcohol consumption165-167, 169, 186-188 and the separate effects of drinking pattern 
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and average quantity of consumption.167, 173, 174  Most studies categorize alcohol consumption, 
sometimes into broad categories.  These categories often differ across studies, precluding easy 
comparison of results.  In addition, most studies assessed ‘dose-response’ relationships by way of 
category-by-category comparisons to a single referent group using multiple significance tests 
instead of estimating the dose-response with flexible models.  Finally, early studies and some recent 
ones included never and former drinkers in the referent group.41, 42, 164, 168, 174, 176-179, 181-183, 185, 187-194  
Individuals with health problems may stop drinking, artificially elevating risk among the referent 
group if combined with never drinkers.131  Solutions are to separate ex-drinkers from never drinkers 
and/or to exclude early outcomes that may result from pre-existing disease.171  Residual 
confounding is a concern in most previous studies, particularly from difficult to measure variables 
such as SES and social support and strong confounders like smoking that were only crudely 
operationalized (i.e. yes vs. no).  Cardiovascular conditions such as hypertension, atrial fibrillation, 
cardiomyophathy, and heart disease are affected by alcohol and may in turn affect risk of stroke.  
Whether to treat these as confounders or causal intermediates depends on their temporal relation 
with the exposure and outcome and is difficult to determine in many studies that do not have 
multiple assessments over follow-up.  Finally, most studies estimate relative effects of alcohol 
consumption.  Few report absolute measures, which are more easily interpreted and less likely 
skewed by small baseline risks, or measures of population burden, which provide data on the 
potential public health impact of interventions. 
 The study proposed herein will address several of the limitations of previous research.  First, 
stroke ascertainment and validation is robust and included multiple overlapping ascertainment 
methods coupled with physician validation of suspected cases.  Alcohol was measured at 4 time 
points over follow-up, providing information about cumulative and time-varying exposure.  
Questions were included in the alcohol survey to differentiate former and never drinkers, as well as 
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to separate effects of quantity and frequency at later visits.  The statistical approach will include 
careful consideration of numerous confounders identified and analyzed using directed acyclic graphs 
as well as effect measure modifiers.  This technique will minimize confounding bias and prevent 
inappropriate adjustment for causal mediators.  Some limitations will remain; most notably 
exposure measurement error (i.e. under-reporting of consumption), survival bias, and under-
representation of heavy drinkers in the study population. 
 
3.7 Studies Assessing the Relationship Between Alcohol and Cognitive Decline  
A. Overview 
The body of literature on alcohol and cognitive decline is not as fully developed as for stroke 
and heart disease.  There have been a number of studies that assessed the cross-sectional 
association between alcohol intake and cognitive function.195-199  These have mixed findings, with 
several reporting a possible beneficial effect of moderate drinking.  They are hardly conclusive, 
however, because of strong selection biases and potential for reverse causality.  Other studies have 
examined the relationship between alcohol and dementia.19, 20, 22-24, 26, 200, 201  There is good support 
for reduced risk associated with moderate intake, and some analyses identified a U-shaped dose 
response relationship similar to that reported in studies of alcohol and cardiovascular disease.  A 
meta-analysis in 2008 reported that moderate alcohol intake was associated with reduced risk of 
dementia (RR=0.63, 95% CI: 0.53-0.75) and Alzheimer’s disease (0.57, 0.44-0.74) and smaller 
reductions in risk of vascular dementia (0.82, 0.50-1.35) and cognitive decline (0.89, 0.67-1.17).63  A 
major limitation of these studies is that many rely on prevalent cases of dementia and have 
significant survivor bias.  Individual studies of cognitive function and dementia will not be reviewed 
in further detail as our focus is on cognitive decline. 
 81 
 
 Studies of alcohol and cognitive decline are relatively few in number and overall are 
methodologically weak, providing limited evidence for an association.  As a whole, the body of 
literature is less strong and not as advanced as for alcohol and stroke.  Very few studies have 
assessed the sensitivity of results to sample attrition (drop-out and death), which was considerable 
in most cohorts.  Furthermore, few have long-term follow-up, utilize appropriate models to examine 
changes in cognition over time, or assess drinking patterns, beverage types, or time-varying alcohol 
exposure.  Additional limitations include inclusion of mostly White populations, restriction to older 
adults at baseline, and infrequent cognitive assessments.  Roughly a dozen papers examining alcohol 
and cognitive decline were identified (Appendix 3).  Most measure cognitive decline using global 
cognitive measures including the MMSE, 3MS, and TICS.  Many estimate mean changes in scores, 
but some estimate the odds of ‘significant’ decline, which results in loss of information.  Below are 
described 4 studies that in this author’s opinion represent the highest quality published reports. 
 
B. Description of Four Key Studies 
Key Study 1 – Women’s Health Initiative Memory Study21 
 The Women’s Health Initiative Memory Study (WHIMS) is an ancillary study of a 
randomized-controlled trial of hormone therapy that enrolled women aged 50-79 beginning in 1996.  
Alcohol consumption was assessed at baseline as part of a food frequency questionnaire.  Beverage-
specific usual consumption (drinks per day) was collected as was status as a former drinker or 
lifetime abstainer.  Alcohol intake was broadly categorized as none, <1 drink per day, and 1 or more 
drinks per day.  Global cognitive function was assessed at baseline and each year for 6 years using 
the 3MSE.  Attrition was significant in this cohort, reaching 17% by Visit 4 and 98% by Visit 6.  
Logistic regression was used to estimate the association between baseline alcohol intake and a 
dichotomized outcome (≥8 point drop in 3MSE any time during follow-up). 
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 Compared with no alcohol intake, consumers of either <1 drink per day or 1+ drinks per day 
had lower odds of cognitive decline of 8 points or more (Table 16). 
 
Table 16. Odds ratios for occurrence of clinically significant declines of 8 or more units in 3MSE score from 
baseline, Women's Health Initiative Memory Study, 1996-200221 
Variable 
Relative to no alcohol intake p value (all 
pairwise 
differences)† 
<1 drink per day 
 
≥1 drink per day 
Odds ratio 95% CI* 
 
Odds ratio 95% CI 
No additional covariates 0.56 0.41, 0.77 
 
0.40 0.22, 0.72 <0.001 
Adjusting for socioeconomic status/lifestyle‡ 0.67 0.48, 0.95 
 
0.51 0.27, 0.94 0.025 
Adjusting for clinical characteristics§ 0.58 0.42, 0.80 
 
0.41 0.23, 0.74 <0.001 
Adjusting for all covariates 0.69 0.49, 0.97 
 
0.53 0.28, 0.99 0.042 
* 3MSE, Modified Mini-Mental State Examination; CI, confidence interval. 
† Results from analysis of covariance. 
‡ Age, no. of years since menopause, education, ethnicity, family income, and smoking status. 
§ Body mass index, hypertension status, prior cardiovascular disease, diabetes, prior hormone therapy, statin 
use, and aspirin use.  
 
This study has several limitations that make conclusions difficult to draw regarding a causal 
effect of alcohol on cognitive decline.  First, the follow-up time was short (mean 4.2 years) and 
alcohol was broadly classified and based on measurement at one point in time.  The highest intake 
group was open-ended and could represent a heterogeneous mix of drinkers.  More problematic is 
the analytic approach, which dichotomizes decline based on only 2 3MSE measurements instead of 
estimating mean declines over time in each group.  Missing data and cohort attrition are not 
accounted for and could substantially bias results.  Finally, the study population was highly selected, 
primarily high-SES White women participating in a clinical trial, which may both limit generalizability 
and represent a healthy selection bias. 
 While this study is stronger than many others of alcohol and cognitive decline, it has several 
major limitations such that it only provides modestly convincing evidence in support of an 
association between alcohol and cognitive decline. 
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Key Study 2 – Nurses’ Health Study1 
 This analysis of the Nurses’ Health Study (described in Section 3.6.6) included women aged 
70+ years in 1995 with no history of stroke.  Cognitive function was assessed using the Telephone 
Interview of Cognitive Status (TICS) and in 1997 included additional tests to assess verbal memory 
(East Boston Memory Test and delayed recall of the TICS 10-word recall), verbal fluency, and 
working memory and attention (digit span backward test).  A global cognitive score was calculated 
by averaging all z-transformed test scores.  Alcohol consumption was measured using the reported 
intake at the last visit that occurred before baseline cognitive assessment, 1994 for most women.  
Alcohol was categorized as none, 1.0-14.9 grams per day, and 15-30 grams per day. Analyses of 
cognitive decline used logistic regression to estimate effects of alcohol consumption on ‘substantial 
decline’, which was defined as a change in the lowest 10% of the distribution of decline.  The mean 
duration of follow-up was short, only 1.8 years.  Models were adjusted for baseline cognitive score 
to account for learning effects, ceiling effects, and within subject variability.  Additional covariates 
are listed in Table 17. 
 Adjusted baseline scores for all tests were slightly lower for drinkers of 1-14.9 grams per day 
than nondrinkers and lower for drinkers of 15-30 grams per day.  Odds of substantial decline in 
cognition over an average of 1.8 years were lower for both groups of drinkers compared with 
nondrinkers (Table 17). 
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There were several sources of selection bias in this study that were not addressed in the 
analytic approach.  Selection into the cohort, i.e. survival to age 70, is a large source of bias.  
Additionally, ~40% of eligible women did not participate in the baseline cognitive assessment and an 
additional 10% of participants were lost to follow-up through death or drop-out prior to the second 
cognitive assessment.  Finally, missing data for individual tests resulted in a total attrition between 
baseline and follow-up of 23% of the sample for the global cognitive function measure.  Alcohol 
exposure was defined using a single measurement taken immediately before cognitive assessment 
after age 70.  It is possible that this exposure did not represent exposure over a longer period, 
particularly the period of critical effect and that it was affected by early cognitive changes.  Given 
that the NHS collected alcohol at 5 times over a 15-year period prior to cognitive assessment, the 
authors could have operationally defined alcohol intake more rigorously.  For example, by 
calculating cumulative average exposure, modeling time-varying intensity and duration 
independently, or by estimating trajectories of drinking patterns.  Finally, the analytic approach did 
not estimate the degree of cognitive decline because the outcomes were dichotomized.  While 
Table 17. Relative risks of a substantial decline in cognitive function over a 2 year period, according to 
alcohol intake1 
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results may be more easily interpreted in this manner, categorizing a continuous outcome results in 
loss of information and may be sensitive to cut-point selection.  Models were adjusted for baseline 
cognition, which is controversial and may bias estimates.202  No sensitivity analyses were presented 
comparing results with and without this adjustment. 
 This study has stronger measurement of exposure and outcome than many other studies in 
Appendix 3, but has significant limitations in its design - with only 1.8 years of follow-up – and the 
statistical approach.  It provides only modest evidence of a beneficial effect of alcohol on cognitive 
decline.  It provides no information on declines over longer periods of time, starting at younger 
ages, or among men or African American populations.  Our study will build upon these results by 
including African Americans, having longer follow-up and estimating rates of decline. 
 
Key Study 3 – Prospective Study of Pravastatin in the Elderly at Risk32 
The Prospective Study of Pravastatin in the Elderly at Risk is a randomized trial of adults 
from Scotland, Ireland and the Netherlands aged 70-82 at baseline who had vascular risk factors or 
vascular disease.  Alcohol intake over the last month was measured at baseline and categorized as 
usual intake per week according to data-driven cut-points.  Cut-points were selected to provide 
equal sized groups (cutpoints: <3 units per week for women and <7 units per week for men).  
Cognitive function was assessed at baseline and at 9, 18, and 30 months and again at the end of the 
trial (~3 years).  Cognitive tests included those for global cognition (MMSE), attention and 
processing speed (Stroop Color-Word test, Letter-Digit Coding test), and memory (Picture-Word 
Recall Test).  Sex-stratified linear mixed models were used to estimate the rate of decline across 
alcohol categories adjusting for age, country, smoking status, BMI, body weight, education, incident 
stroke, history of vascular disease, and baseline cognitive score. 
Cognitive scores over the length of follow-up were better for female drinkers compared 
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with nondrinkers for all tests, but not for male drinkers compared with male nondrinkers.  Models 
with time interactions showed that female non-drinkers declined faster than female drinkers on the 
MMSE score but not on other tests (Table 18).  No differences in cognitive decline were seen for 
men across alcohol categories. 
Table 18. Longitudinal analysis of cognitive decline and alcohol intake by sex32 
 Annual Change Mean Difference over Time Between Alcohol Groups 
 All Subjects Moderate vs. None Low vs. None Trend 
 Estimate (SE) p-value 
Women 
 MMSE −0.02 (0.01) .04   0.09 (0.02) <.001   0.07 (0.02) .001   0.05 (0.01) <.001 
 Stroop   0.60 (0.12) <.001 −0.13 (0.22) .56 −0.19 (0.23) .40 −0.08 (0.11) .46 
 LDCT −0.32 (0.03) <.001   0.03 (0.05) .49 −0.06 (0.05) .24   0.01 (0.02) .73 
 PWRTi −0.03 (0.01) .005   0.02 (0.02) .27   0.02 (0.02) .29   0.01 (0.01) .21 
 PRWTd −0.07 (0.02) <.001   0.02 (0.03) .54 −0.02 (0.03) .60   0.01 (0.01) .66 
Men 
 MMSE   0.002 (0.02) .89   0.01 (0.02) .68   0.01 (0.02) .69   0.004 (0.01) .69 
 Stroop   0.90 (0.18) <.001 −0.28 (0.24) .24 −0.45 (0.24) .06 −0.13 (0.12) .28 
 LDCT −0.37 (0.04) <.001   0.01 (0.05) .82   0.02 (0.05) .67   0.005 (0.03) .84 
 PWRTi −0.01 (0.02) .53 −0.02 (0.02) .33   0.01 (0.02) .60 −0.01 (0.01) .33 
 PRWTd −0.07 (0.02) .001   0.001 (0.03) .97   0.04 (0.03) .18 −0.001 (0.02) .94 
 
A major advantage of this study over many others is the use of analytic methods that 
incorporated all cognitive scores over follow-up.  These models, however, adjusted for baseline 
cognitive status and did not account for attrition and missing measurements (21% of the cohort).  
Primary limitations included a short follow-up time (3 years) and broad grouping of alcohol 
consumption based on sample size driven cut-points that do not necessarily reflect the underlying 
dose-response relationship.  In summary, this study is one of the stronger studies reviewed, with 
more robust measurement of outcome and analytic techniques than others.  The likely exposure 
misclassification and error in exposure assessment is a serious limitation and renders the study of 
modest overall quality. 
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Key Study 4 – The Northern Manhattan Stroke Study34 
NOMAS (described in Section 3.6 Section B) included 3298 stroke-free participants at 
baseline starting in 1993.  A structured alcohol questionnaire assessed average consumption in the 
past year as well as over the life course.  In 2001, a follow-up questionnaire assessed intake over the 
past 6 months, which was the measurement used to define alcohol exposure for this analysis.  Also 
in 2001, a telephone cognitive interview was conducted using the TICS-m on the ~80% surviving 
cohort and was repeated annually thereafter.  Forty-three percent of those who had an initial TICS-
m were lost to follow-up or died.  Generalized estimating equations were used to assess change in 
TICS-m over time, adjusted for the covariates shown in Table 19. 
 At baseline, the mean TICS-m score was 29 among never drinkers, 30 among past drinkers 
and those consuming less than 1 drink per week, 33 among those drinking 1-14 drinks per week, and 
35 among those drinking over 14 drinks per week.  Over a mean follow-up of 2.2 years, the average 
decline in TICS-m was slower among current drinkers than never drinkers.  This was attenuated in 
adjusted models, but the dose-response relationship was maintained (Table 19). 
This study is similar in quality to Stott et al., reviewed above.  The follow-up was short and 
the assessment of exposure could have been improved.  However, the study had unique strengths in 
comparison to the majority of other studies by utilizing more appropriate analytic methods and 
measuring cognitive status at multiple times over follow-up.  The authors chose to condition on 
several potential mediators (e.g., HDL-C, stroke, and hypertension), did not adjust for possible 
confounders (e.g., social support), and did not account for attrition, all of which may have biased 
estimates.  Overall, this study provides modest support for a decrease in the rate of cognitive 
decline associated with light to moderate alcohol consumption compared with abstention. 
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Table 19. Relation between reported alcohol intake and performance on repeated measures of TICS-m34 
 Reported alcohol intake 
 Never Past 1 dk/m to < 1 dk/wk 1 dk/wk up to 2 dk/d >2 dk/d 
  β (95% CI) P β (95% CI) P β (95% CI) P β (95% CI) P 
Model 1 Ref β† =0.6 
(−0.2,1.3) 
0.14 β =1.5 
(0.5,2.5) 
0.003 β =2.2 
(1.3,3.0) 
<0.0001 β =2.9 
(1.4,4.4) 
0.0002 
Model 2 Ref β =0.3 
(−0.4,1.1) 
0.40 β =1.0 
(0.03,1.9) 
0.04 β =1.6 
(0.7,2.4) 
0.0003 β =2.1 
(0.6,3.6) 
0.008 
Model 3 Ref β =0.4 
(−0.4,1.2) 
0.36 β =0.9  
(-1.2,1.9) 
0.09 β =1.5 
(0.6,2.4) 
0.001 β =2.4 
(0.8,4.0) 
0.003 
*TICS-m – modified Telephone Interview for Cognitive Status. 
†Beta coefficient represents the change in points on the TICS-m over time compared to never drinkers; 
positive denotes better scores. 
Model 1 – Adjusted for age and education. 
Model 2 – Model 1 + gender, race-ethnicity, and insurance status. 
Model 3 – Model 2 + history of hypertension, diabetes, cardiac disease, physical inactivity, depression, 
current smoking, HDL-C level, and BMI. 
 
C. Summary and Gaps in the Current Literature 
 There are several gaps in the literature on the association between alcohol and cognitive 
decline.  In general, alcohol intake was measured at a single point in time - often late in life at the 
start of cognitive measurement – and was summarized as average consumption.1, 21, 27-35  No study of 
which the author is aware assessed time-varying alcohol exposure or the effect of different drinking 
patterns on rate of cognitive decline.  One study did categorize participants according to rough 
drinking patterns, such as ‘habitual users’ and ‘social users’, but this categorization utilized exposure 
data collected after measurement of cognitive function which may result in misclassification and 
immortal time bias.  Putative effects of alcohol on cognition are cumulative and occur over decades 
of exposure.  Baseline only definition of intake occurring relatively late in life is likely subject to 
misclassification.  Furthermore, the referent group in some studies was mixed, including both 
former and nondrinkers and can result in biased estimates.21, 28, 29, 31, 32, 35   
 Sophisticated analytic approaches for modeling repeated outcome data were used by a few 
researchers,27, 32, 34-36 and only one attempted to assess or correct for selection bias due to 
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attrition.27  Cognitive decline was dichotomized in several of the analyses which is not as informative 
for quantifying the degree of decline among alcohol groups.1, 21, 28, 35  Another major limitation, 
particularly in studying cognitive decline, is the short follow-up of these cohorts.  Most were 
followed for fewer than 5 years.1, 21, 27-32, 34  Confounding bias may be a problem in many studies, 
with some results not being adjusted for SES, smoking, social support, depression, diet or physical 
activity,1, 28-32, 34-37 and others adjusted for possible effect mediators including hypertension, HDL-C, 
and incident stroke during follow-up.1, 21, 27, 30-32, 34, 35  Finally, several studies only used the MMSE to 
measure cognitive changes.  This neuropsychological assessment is relatively insensitive to changes 
at the higher end of cognition and is not the best tool for large population-based studies of 
cognitively normal individuals, particularly with high levels of education.28, 30, 31, 37 
 The ARIC study shares some limitations with others including the small proportion of heavy 
drinkers, high degree of participant attrition over time, and reliance on self-reported alcohol 
consumption, which is subject to reporting errors and under-reporting of intake.  The ARIC study 
data are well suited to address many of the limitations of previous studies, however.  First, there are 
multiple measures of alcohol over a long period of follow-up that capture mid-life consumption.  
Other unique strengths of the ARIC study design are long-term follow-up (20 years) with multiple 
measurements of cognitive performance beginning at ages 48-67, assessment of many confounders 
and effect measure modifiers, and inclusion of a biracial population.  Not much is known about non-
White populations, with only a few studies examining effects in minority populations.198  
Furthermore, the approach proposed herein will improve on previous research by estimating group 
differences in the rate of decline using repeated measures and will include correction for selection 
bias from drop-outs and deaths.  Methods to account for attrition are critical because cognitive 
impairment is known to be associated with drop-out and mortality.60 
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3.8 Public Health Significance 
 Stroke and cognitive decline are important targets for public health prevention.  Both are 
associated with significant morbidity and heath care costs and are estimated to increase over the 
next few decades due to longer life expectancies and demographic population changes.51, 52  Stroke 
is a leading cause of mortality in the US and worldwide.  Approximately 1 in 3 Americans will have a 
stroke or develop dementia in their lifetime, underscoring the need for continued examination of 
potentially modifiable risk factors for these diseases.9  Furthermore, given the current lack of 
treatments for dementia, understanding modifiable factors to prevent or delay cognitive decline and 
dementia onset is critical.  One study estimated that delaying the onset of AD by 1 year would 
potentially prevent 12 million cases in 2050. 
 Alcohol has been studied as a potential factor in the etiology of both stroke and cognitive 
decline, with many studies reporting decreased risk associated with moderate intake and increased 
risks with high average intakes and harmful patterns of drinking.  There are biologically plausible 
pathways to support the beneficial effects of moderate drinking including positive effects on HDL-C 
levels, platelet aggregation, fibrinogen levels, insulin sensitivity, antioxidant activity, and blood 
pressure.  Harmful effects of heavy drinking include increased blood pressure, neurotoxicity, risk of 
atrial fibrillation and cardiomyopathy, decreased cerebral blood flow, elevated state of 
inflammation, and insulin insensitivity.  Research to date, however has been inconsistent with 
regard to the effects of moderate intake and is subject to methodological limitations that preclude 
drawing strong conclusions about causal relationships.  A comprehensive technical report from the 
US National Institutes of Health on evidence for the prevention of dementia and cognitive decline 
found that evidence supporting a beneficial role of alcohol is weak.33, 203  The authors recommend 
additional research from rigorous population-based studies with careful control of confounding.  
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Estimating this association in a study with long-term follow-up, multiple measurements of alcohol 
intake and cognitive performance, will contribute additional knowledge to this topic.   
With a large proportion of adults reporting current drinking (70%) and considerable 
numbers reporting heavy or episodic drinking (30% of adults; 20% of men >60 years) there could be 
significant impact on stroke and cognitive impairment burden by reducing harmful drinking 
behaviors.68, 70  The total burden of stroke due to alcohol will depend on the prevalence of alcohol 
consumption, alcohol’s effects on the two major stroke types, and their relative prevalence in a 
given population.  Estimating impact fractions of changes to current alcohol consumption patterns in 
the US on stroke incidence has not been done to this author’s knowledge and, if feasible, represents 
a novel component of the proposed study. 
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CHAPTER 4. RESEARCH METHODS 
4.1 Study population 
The ARIC cohort will serve as the study population for Specific Aims 1-3 and is described 
below in general terms.  Inclusion and exclusion criteria specific to each Aim will be described in 
greater detail in future sections that delineate the research plans for each Specific Aim. 
The ARIC study is a population-based cohort recruited using probability sampling of adults 
45-64 years of age from four US communities: Forsyth County, NC; Jackson, MS; the suburbs of 
Minneapolis, MN; and Washington County, MD.  Institutional review boards from each site 
approved the ARIC study and all participants provided written informed consent.  The ARIC study 
design and rationale are described in detail elsewhere.204 The racial distribution of the sample from 
Minneapolis and Washington County is primarily white and is representative of the area.  Blacks 
were oversampled in Forsyth County and exclusively sampled in Jackson.  The response rates were 
modest, 46% in Jackson and 65-67% for the other communities.  A total of 15,792 participants were 
enrolled at visit 1 in 1987-1989 and underwent an in-home interview and physical examination.  
During annual follow-up telephone calls, ARIC investigators obtained information on hospitalizations 
and medical history over the preceding year.  Four additional study visits consisting of an interview 
and physical examination occurred over the subsequent 25 years, with return rates of 91% at visit 2 
to 70% at visit 4.   Much of the attrition at later visits is attributable to death (5% at visit 4) and visit 
nonattendance (14% at visit 4).  Comparisons of responders and non-responders at visit 1 (based on 
data from the 75% of non-responders that completed the in-home interview) have been reported.205  
Briefly, white respondents were more highly educated, had higher incomes, reported better health 
status, and were less likely to be current smokers than white non-respondents.  Black respondents 
 93 
 
had more education and less current smoking than black nonrespondents.  In general, differences by 
response status were smaller for blacks than for whites.   
Table 20 below shows descriptive statistics for the ARIC cohort at baseline in terms of 
demographic characteristics, cardiovascular risk factors, prevalent disease, and self-reported alcohol 
consumption.  Black participants comprised 27% of the sample and women 55%.  Current alcohol 
consumption at baseline was reported by 25% of the sample, lifetime abstention by 19% and former 
drinking by 32%. 
Table 20. Selected characteristics of ARIC cohort participants at Visit 1, 1987-1989 
Characteristic Proportion or mean (SD) 
Age, years 54 (5.8) 
Sex-Race Group  
White men 34.4 
Black men 10.3 
White women 38.3 
Black women 16.7 
Highest level of education  
Grade school 9.7 
High school (no degree) 14.1 
High school graduate/vocational school 40.6 
College or higher 35.4 
Body mass index, kg/m2 27.7 (5.4) 
HDL-cholesterol, mg/dL 37.3 (11.1) 
Hypertension 35.0 
Diabetes mellitus 12.0 
Prevalent myocardial infarction 4.2 
Smoking  
Never 41.7 
Former 32.1 
Current 26.2 
Alcohol consumption  
Lifetime abstainer 19.0 
Former drinker 55.5 
Current drinker 25.0 
 
4.2 Research Plan for the Assessment of Alcohol and Stroke (Aims 1 and 2) 
A. Analytic Sample 
 The study population will exclude 1) participants not classified as white or black because of 
our interest in race as a potential modifier (N= 48); 2) participants missing alcohol at baseline visit 
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(N=106); and 3) participants with a history of stroke at baseline (N=284).  Total participants excluded 
were 434 individuals representing 2.7% of the cohort.  After these exclusions, the total sample size is 
15,358. 
 
B. Exposure Assessment 
Alcohol consumption was ascertained at all 5 study visits (see Appendix 4 for 
questionnaires); for this analysis, only data from visits 1-4 will be used as visit 5 data were collected 
after the last year for which we have validation of stroke events.  During visit 1 (1987-1989) alcohol 
intake was assessed using an interviewer-administered dietary questionnaire developed in 
accordance with the validated Willett 66-item FFQ.  Measurement of alcohol at visit 2 (1990-1992) 
occurred as part of the health history questionnaire, at visits 3 (1993-1995) and 4 (1996-1998) as 
part of the personal history questionnaire, and at visit 5 (2011-2013) with the alcohol use form.  
Missing data patterns for alcohol intake across the first 4 study visits are summarized in Table 21 
and show relatively small degrees of missing data, with <1% of cohort participants missing all 4 
measurements.  A large proportion (82%) have at least 3 measurements and 92% have at least 2 
measurements. 
 
 
Participants were first asked to report whether they currently consumed alcoholic 
beverages.  Nondrinkers were then asked if they had ever consumed alcohol and if so how long ago 
they ceased drinking and for how many years they drank.  Current drinkers were asked to report 
their usual intake over the past 12 months in units of drinks per week.  Later questionnaires (visits 3-
5) asked both average quantity per week (drinks per week) and frequency (number of drinking days 
Table 21. Percent missing alcohol intake data according to the cumulative number of missing measurements 
from Visit 1 through 4 
Total number of missing 
alcohol measurements 
0 (Complete data) 1 Missing 2 Missing 3 Missing 4 Missing 
Percent of ARIC cohort 69% 13% 10% 7% 0.1% 
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per week).  Separate questions were asked at all study visits for wine, beer, and hard liquor 
consumption with respective serving sizes for each specified as 4, 12, and 1.5 ounces.  Calculation of 
ethanol content was based on the following conversions: 4 ounces of wine contains 10.8 grams of 
ethanol, 12 ounces of beer contains 13.2 grams, and 1.5 ounces of liquor contains 15.1 grams. 
In dose-response analysis, alcohol exposure will be defined as baseline drinks per day.  The 
0-drink level includes never drinkers as well as current drinking reporting <0.5 glasses per week 
(recorded as ‘0’).  Polynomial and spline terms will be used to flexibly model the association with 
stroke incidence.   
 In addition, exposure will be categorized to obtain estimates for calculation of impact 
fractions.  Categories will include former drinkers, never drinkers, occasional (<1 drink/week), light 
(1.1-7 drinks per week), moderate (7.1-14 drinks/week), and heavier drinkers (>14 drinks per week).  
The categories proposed herein are based on previous research and are in accordance with current 
recommendations for intake by the USDA Dietary Guidelines for Americans.  Further analysis will 
assess the sensitivity of results to a priori defined cut-points by generating data-driven cut-points 
based on observed dose-response patterns and possible sex-specific values.  We will explore effects 
specifying alcohol by cumulative dose or time-varying, but our primary goal is to estimate effects of 
mid-life consumption as this is hypothesized to be the critical period for effect. 
 
C. Outcome Assessment 
 Possible strokes were ascertained by self-report during in-home interviews, at study visits, 
and during annual follow-up telephone calls.  Additionally, ARIC study coordinators conducted 
regular surveillance of local hospital discharge lists.  Potential stroke hospitalizations were eligible 
for further review if any of the following were found: 1) a cerebrovascular disease related discharge 
code (International Classification of Diseases, 9th Revision, Clinical Modification 430-438); 2) at least 
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1 keyword listed in the discharge summary or nursing notes; 3) a diagnostic CT or MRI scan with 
cerebrovascular findings in the medical record; or 4) the patient had ever been admitted to the 
neurological intensive care unit.  Keywords used to screen the discharge summary and nursing notes 
included ‘stroke’, ‘transient ischemic attack’, ‘cerebrovascular disease’, ‘cerebral hemorrhage’, 
‘cerebral infarction’, ‘subarachnoid hemorrhage’, ‘cerebral embolus’, ‘paralysis’, ‘aphasia’, ‘diplopia’, 
‘lacunar infarction’, ‘dysarthria’, ‘cerebral angiography’, ‘carotid’, and ‘endarterectomy’.  Out-of-
hospital fatal strokes were also monitored but were not validated.  These events, which are few in 
number, will be excluded. 
 Possible stroke events were further validated.  Medical records were abstracted by a single 
trained nurse at the Minneapolis site.  Abstracted elements included medical history, neurological 
symptoms and deficits, results of any procedures performed during the hospitalization (e.g. CT and 
MRI scans, carotid endarterectomy, B-mode and Doppler ultrasound), in-hospital therapies, and 
autopsy evidence in the case of death.  All stroke diagnoses and classifications were conducted 
independently by a computer-derived algorithm and a physician medical record reviewer, with 
differences adjudicated by a second physician reviewer.  Stroke classification was based on criteria 
adopted from the National Survey of Stroke206 and required, at a minimum, evidence of sudden or 
rapid onset of neurological symptoms lasting >24 hours or leading to death, in the absence of 
evidence for a nonstroke cause.  Strokes related to brain trauma, neoplasm, coma due to metabolic 
disorders or disorders of fluid or electrolyte balance, vasculitis involving the brain, peripheral 
neuropathy, hematologic abnormalities, or central nervous system infections were excluded.  The 
presence of major symptoms (hemiparesis of ≥2 body parts, homonymous hemianopia, or aphasia) 
or minor symptoms (diplopia, vertigo or gait disturbance, dysarthria, dysphagia, dysphonia, or 
unilateral numbness of ≥2 body parts) were considered in subtype classification along with CT and 
MRI findings.  Strokes were classified as ischemic (thrombotic brain infarction, lacunar infarction, 
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cardioembolic stroke), hemorrhagic (intracerebral hemorrhage [ICH], subarachnoid hemorrhage 
[SAH]), possible stroke of undetermined type, no stroke, and fatal out-of-hospital stroke.  Additional 
details of these subtype classifications have been published.207  Fatal out-of-hospital stroke 
classification was based only on the underlying cause of death reported on the death certificate 
without further validation.  Deaths were discovered during annual phone calls and by searching 
health department death certificate files.  Instances of a case meeting 2 diagnostic criteria were 
rare, but when they occurred a hierarchy was used to assign stroke type (ICH, SAH, cardioembolic 
stroke, thrombotic brain infarction).  As of December 31, 2010, there were 1,461 definite/possible 
incident strokes (1,252 ischemic, 166 hemorrhagic, 24 possible strokes of undetermined type, 19 
fatal out-of-hospital).  Misclassification is possible as out-of-hospital stroke deaths are not validated 
and there is a chance that cases were missed that either did not present to the hospital or presented 
to hospitals outside the catchment area and were not reported at annual phone calls or study visits.  
The probability of these occurrences is assumed to be low, a reasonable assumption.  If we have no 
false positives, missed cases would not bias effect estimates. 
 
D. Confounder Selection and Assessment 
Potential confounders were identified based on substantive knowledge of factors associated 
with alcohol129 and risk of stroke7 and from existing literature on the association between alcohol 
and stroke.  Selection of confounders to include in primary analyses was based on directed acyclic 
graph analysis (Figure 13) that included all potential confounders identified from the literature: 
demographic characteristics (age, gender, race, SES), lifestyle factors (smoking, physical activity, 
social support, marital status, diet), and medical history (myocardial infarction, heart failure, atrial 
fibrillation, diabetes mellitus).  Potential mediators include blood pressure, HDL-C level, and atrial 
fibrillation.  There was 1 minimally sufficient set of adjustment variables for the estimation of the 
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total effect of alcohol on stroke, which included age, sex, race, baseline comorbid conditions, diet, 
SES, smoking, and social support.  
  
Information on covariates was obtained from home interviews and clinic visits.  
Socioeconomic status was measured as the highest level of completed education and family income.  
Dietary factors were assessed using the interviewer-administered 66-item FFQ administered at visits 
1 and 3.  Participants were asked to report their usual intake of foods over the past year according 
to categories of intake ranging from ‘never or less than once per month’ to ‘>6 times per day’.  Food 
models were used by interviewers to convey portion sizes and nutrient content was calculated by 
linking with the nutrient database developed by Willett et al.208 
 Anthropometric measurements (i.e. weight, height, waist circumference) were carried out 
on participants while wearing light clothing and without shoes.  Body mass index (BMI) was 
calculated as weight (kg) divided by height squared (m2).  Blood pressure was measured using 
standard methods, averaging the second 2 measurements of 3 following a 5-minute rest. 
Figure 13. Directed acyclic graph for the association between alcohol and stroke 
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 Smoking status was assessed at all 4 study visits (current, former, and never) and the total 
number of years of smoking was measured.  Both continuous and categorical definitions of smoking 
will be assessed in analyses and the operationalization that best reflects the dose response 
relationship between smoking and stroke will be used in adjusted analyses.  Physical activity was 
measured using the Baecke physical activity questionnaire that provides indices ranging from 1 to 5 
for leisure, sport, and occupational activity.209   
 Social support was measured at visit 2 with the 40-item Interpersonal Support Evaluation 
List, which has high correlations with other social support scales, test-retest reliability, and internal 
consistency.210  This tool assesses the perception of available support in four areas: tangible, 
belonging, self-esteem and appraisal.  Six questions from the four subscales comprise the Perceived 
Social Support Scale. The questions asked whether social support (family and friends, helping with 
daily chores, dealing with personal problems, cooking and giving trustworthy advice) is available 
when needed.  Scores ranged from 6 to 24, with lower scores indicating higher levels of perceived 
social support.   
Finally, baseline medical history included myocardial infarction (self-reported physician 
diagnosis or positive ECG findings) and diabetes (self-reported physician diagnosis, fasting glucose 
>126 mg/dL, or self-reported pharmacologic treatment for diabetes).  Hypertension was defined as 
any of the following: current use of antihypertensive medications, systolic blood pressure ≥140 
mm/Hg, or diastolic blood pressure ≥ 90 mm/Hg.  In primary analysis, we will consider covariates 
that could be both mediators and confounders as temporally after alcohol because we believe that 
baseline alcohol represents the long-term mid-life exposure. 
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E. Statistical Analysis 
Cox proportional hazards regression will be used to estimate hazard ratios and 95% 
confidence intervals for the association between alcohol and incident total, ischemic, and 
hemorrhagic stroke.  The time scale for these models will be time on study.  Follow-up will continue 
until the earliest of stroke, death, loss to follow-up, or end of follow-up on December 31, 2011.  The 
Cox proportional hazards method is semi-parametric and uses quasi-likelihood estimation.  An 
advantage over parametric models is that the functional form of the baseline hazard does not need 
to be specified, but there is an assumption of proportionality over time.  We will test the 
proportional hazards assumption by examining log-log survival plots and testing interactions of 
alcohol with time.   
 Another, stronger, assumption of this method is noninformative censoring.  This is likely 
satisfied for loss to follow-up as the probability of dropping out was independent of reported 
alcohol consumption at baseline.  Based on data through 2010, the proportions lost to follow-up 
were 2% for never drinkers, 0.7% for light drinkers, 0.2% for moderate drinkers, 0.2% for high 
drinkers, and 0.04% for heavy drinkers; p=0.3).  However, censoring for death may violate this 
assumption as death is a common event in this population (31% by 2010) and may not be 
independent of the outcome conditional on covariates.  Standard survival analysis, e.g. Cox PH 
regression, estimates cause-specific relative hazards in the hypothetical absence of competing 
risks.211  There are several methods to address competing risks.  One option is to estimate the risk of 
a combined endpoint, stroke + death, which has no competing risk.  While the most straightforward, 
this option is not ideal given our study question.  The resultant estimate would not necessarily 
reflect the etiological effect of alcohol on risk of stroke.  A second option for addressing competing 
risks is to use inverse-probability of censoring weights in Cox models to account for death and loss 
to follow-up.212-215  A third option is to estimate sub-distribution hazards, which reflect the likelihood 
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of the outcome given exposure while allowing competing risks to occur.  The subdistribution HR may 
not be generalizable to populations with different competing risk distributions, however.  If 
competing risks are deemed to be of concern, we will use the second or third options above in 
sensitivity analyses. 
 Confounders will be operationalized in statistical models based on the confounder-outcome 
relationship in the data.  Therefore, unlike selection of confounders which is DAG-driven, the 
modeling strategy will be data-driven.  For continuous variables, we will explore linear, quadratic, 
and spline terms as well as categorization in the prediction of the outcome of interest.  The different 
options for modeling confounders will be compared to each other based on the shape of the dose 
response curve and precision of point estimates.  Precision-validity tradeoff considerations balance 
minimizing confounding bias and maximizing precision.  The equation below represents the Cox 
proportional hazards model for our study, where Z is used to represent the covariates.  
Parameterization of covariates will be explored to best represent their relationship with the 
outcome and will include exploration of disjoint indicator variables, polynomial, and spline terms. 
 
𝑙𝑙𝑙 ℎ𝑖(𝑡) =  ℎ0(𝑡) + 𝛽1𝑎𝑙𝑎𝑙ℎ𝑙𝑙𝑖 + 𝛽2𝑎𝑙𝑎𝑙ℎ𝑙𝑙𝑖(𝑡) + �𝛽𝒁 + 𝜀 
 
Effect measure modification by race-ethnicity and sex will be assessed using interaction 
terms between alcohol and the modifier.  Likelihood ratio tests comparing nested models with and 
without interaction terms will be used to test interaction terms using a conservative p-value cut-
point of 0.2.  A conservatively high p-value cut-point was chosen because of the low power of tests 
of interaction and our interest in identifying heterogeneity in the dose-response relationship 
between alcohol and stroke according to the selected characteristics.  Stratified models will 
estimate the dose-response patterns for subgroups separately if a meaningful interaction is present. 
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For Aim 2, we will investigate the feasibility of estimating  proportional changes in total, 
ischemic, and hemorrhagic stroke incidence resulting from changes in the distribution of alcohol 
intake using generalized impact fraction methods.216, 217  Feasibility will depend primarily on the 
number of confounders and the number of resultant strata within which point estimates must be 
calculated.  If cells become too small and confidence intervals too wide, then our proposed method 
will not be feasible.  Second, if our main effects are close to the null, we will not need to further 
calculate impact fractions, as these are only useful for exposures that are associated with the 
outcome of interest.   
If deemed feasible, generalized impact fractions will be estimated within strata of age, sex, 
and race using effect estimates obtained from Cox regression models.  Sex-race groups will include 
white men, white women, African-American (AA) women, and AA men.  The impact fraction 
estimated by these methods accommodates proportionate changes in a polytomous exposure, for 
example, a 5% shift of the population from heavy to moderate drinking and 5% shift from never to 
moderate drinking.  The formula below shows the calculation of GIF for a general scenario, where 𝑃𝑖 
represents the exposure prevalence in the population, 𝑃𝑖
′ represents the exposure prevalence after 
intervention, and 𝑅𝑅𝑖 represents the crude hazard ratio of exposure compared with referent group.  
We will calculate GIF within strata of strong confounders (hypothesized to be age, sex, and race) and 
use weighted case-load methods to combine estimates. 
𝐺𝐺𝐺 = ∑𝑃𝑖𝑅𝑅𝑖 −∑𝑃𝑖′𝑅𝑅𝑖
∑𝑃𝑖𝑅𝑅𝑖
 
Bootstrapping methods will be used to estimate 95% confidence intervals for GIF estimates. 
We will consider several scenarios: 
1) Achieving the Healthy People 2020 goal of a 3% reduction in heavy drinking.  We will 
assume a shift to moderate drinking for these individuals. 
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2) Pricing policy: 10% relative increase.  Based on published elasticity values for alcohol, this 
change in price will reduce consumption roughly 5%.  We hypothesize based on published 
econometric data that light and moderate drinkers will be more inelastic to price change 
than heavy drinkers and therefore the relative reduction in consumption will be smaller in 
these groups than heavy drinkers. 
3) Brief intervention in primary care setting of high-risk individuals.  Based on a Cochrane 
review, this intervention is associated with risk differences of binge and heavy drinking of -
11% and -15%, respectively. 
 
F. Strengths and Limitations 
Strengths of the ARIC data and this proposed study include multiple measurements of 
alcohol intake, a prospective study design with up to 23 years of follow-up, a racially diverse 
population, and robust ascertainment of stroke events.  Strokes were ascertained using multiple 
overlapping methods and validated with medical record abstraction and physician review.  Alcohol 
was measured at 4 time points, was beverage specific, reducing under-reporting.  In addition, 
questions were asked that allow separate of nondrinkers into categories of lifetime abstainers and 
former drinkers. 
 There remain several limitations to the proposed study.  First, selection bias is possible if 
heavy drinkers were less likely to participate in the study or to be lost to follow-up than moderate 
drinkers.  As discussed above, we will perform several sensitivity analyses to assess possible 
selection bias in this study due to censoring and competing risks.  Selection bias from loss-to-follow-
up (censoring) is likely not a threat as it did not differ by alcohol consumption and was minimal 
(<5%).  Data through 2010 suggest that drinking status at visit 1 is unrelated to loss-to-follow-up and 
therefore not a serious threat to validity (percent LTF by drinking category are as follows, 2% never 
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drinkers, 0.7% light drinkers, 0.2% moderate drinkers, 0.2% high drinkers, and 0.04% heavy drinkers; 
p=0.3).  Second, while stroke ascertainment was thorough and utilized several capture methods, 
out-of-hospital events that were not reported by participants during study visits or at annual follow-
up were not captured.  Nor were out-of-hospital fatal stroke events for which the death certificate 
failed to list stroke as the underlying cause of death. 
 Exposure measurement error is one of the primary threats to validity in this study.  Previous 
studies have supported the validity of FFQs, reporting high correlations between alcohol intake 
measured through diet records and FFQs (0.83-0.90) and modest correlations between FFQ and 
serum high-density lipoprotein levels (0.31-0.40).123  Studies have reported that errors are generally 
linearly related to intake, which would result in incorrect absolute values of intake, but would 
provide reasonably reliable ranking of individuals.122, 123  Without a gold standard measure of 
consumption, however, the true validity of self-reported consumption using FFQs is unknown.  
Greater under-reporting of alcohol by heavy drinkers is possible and may lead to underestimation of 
the effect in this group.  The ARIC study does not have a second, independent measure of alcohol 
consumption with which to estimate error and calibrate effect estimates. 
 Confounding, either from failure to account for an important factor or through residual 
confounding, is a concern.  The ARIC study collected data on several potential confounders that 
were unavailable in many previous analyses including SES, social support, smoking amount, and 
physical activity.  Moderate drinking is associated with a general healthy lifestyle and we may not be 
able to fully account for this confounding with the selected covariates.  Nor can we determine with 
certainty if confounders were perfectly measured and modeled.  Finally, it is difficult to determine 
the temporal order at baseline of alcohol and prevalent diseases.  Whether baseline diseases are 
true confounders, i.e. preceded alcohol, or as mediators, i.e. were the result of alcohol 
consumption, cannot be determined.  In primary analyses we will treat these as confounders, as I 
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feel this is the most likely scenario.  We will assess different causal relationships in sensitivity 
analysis. 
 Finally, the prevalence of heavy drinking is low in the ARIC cohort (6.3% consumed 24-60 
g/d and 1.2% consumed >60 g/day at Visit 1).  This may limit our ability to estimate effects with 
adequate precision in these groups.  Furthermore, the heavy drinkers that participated in the ARIC 
study may not represent the larger population of heavy drinkers, limiting generalizability of study 
results. 
 
4.3 Research Plan for the Assessment of Alcohol and Cognitive Decline 
A. Analytic Sample 
The sample for analysis will consist of all ARIC cohort participants without prevalent stroke 
at visit 2.  Visit 2 will serve as study baseline because it was the first visit at which cognitive 
performance was assessed.  Between visits 1 and 2, loss to follow-up was small, only 9%, resulting in 
a total of 14,348 participants.  We will exclude non-white or black participants as well as those with 
missing alcohol exposure, visit 2 cognitive scores, or covariates.  After these exclusions, there will be 
13,704 participants for analysis. 
 
B. Exposure Assessment 
 Assessment of alcohol consumption was described in section 4.2 B.  For Aim 3, we will 
operationalize alcohol exposure as baseline (i.e. visit 2) average consumption.  Participants will be 
categorized into groups because this will facilitate graphical presentation of cognitive declines (i.e. 
displaying slopes by alcohol consumption group).  We will explore different categorizations to best 
capture the dose-response relationship between alcohol volume and cognitive decline.  In 
secondary analysis, we will assess effects of alcohol consumption measured at visit 1 (closer to mid-
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life exposure), cumulative average of visits 1 and 2, and according to different categorizations of 
light, moderate, and heavier consumption. 
C. Outcome Assessment 
 Cognitive function was measured using 3 tests at visit 2 in 1990-1992, at visit 4 in 1996-
1998, and at visit 5 in 2011-2013.  There were 3 components to the cognitive testing: the Delayed 
Word Recall Test (DWRT), Digit Symbol Substitution Task (DSST), and the Word Fluency Task (WFT; 
Appendix 5).  These tests have no ceiling effects, except possibly for the DWRT, which is an 
advantage in a relatively young population without frank dementia.  The tests are summarized in 
Table 22 with regard to the cognitive domains they assess, the task involved, and the theoretical 
score range. 
Table 22. Neuropsychological assessments in the ARIC study 
Neurocognitive 
Assessment 
Domains Task Score 
Range 
Delayed Word Recall 
Test 
Verbal learning 
Short-term memory 
Learn 10 common nouns, use each in 2 sentences, 
recall the words after a 5 minute delay during 
which another task is performed 
0-10 
Digit Symbol 
Substitution Test 
Executive function 
Processing speed 
Participants are provided with a key that links 
different symbols with numbers 1 through 9 and 
asked to write out symbols corresponding to a 
series of numbers in 90 seconds 
0-93 
Word Fluency Test Executive function 
Expressive language 
Generate as many words as possible that start with 
a given letter (F, A, S) within 3 60-second trials  
0-X 
   
Tests were administered by trained and certified staff in a quiet environment without 
distraction.  Administrators were re-certified annually and both technique and protocol adherence 
were monitored over the study.  The scores for the DWRT and WFT are recorded by the test 
administrator, while the DSST is recorded by the participant and scored by the staff member. 
 We will calculate Z-scores for each test at each study visit for analysis.  These scores will be 
standardized to the population mean and standard deviation at Visit 2.  A global cognitive score will 
be calculated by averaging the 3 test-specific z scores at each visit; these global scores will be 
standardized to the visit 2 global mean and standard deviation. 
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D. Confounder Selection and Measurement 
 Potential confounders were identified based on substantive knowledge of factors associated 
with alcohol129 and risk of cognitive decline33, 203 and from existing literature on the association.  
Selection of confounders to include in primary analyses was based on directed acyclic graph analysis 
(Figure 14) that included all potential confounders identified from the literature: demographic 
characteristics (age, gender, race, SES), lifestyle factors (smoking, physical activity, social support, 
marital status, omega-3 fatty acid intake), and medical history (CAD, diabetes mellitus, depression).  
Potential mediators include blood pressure, HDL-C level, atrial fibrillation, fibrinogen, and platelet 
concentrations.  ApoE alleles have been implicated in risk of cognitive decline (ApoeE4) and 
atherosclerosis (ApoE2 and ApoE4) and will be considered as potential covariates.  Allele status is 
not a confounder of the relationship according to the DAG analysis as there are no backdoor paths 
from alcohol to ApoE, but many researchers adjust for this variable because it is highly predictive of 
the outcome.  There was 1 minimally sufficient set of adjustment variables for the estimation of the 
total effect of alcohol on cognitive decline, which included age, sex, race, education, income level, 
diet (i.e. omega-3 fatty acid consumption), physical activity, social support, and history of stroke, 
diabetes, and depression.  In later analysis, income level and depression were not included because 
1) income had a high degree of missing data and it is hypothesized that education adequately 
captures the SES effect on cognition; 2) depression has not yet been validated in ARIC data and we 
believe that adjustment for social support and network size will serve as an adequate proxy for 
depression.  Furthermore, omega-3 fatty acid level was adjusted for as part of a comprehensive diet 
quality score. 
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Information on covariates was obtained from home interviews and clinic visits.  Collection 
and operationalization is described in more detail in Section 4.2.4 for those covariates in common 
with Aim #1.  As discussed above, questions have unknown validity in these data for diagnosis of 
depression and may potentially reflect symptoms of early dementia instead of depression.  
Furthermore, depression is relatively common in the stages of cognitive impairment.  Adjustment 
for factors reflecting early cognitive decline would bias results toward the null.  For these reasons, 
they will not be used in primary analysis.  Current work in the ARIC study is being done to generate 
and validate a depression diagnosis using items from the Vital Exhaustion Scale, a 21-item 
questionnaire that assesses fatigue lack of energy, and feelings of hopelessness.218 
 
E. Statistical Analysis 
Linear regression models with generalized estimating equations (GEE) will be used to 
estimate rates of cognitive decline by alcohol consumption status and additional changes in 
cognitive scores relative to never drinkers.  GEE is an alternative estimating technique to maximum 
likelihood that is appropriate for longitudinal data analysis with correlated responses.  These models 
Figure 14. Directed acyclic graph for the relationship between alcohol and cognitive decline 
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are marginal (i.e. population-averaged, with effects contrasting outcomes of a randomly selected 
exposed individual to a randomly selected unexposed individual) and therefore allow for group-level 
inferences.219  This is in contrast to mixed modeling approaches in which estimates relate to 
inferences about the subject-specific likelihood of an outcome given exposure (i.e. the effect on an 
outcome for an individual selected at random if they experience a change in exposure status).  
Marginal models are well suited for our scientific aim of comparing cognitive decline patterns 
between sub-populations defined by alcohol consumption level.  Another reason they are well-
suited is that GEE is best for data that have large sample size, but relatively small number of 
repeated observations within a subject, which is satisfied by our data. 
 GEE models are robust to misspecification of the correlation structure of repeated 
observations within a subject because the mean response is conditional only on covariates and not 
within subject correlation.219  Valid standard errors are obtained with the “sandwich” estimator and 
higher precision is achieved with correct specification of the working correlation matrix.  A limitation 
of GEE as compared with mixed models is its stricter assumptions for missing data.  In GEE, outcome 
data are assumed to be missing completely at random, dependent on covariates but not observed 
or unobserved outcomes.  This assumption may be violated.  Mixed models assume missingness at 
random and therefore missing data can be associated with both covariates and observed outcomes.  
Potential bias from missing data will be explored in sensitivity analysis using inverse-probability 
weights or other methods (see Section 4.4).  In addition, we will estimate effects using mixed 
models to assess the robustness of our estimates obtained from GEE compared with mixed models 
with random intercepts and with both random intercepts and slopes. 
The proposed model for our analysis is shown below, where u represents the mean 
response (cognitive score) and the matrix Z represents the covariates identified in Section 4.3.4 and 
study center.  We will model the working correlation matrix using unstructured correlation, as this is 
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flexible and can be fit with our large sample size.  Exposure will be included as a class variable, with 
lifetime abstainers serving as the reference group.  Time on study will be represented by linear 
spline variables with a knot at 6 years as recommended by the NCS analytic team.  This 
parameterization will allow estimation of mean changes from years 1 to 6 and from 6 to 20.  
Interactions between all covariates and time will be included unless not statistically significant at 
alpha=0.2.  Our primary interest is on the parameter estimate for the interaction between alcohol 
and time, 𝛽3.  This estimate reflects how the average rates of cognitive decline differ between 
groups, for example moderate drinkers compared with lifetime abstainers. 
𝑢𝑖𝑖 = 𝛽0 + 𝛽1𝑎𝑙𝑎𝑙ℎ𝑙𝑙 + 𝛽2𝑡𝑡𝑡𝑡 + 𝛽3𝑎𝑙𝑎𝑙ℎ𝑙𝑙 ∗ 𝑡𝑡𝑡𝑡 + �𝛽𝒁 + �𝛽𝒁 ∗ 𝑡𝑡𝑡𝑡 + 𝜀 
Effect measure modification of alcohol consumption by sex-race and ApoE ε4 allele status 
will be assessed using interaction terms as well as by comparing stratum-specific effect estimates.  
Finally, models will be re-fit in sensitivity analysis using a re-weighted sample or multiple imputation 
of missing data to correct for subject attrition over time.  Selection of the methodological approach 
to account for attrition and additional details of this analysis are described in Section 4.4. 
 
F. Strengths and Limitations 
 Strengths of the ARIC data and this proposed study include its prospective study design with 
20 years of follow-up, a racially diverse population, and multiple measurements of cognitive 
function over time.  The cognitive assessments used are sensitive to changes at higher levels of 
cognition unlike in many other studies that relied solely on MMSE scores.  Alcohol consumption was 
measured mid-life with a further 20 years for outcome follow-up.  Finally, we will utilize the richness 
of the ARIC data to build predictive models for attrition that will allow us to correct for selection 
bias. 
 111 
 
 There remain several limitations to the proposed study.  First, in-selection bias is possible if 
heavy drinkers were less likely to participate in the study or to be lost to follow-up than moderate 
drinkers.  As discussed above, drinking at baseline was not associated with attrition by Visit 2 and 
total attrition prior to Visit 2 was small.  The greater concern for selection bias is out-selection bias 
occurring after Visit 2 by way of drop-out or death.  This bias may remain even after we correct for 
attrition in sensitivity analyses.  There is potential for floor and practice effects in cognitive 
assessments. 
 As in Aim #1, exposure measurement error and confounding are threats to validity.  While 
relative validity studies support FFQ measurement of alcohol, there is no gold standard for true 
validation.  Under-estimation of consumption by heavy drinkers is possible and would result in 
misclassification.  Confounding, either from failure to account for an important factor or through 
residual confounding, is a concern.  The ARIC study collected data on several potential confounders 
that were unavailable in many previous analyses including SES, social support, and physical activity.  
Moderate drinking is associated with a general healthy lifestyle and we may not be able to fully 
account for this confounding with the selected covariates (diet, smoking, physical activity).  Finally, 
the prevalence of heavy drinking is low in the ARIC cohort and may limit our ability to estimate 
effects with adequate precision in these groups.  Furthermore, the heavy drinkers that participated 
in the ARIC study may not represent the larger population of heavy drinkers, limiting generalizability 
of study results. 
 
4.4 Sensitivity Analyses 
A. Alternative Approaches of Specifying Alcohol Exposure 
 Alcohol is a complex exposure variable, with multiple dimensions including quantity, 
frequency, duration, and type.  It is also non-monotonic with respect to disease risk.  Time 
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permitting, we will consider several alternative approaches to operationalizing exposure including 
assessing independent effects of quantity and frequency if feasible (and possible cross-classifications 
of these) and cumulative intake metrics to capture duration effects.  We will consider calculating 
average intake over follow-up using reported intake at all study visits prior to the outcome (i.e. visit 
immediately prior to the date of first stroke or censored date for Aim #1 and visit 2 for Aim #3).  
Finally, we will compare our effect estimates in categorical analysis (based on data-driven cut-
points) to a variety of different definitions for light, moderate, and heavier drinking used in the 
literature and in guideline recommendations for alcohol consumption. 
 
B. Accounting for Informative Visit Nonattendance and Death 
 Sample weighting is a method that can be used to correct for selection bias from missing 
data, in our case from visit nonattendance and death in Aim #3.  The method proposed herein has 
been guided by work done by the Neurocognitive Study Analysis Workgroup.220  We will assume a 
monotone drop-out model as opposed to an intermittent missingness model because it requires 
fewer assumptions and is appropriate for the majority of attrition in our study.  We will therefore 
consider an individual as exiting the study at the time of their first missing cognitive score regardless 
of subsequent non-missing scores.  If intermittent missingness is common, which we assume is not 
the case, we will consider using multiple imputation to predict these intermittent missing values. 
 We will calculate observation-specific weights that are the inverse cumulative probability of 
death as estimated using logistic regression.  First, we will fit logistic regression models to predict 
being alive at a study visit conditional on being observed at the previous visit.  Second, we will 
calculate conditional probabilities for non-dropout conditional on being alive.  Third we will 
calculate joint probabilities of being alive and observed at each visit as the product of probabilities in 
Steps 1 and 2.  Fourth, we will calculate cumulative probabilities as the product of joint probabilities 
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at each previous visit.  Fifth, we will calculate weights as 1/cumulative probability.  Weights will be 
stabilized if there is instability defined as a maximum weight that is more than 20 times the 
minimum weight. 
 IPW analysis will be carried out assuming an independent correlation structure, which is the 
more conservative option without a large penalty of increasing standard errors.  We will calculate 
bootstrapped standard errors, which are more precise than model-derived standard errors.  As our 
analysis will include correction for both death and dropout, it will provide estimates of etiologic 
associations between alcohol and cognitive decline with inference to a hypothetical population in 
which death is related only to the exposure.  This approach will be unbiased assuming the models 
for death and dropout are correctly specified.  Covariates to be included in these models will include 
observed outcomes at previous visits, main model covariates, additional variables from annual 
follow-up data including disease status (incident stroke, MI), and interactions between these 
variables. 
 Since the initial proposal of this method, simulation results from models estimating 
cognitive decline with other exposures has shown IPW methods ineffective at modeling the drop-
out and death in the population.  An alternative method, multiple imputation with chained 
equations, was identified, tested, and found to be superior.  Unlike with IPW, MICE-corrected 
estimates differed from complete case analysis and changed in the hypothesized direction.  
Therefore, we opted to use the MICE method instead of IPW for our sensitivity analysis.   
 MICE is a method to handle missing data that generates multiple imputations for variables 
of interest and therefore is able to incorporate uncertainty in the imputation process into the final 
variance of point estimates from analysis models.221, 222  The assumption of this method is that the 
data are missing at random, i.e. on observed values only.  We will use MICE to impute missing 
covariates and missing cognitive scores at visits 4 and 5.  A set of chained equations is used whereby 
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each successive variable is imputed, beginning with those with the least amount of missing data.  
The link function of a given imputation model depends on the variable type, e.g. logit for binary 
data, identity for continuous variables.  Because the proportion missing alcohol exposure is very low 
(0.3%), we will not impute missing exposure.  The imputation process will be repeated 24 times so 
that a total of 25 datasets with ‘complete’ data are generated.  Analysis models will be run, using 
GEE and mixed models, on each of the 25 datasets to obtain estimates for the alcohol-cognitive 
decline relationship.  These points estimates are then combined into a single estimate with variance 
calculated to account for the uncertainty in the imputations (between variance) as well as the within 
dataset variance.  The covariates for the imputation models will include all covariates in the analysis 
model, alcohol, as well as predictors of missingness.  These latter variables include: self-reported 
outcomes on annual follow-up (stroke, CHD, diabetes, hypertension, lung disease), nursing home 
residence, proxy respondent on annual follow-up, functional status, hospitalizations, previous 
measured cognitive scores, clinical dementia rating score, Mini Mental State Exam score, TICS score, 
suspected dementia based on ICD-9 hospitalization codes, and APOE allele status. 
 Diagnostics of imputed data will be performed by examining descriptive statistics for 
observed and imputed variables, identifying outlying values, and graphical representations.  The 
MICE procedure will be carried out using code provided by the ARIC Neurocognitive Study working 
group using STATA.  Analysis models will be run on 1) complete data, 2) data with imputed 
covariates only, 3) data with imputed covariates and outcomes for alive persons, and 4) imputed 
covariates and outcomes for the living and the dead.  Because we will be imputing cognitive scores 
for participants that die 6 months prior to their date of death, the study design becomes unbalanced 
with regard to timing of cognitive measurements.  As such, GEE models may not be appropriate and 
therefore we will also estimate effects using mixed models. 
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C. Additional Sensitivity Analyses 
 Several other sensitivity analyses will be performed for Aims #1 and #3.  In particular these 
include: 
1) Comparing points estimates and 95% confidence intervals from Cox models in Aim #1 with 
and without adjustment for baseline factors that could act as confounders or mediators (i.e. 
hypertension and body mass index). 
2) Investigate possible floor effects in cognitive scores that may prevent measurement of 
declines in z scores over time.  This will be achieved by dropping participants in the lowest 
5% of a given z score and re-running linear regression models to estimate additional 
cognitive changes.  These points estimates and confidence intervals will be compared to 
those from models without dropping low baseline scores. 
3) Assessing the stability of the MICE models by repeating the imputation procedure and 
comparing point estimates and their confidence intervals between the two sets of 
imputations.  If similar, this will be taken as evidence of stability.  If they differ, we will 
investigate using more imputations or altering the MICE models to achieve stability. 
4) Re-running MICE models with a 20% validation sample.  We will compare the (‘true’) scores 
of this 20% sample with the imputed scores using regression, the R-squared statistic, and 
plots showing Lowess fit curves.  We will also compare the performance of the imputation 
by education, sex-race, and alcohol intake category. 
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CHAPTER 5. MANUSCRIPT #1: MIDLIFE ALCOHOL CONSUMPTION AND THE RISK OF STROKE IN THE 
ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY 
 
5.1 Overview 
Background: Alcohol consumption is common in the U.S. and may confer beneficial cardiovascular 
effects at low-to-moderate doses.  The alcohol-stroke relationship remains debated.  We sought to 
estimate the relationship between mid-life, self-reported alcohol consumption and ischemic stroke 
(IS) and intracerebral hemorrhage (ICH) in a biracial cohort. 
Methods: We examined 12,433 never and current drinkers in the Atherosclerosis Risk in 
Communities Study, aged 45-64 at baseline.  Participants self-reported usual drinks/week of beer, 
wine, and liquor at baseline.  We used multivariate Cox proportional hazards regression to assess 
the association of alcohol with incident IS and ICH and effect modification by sex-race group.  We 
modeled alcohol intake with quadratic splines to further assess dose-response relationships. 
Results:  One-quarter of participants self-reported abstention, 33% and 20%, respectively, 
consumed ≤3 and 4-17 drinks/week, and only 4% reported heavier drinking.  There were 773 IS and 
81 ICH over follow-up (median ~22.6 years).  Light and moderate alcohol consumption were not 
strongly associated with IS (HRLight=0.98, 95% CI 0.79-1.21; HRMod=1.06, 0.84-1.34) while heavier 
drinking was associated with a 31% increased rate relative to abstention.  There was no support for 
a J-shaped curve; rather we noted a roughly linear relative increase across intake.  Moderate (2.07, 
1.10-3.87) and heavy (1.48, 0.47-4.63), but not light, consumption tended to increase the rate of 
ICH. 
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Conclusion: Self-reported light-to-moderate alcohol consumption at mid-life was not associated 
with reduced stroke risk compared with abstention over 20 years of follow-up in the ARIC study.  
Heavier consumption increased the risk for both outcomes as did moderate intake for ICH. 
 
5.2 Introduction 
Stroke is a leading cause of mortality and disability worldwide, a major contributor to U.S. 
health care costs, and is projected to increase in burden as the population ages.7, 9, 223  Given the 
high burden of stroke, continued examination of modifiable risk factors and behaviors that may 
prevent disease occurrence is needed.  One such factor may be alcohol, a prevalent exposure both 
in the U.S. and worldwide.  Seventy percent of U.S. adults report current drinking and more than 
one-quarter report excessive drinking (either heavy episodic or average consumption). 50, 67 
The relationship between alcohol intake and stroke has been widely studied, yet 
uncertainties remain; results from observational studies are inconsistent and randomized trials are 
infeasible.  Light-to-moderate alcohol consumption may reduce the risk of stroke, but some studies, 
particularly older ones, have not found beneficial effects.  Current meta-analyses suggest that 
moderate intake is protective for ischemic stroke (IS), but not intracerebral hemorrhagic (ICH), with 
possible differential dose-responses between women and men.2, 6, 14  Limitations of our 
understanding stem from 1) the assessment of alcohol intake late in life, a period that may not 
reflect the most critical exposure window for disease risk and that may be influenced by other 
medical conditions developing in later life; 2) alcohol measurement errors and misspecification due 
to variations in drinking patterns; and 3) limited generalizability.2, 6, 14, 39, 164, 166, 167, 169, 186, 190  
Furthermore, some studies do not adjust for lifestyle and socioeconomic factors that may account 
for protective effects in light drinkers or combine never and former drinkers into a single referent 
group.  In contrast to the evidence on effects of light-to-moderate intake, consistent and convincing 
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evidence supports the harmful effects of heavy consumption on stroke risk.  The precise dose-
response relationship, however, is unclear.   
Despite the large body of work on alcohol and stroke, few studies have included substantial 
numbers of minority populations.  Blacks have higher stroke incidence and different drinking 
patterns from whites and therefore warrant investigation.7  In addition, studies to date have not 
accounted for the competing risk of mortality, which may be substantial in prospective studies.  
Subdistribution hazard estimation may be particularly useful to public health scientists interested in 
assessing risks and benefits of alcohol in a population in the presence of competing risks.224  In our 
study, we estimated the dose-response relationship between usual, mid-life alcohol consumption 
and incident stroke among black and white adults in the Atherosclerosis Risk in Communities (ARIC) 
study, a population-based cohort drawn from 4 U.S. communities. 
 
5.3 Methods 
Study Population 
The ARIC study is a population-based cohort recruited using probability sampling of adults 
aged 45-64 years from 4 U.S. communities: Forsyth County, NC; Jackson, MS; suburbs of 
Minneapolis, MN; and Washington County, MD.  The ARIC study design and rationale are described 
in detail elsewhere.204  A total of 15,792 participants were enrolled at Visit 1 (1987-1989) and 
underwent an in-home interview and physical examination.  Four additional study visits consisting of 
an interview and physical examination occurred over the subsequent 25 years.  The study 
population for analysis excluded participants not classified as white or black (N= 48), blacks from 
Minnesota or Washington County (N=55), missing alcohol intake at baseline (N=106), and those with 
a history of stroke at baseline (N=284).  After these exclusions, the analytic cohort totaled 15,305.  
We further limited our population to current or never drinkers (N=12,433) because of the 
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heterogeneity in exposure among former drinkers in our population with regard to duration and 
quantity of consumption and time since cessation.167 
Alcohol Assessment 
Alcohol consumption was measured at baseline using an interviewer-administered dietary 
questionnaire developed in accordance with the validated Willett 66-item food frequency 
questionnaire (FFQ).208  Participants were asked to report whether they currently consumed 
alcoholic beverages and if so, their usual intake over the past 12 months in units of drinks per week.  
Separate intake frequency questions were asked for standard drinks of wine (4-oz), beer (12-oz), 
and hard liquor (1.5-oz).  
Stroke Definition 
Suspected stroke hospitalizations were ascertained by self-report during in-home 
interviews, at study visits, and during annual follow-up as well as through surveillance of local 
hospital discharge lists.  Validation of suspected events and determination of stroke diagnosis were 
conducted independently by a computer-derived algorithm and a physician reviewer using data 
abstracted from the medical record; differences were adjudicated by a second physician reviewer.  
Strokes were classified using criteria adopted from the National Survey of Stroke206 and required, at 
a minimum, evidence of sudden or rapid onset of neurological symptoms lasting >24 hours or 
leading to death in the absence of evidence for a nonstroke cause.  Out-of-hospital fatal strokes 
(N=19) were not validated and are not included.  Additional details of stroke subtype classification 
have been published.207   
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Covariates 
Confounders were identified based on substantive knowledge and from existing literature.  
Directed acyclic graph analysis was used to obtain a minimally sufficient set of adjustment variables: 
age, sex, race, study center, baseline comorbid conditions, diet score, low-density lipoprotein 
cholesterol, education, smoking status, and marital status.  Mediators included blood pressure, high-
density lipoprotein cholesterol, and atrial fibrillation.   
Dietary factors were assessed using an interviewer-administered 66-item FFQ measuring 
usual intake of foods over the past year.  Food models were used by interviewers to convey portion 
sizes and nutrient content was calculated through linkage with the nutrient database developed by 
Willett et al.208  We calculated a diet score as described elsewhere225 based on quintile values for 6 
dietary components: percent energy from trans-fatty and omega-3 fatty acids, fiber, folate, glycemic 
load, and polyunsaturated:saturated fatty acid ratio.  Physical activity was measured using the 
Baecke physical activity questionnaire.209  Baseline medical history included diabetes (self-reported 
physician diagnosis, fasting glucose ≥126 mg/dL, or self-reported pharmacologic treatment) and 
coronary artery disease (electrocardiogram-adjudicated or self-reported myocardial infarction or 
any of self-reported heart/arterial surgery, coronary bypass, or angioplasty).   
Statistical methods 
Descriptive statistics for participant characteristics were calculated according to categories 
of alcohol intake and weighted according to the person-time in each exposure group.  Cox 
proportional hazards regression was used to estimate hazard ratios and 95% confidence intervals for 
the association between alcohol and incident IS, ICH, and total stroke.  Participants contributed 
person-time until the earliest of: incident stroke, death, loss to follow-up, or end of follow-up on 
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December 31, 2011.  The proportional hazards assumption was tested using interaction terms 
between exposure and time. 
Alcohol consumption was categorized as drinks per week by examining the dose-response 
relationship as well as using a priori values selected to align with prior research and recommended 
intake guidelines.  Results were similar for both sets of cut-points and are presented herein as <0.5-
3, 4-17, and 18 or more drinks per week.  In secondary analyses, we assessed possible non-linear 
relationships using quadratic splines.  Knots were selected based on AIC values compared across 
models with 2, 3, and 4 knots located at percentile values.226, 227  Secondary models for IS were 
stratified by sex-race group. 
Finally, in sensitivity analysis, we estimated sub-distribution hazard ratios to assess the risk 
of stroke given the relatively high proportion of death (26%) over follow-up.  Censoring for death, as 
in cause-specific hazards models, yields estimates that reflect the relative rate of stroke.  Sub-
distribution hazards ratios, on the other hand, reflect the relative risk over a period of time.224  
These were obtained using the SAS macro PSHREG based on the proportional sub-distribution 
hazards model proposed by Fine and Grey.228  All analyses were conducted using Statistical Analysis 
Software Version 9.2 (SAS Inc., Cary, N.C.). 
 
5.4 Results 
Nearly one-third of the cohort were light alcohol drinkers, consuming ≤3 drinks/week (Table 
23).  Twenty percent were moderate drinkers of 4-17 drinks/week, and only 4% consumed >18 
drinks/week.  A quarter of participants reported lifetime abstention from alcohol.  Women 
comprised the largest proportion of abstainers and white men accounted for nearly three-quarters 
of heavier drinkers.  Light-to-moderate drinkers were of higher socioeconomic status – in the form 
of greater educational attainment, more managerial occupations, and higher family income - than 
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heavier drinkers and lifetime abstainers.  Current smoking was reported by 46% of heavier drinkers 
but only 23% of light drinkers.  The prevalence proportion of diabetes was low overall (8.6%) and 
was roughly twice as high in abstainers compared with current drinkers.  Finally, blood pressure and 
HDL-C increased across alcohol consumption level. 
 
Table 23. Characteristics of ARIC participants according to self-reported usual alcohol consumption at baseline.* 
 
Alcohol consumption, drinks per week 
  
Lifetime 
abstainer ≤3 4-17 18+ 
Number of participants 3851 4876 3042 664 
Person-years 76974.8 99125.5 60479.2 11947.2 
Alcohol consumption, median (25th-75th) 
    Grams ethanol per week 
 
0 (0-24) 95 (68-151) 317 (277-415) 
Glasses per week 
 
0 (0-2) 7 (5-11) 24 (20-30) 
Age, years 54.6 (5.7) 53.7 (5.8) 53.8 (5.7) 53.9 (5.8) 
Sex-race group 
    White men 14 34 50 71 
White women 40 55 34 11 
Black men 8 4 11 17 
Black women 38 7 5 2 
Educational attainment 
    <High school 30 13 14 19 
High school or vocational 41 45 38 43 
College degree or higher 29 43 49 38 
Occupation 
    Managerial 18 29 34 25 
Non-managerial 69 59 53 57 
Retired 13 13 14 19 
Income 
    <$12,000 22 7 7 10 
$12,000-$49,999 65 60 52 60 
$50,000+ 13 34 41 30 
Physical activity index score 2.2 (0.7) 2.5 (0.8) 2.6 (0.8) 2.4 (0.8) 
Diet score 12.3 (3.8) 11.8 (3.9) 12.0 (3.8) 12.0 (3.7) 
Cigarette smoking 
    Current 13 23 30 46 
Former 16 33 43 43 
Never 71 44 27 12 
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Lifetime 
abstainer ≤3 4-17 18+ 
Blood pressure, mmHg  
    Systolic 124.0 (19.9) 117.9 (17.3) 120.9 (18.4) 127.1 (18.8) 
Diastolic 74.5 (11.5) 72.2 (10.6) 74.3 (11.2) 77.0 (11.5) 
LDL-c, mg/dL 139.4 (40.7) 136.3 (38.1) 135.3 (39.7) 132.4 (39.8) 
HDL-c, mg/dL 37.8 (10.7) 37.0 (10.9) 39.4 (11.7) 40.5 (12.1) 
Body mass index, kg/m2 29.0 (6.1) 27.1 (4.9) 26.6 (4.5) 26.7 (4.5) 
Coronary artery disease 2 3 3 4 
Diabetes 13 7 7 7 
* Population includes never and current drinkers (N=12,799), excluding participants with history of stroke, not of 
white or black race, blacks from Washington County or Minnesota, and missing alcohol information (N=366).  
Proportions reflect person-time distributions of covariates.  Values are presented as %, or mean (SD), unless 
otherwise specified 
 
Over a median follow-up of 22.6 and 22.7 years, respectively, there were 773 IS and 81 ICH.  
Ischemic stroke incidence rates per 100,000 person-years increased across alcohol intake categories: 
251 for ≤3/wk, 313 for 4-17/wk, 435 for ≥18/wk, and 368 for abstainers (Table 24).  After 
adjustment, light and moderate drinking were not associated with IS (HR=0.98, 95% CI 0.79-1.21; 
1.06, 0.84-1.34, respectively; Table 24).  Heavier drinking was associated with a 31% relative 
increase (HR=1.31, 0.92-1.86). 
Table 24. Hazard ratios and 95% confidence intervals (CI) for the association of alcohol consumption and IS 
and ICH 
 Alcohol Consumption, drinks per week 
N Events 
  Lifetime abstainer ≤3 4-17 18+ 
Ischemic stroke 
    
 
 Events 283 249 189 52  
 Person-years 76,975 99,126 60,479 11,947  
 Incidence rate per 
100,000 PY (95% CI) 
367.7 
(324.8-410.5) 
251.2 
(220.0-282.4) 
312.5 
(268.0-357.1) 
435.2 
(316.9-553.6)   
Hazard ratio (95% CI) 
   
 
 Unadjusted 1 0.68 0.85 1.22 12,433 773 
(0.57-0.81) (0.71-1.02) (0.91-1.64) 
Model 1* 1 0.90 0.97 1.17 12,407 771 
(0.74-1.10) (0.78-1.20) (0.84-1.63) 
Model 2** 1 0.98 1.06 1.31 11,452 684 
(0.79-1.21) (0.84-1.34) (0.92-1.86) 
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 Lifetime abstainer ≤3 4-17 18+ N Events 
Intracerebral 
hemorrhage  
     
Events 31 20 26 4   
Person-years 78,599 100,456 61,415 12,296   
Incidence rate per 
100,000 PY (95% CI) 
39.4 
(25.6-53.3) 
19.9 
(11.2-28.6) 
42.3 
(26.1-58.6) 
32.5 
(0.7-64.4)   
Hazard ratio (95% CI)      
Unadjusted 1 0.50 1.08 0.85 12,433 81 
  (0.29-0.89) (0.64-1.81) (0.30-2.40)   
Model 1* 1 1.03 2.07 1.48 12,407 81 
  (0.55-1.93) (1.10-3.87) (0.47-4.63)   
* Model 1 is adjusted for age (linear), center-race interaction (5 levels), sex, educational attainment (<high 
school, high school, college or higher), and cigarette smoking (current, former, never). 
** Model 2 is additionally adjusted for marital status (married, divorced/separated, widowed, never married), 
LDL-C (quadratic), diet score (linear; comprised of % energy from trans-fatty acid and ω-3 fatty acid, fiber (g), 
folate (mg), glycemic load, and polyunsaturated:saturated fatty acid ratio), physical activity at work, leisure, 
sports (continuous), and prevalence of coronary artery disease (binary) and diabetes (binary) at baseline. 
 
Associations of light drinking compared with abstention were close to the null and largely 
similar across sex-race sub-groups, though whites had lower HRs compared with blacks (Figure 15).  
Moderate drinking estimates differed somewhat across subgroups, although confidence intervals 
overlapped considerably: there was a protective effect among white women (HR=0.63, 0.39-1.02), 
effects closer to the null in white men and black women, and increased risk among black men. 
Figure 15. Associations of midlife alcohol consumption and IS by sex-race group 
Diamonds and whiskers represent hazard ratios with 95% confidence intervals, respectively.  The left 
panel compares effects by race among women; the right panel compares effects by race among men. 
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ICH incidence rates ranged from 20 per 100,000 person-years among light drinkers to 42 
among moderate drinkers.  We found no association with light drinking (HR=1.03, 0.55-1.93) after 
adjustment for age, race, sex, smoking status and education (Table 24).  Both moderate and heavy 
drinking, however, were associated with higher ICH rates compared with abstention (HRmoderate=2.07, 
1.10-3.87; HRheavy=1.48, 0.47-4.63).  The precision of these estimates was low because of small 
numbers of events, which also precluded adjustment for additional lifestyle factors.  Effect 
estimates for total stroke (IS+ICH) were similar to those for IS alone: HRlight=0.98, 0.80-1.20; 
HRmoderate=1.13, 0.91-1.42; and HRheavy=1.36, 0.97-1.91. 
Results from Cox models with quadratic spline for alcohol intake did not support a J-shaped 
relationship (Figure 16).  Furthermore, the log-hazard ratio of IS was roughly linear across intake 
(β=0.06 for a 1 drink-per-week increase; HR=1.06, 0.99-1.13).  Additional quadratic (p=0.3) and cubic 
terms (p=0.9) were not statistically significant compared with the linear model. 
Figure 16. Dose-response relationship between midlife alcohol consumption and IS estimated with 
quadratic splines. 
   
Shading indicates 95% confidence bands.  Knots were placed at 0.5, 3, and 17 drinks/week.  Point estimates 
and 95% confidence intervals from categorical analysis are overlaid at the median of each category. 
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 More than one-quarter of the participants died over follow-up, ranging from 24% in light to 
42% in heavier drinkers.  In sensitivity analyses, we estimated sub-distribution hazards models that 
account for this underlying risk of mortality to produce HRs that reflect the relative cumulative 
incidence – or risk - in our population.  As expected, effect estimates were attenuated slightly for 
heavy drinkers, but conclusions were largely unchanged; light and moderate alcohol consumption 
were not associated with reduced IS risk compared with abstention and may increase ICH risk (Table 
25). 
Table 25. Cause-specific and subdistribution hazard ratios and 95% confidence intervals (CI) for the 
association of alcohol consumption and IS and ICH 
 Alcohol Consumption, drinks per week 
  
Lifetime 
abstainer ≤ 3 4-17 18+ 
Ischemic stroke* 
    Hazard ratio (95% CI) 
   Unadjusted 1 0.68 0.85 1.22 
(0.57-0.81) (0.71-1.02) (0.91-1.64) 
Cause-specific 1 0.98 1.06 1.31 
(0.79-1.21) (0.84-1.34) (0.92-1.86) 
Subdistribution 1 0.97 1.06 1.19 
(0.79-1.21) (0.84-1.35) (0.83-1.72) 
Intracerebral hemorrhage**    
Hazard ratio (95% CI)    
Unadjusted 1 0.50 1.08 0.85 
(0.29-0.89) (0.64-1.81) (0.30-2.40) 
Cause-specific 1 1.03 2.07 1.48 
(0.55-1.93) (1.10-3.87) (0.47-4.63) 
Subdistribution 1 1.07 2.13 1.37 
(0.55-2.05) (1.07-4.23) (0.43-4.40) 
* IS models are adjusted for covariates listed in Model 2 of Table 2. 
** ICH models are adjusted for covariates listed in Model 1 of Table 2. 
 
5.5 Discussion 
We did not find support for a J-shaped relationship between mid-life alcohol consumption 
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and IS in this study of a bi-racial population-based cohort of U.S. adults.  There was little effect of 
drinking on rates of IS until heavier drinking levels.  ICH rates were increased even at moderate 
levels of drinking compared with lifetime abstention, though strict monotonicity was not observed 
and confidence intervals were wide.  Sex-race stratified results suggest a possible protective effect 
of light-to-moderate drinking on IS among white women, but not other groups.  Heterogeneity by 
sex-race may reflect different drinking patterns, lifestyle and socio-cultural factors, measurement 
error, or imprecision in our estimates. 
Alcohol consumed moderately in mid-life has been suggested to reduce IS risk through its 
chronic anti-thrombotic, anti-inflammatory, and anti-atherogenic effects.  It beneficially alters 
several vascular risk factors including high-density lipoprotein cholesterol, fibrinogen, blood 
pressure, platelet aggregation, inflammatory markers and insulin sensitivity compared with no 
drinking.6, 42-44  In contrast, high doses of alcohol have well-established deleterious effects mediated 
through elevations in blood pressure, reduction in cerebral blood flow, and development of atrial 
fibrillation and cardiomyopathy that in turn increase stroke risk.18  Alcohol at lower doses may also 
increase the risk for hemorrhage through hemostatic changes that promote bleeding.  Biological 
mechanisms may differ by sex.  Women attain higher blood alcohol levels than men because of 
higher body fat percentages, lower water concentrations, and slower alcohol metabolism.49 
A J-shaped relationship between alcohol consumption and ischemic stroke is frequently 
reported.6, 14, 39, 166, 169  For example, consumption of ≤1 drink/d was associated with a 20% reduced 
risk of ischemic stroke and 1-2 drinks with a 28% reduced risk in pooled data analysis.6  Pooled 
hazard ratio estimates may be limited by inclusion of non-validated stroke events, lack of 
adjustment for lifestyle factors such as physical activity and diet, and inclusion of causal 
intermediates (e.g. blood pressure and HDL-C) in regression models.  Our results, based on well-
validated stroke events, were controlled for important confounders and suggest no clear J-shaped 
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relationship.  The dose-response relationship we estimated was imprecise, but was approximately 
linear and above the null across alcohol intake. 
Stronger protective effects of low-dose alcohol may be present among women compared 
with men.6, 14  Meta-analyzed hazard ratios comparing light drinking with abstention are 0.66, 95% CI 
0.61-0.71 for women and 0.80, 0.67-0.96 for men, consistent with our results for white women, but 
not men, in the ARIC Study.6  Women who consumed less than ~2 drinks/d in the Nurses’ Health 
Study had a 12-18% lower risk of IS compared with non-drinkers.169  The Nurses’ Health Study 
population was almost exclusively white and our results align with these, showing similar effects of 
moderate drinking in white, but not black, women in the ARIC study.  Our results for men were 
similar to those reported by the Health Professionals Follow-up Study that found no association for 
<1 drink/d and slightly elevated risk at ≥1 drinks/d.167  In addition to sex differences, we noted 
possible differences by race such that blacks had higher HRs than whites.  These differences may be 
explained by different drinking patterns between whites and blacks.229  Interactions between 
quantity and volume may exist such that moderate drinking is beneficial when consumed at 
moderate but not high frequency.167  One of the few studies to report race-specific results found 
similar protective effects of light drinking in both blacks and whites.  Differences between these and 
our study results may reflect the timing of alcohol measurement (mid-life at baseline in ARIC vs. 
post-stroke self-report) and our adjustment for diet and physical activity.39 
ICH risk appears to increase log-linearly with increasing alcohol consumption based on 
current literature.  Consumption of 2 or fewer drinks per day compared with abstention was 
associated with a 12-24% reduced risk of hemorrhagic stroke in the Nurses’ Health Study.  We found 
no evidence of a protective effect of light drinking in our population.  Rates increased even at 
moderate drinking levels (4+ drinks/wk).  Our results, however, were limited by small numbers of 
events. 
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In sensitivity analysis, we assessed whether alcohol increases the risk of experiencing stroke 
– as opposed to the rate of disease – as this is a relevant question for population scientists 
estimating disease burden.  The results of sub-distribution hazards models were unchanged for light 
and moderate drinking categories and attenuated slightly for heavier drinking compared with cause-
specific hazards. 
Our results should be interpreted in light of several limitations.  Participants may under-
report alcohol consumption.  While we were unable to quantify errors or calibrate effect estimates, 
construct and rank-order validity of our measure was supported by positive correlations of alcohol 
with both HDL-C and blood pressure.  Selection bias from loss to follow-up is unlikely as it was rare 
(<5%) and independent of alcohol consumption conditional on model covariates. Residual 
confounding is possible, although we adjusted for many important confounders to minimize bias.  
The prevalence of heavy drinking was low (7.5% consumed >2 drinks/d) and limited our ability to 
estimate the impact of heavier drinking.  Finally, race-specific results may not generalize to the U.S. 
population outside of the ARIC communities. 
 Strengths of our study include a prospective study design with ~23 years of follow-up, a bi-
racial population, and robust ascertainment of stroke events.  Alcohol consumption was assessed 
using a validated instrument with beverage-specific questions (thus reducing under-reporting) that 
differentiated never from former drinkers.  We had rich covariate data, allowing adjustment for 
lifestyle factors, smoking, and SES. 
Public health recommendations on alcohol consumption must consider both its associated 
benefits and risks.  While light-to-moderate intake may reduce the risk of some cardiovascular 
outcomes, harmful effects may exist even at low doses (e.g., dependency, cancer, medication 
interaction).  As such, the American Heart Association does not recommend initiation of drinking for 
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disease prevention.47  Our results support this recommendation.  We found no risk reduction for IS 
or ICH with light-to-moderate mid-life alcohol consumption and increased risks at heavier intake 
levels.  Our observed sex-race differences, limited by sample size, warrant further investigation in 
other cohorts.  Understanding the alcohol-stroke relationship would also be advanced by assessing 
dose-dependent exposure measurement errors and estimating their impact on effect estimates. 
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CHAPTER 6. MANUSCRIPT #2: MIDLIFE ALCOHOL CONSUMPTION AND COGNITIVE DECLINE IN THE 
ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY 
 
6.1 Overview 
Background: The effect of alcohol at low-to-moderate doses on cognitive aging trajectories is 
uncertain.  Identifying modifiable factors that may delay or prevent cognitive impairments is critical 
given the high burden on patients, their caregivers, and the healthcare system.  We estimated 
additional 20-year cognitive changes according to self-reported alcohol consumption. 
Methods: We analyzed 13,704 Black and White adults in the Atherosclerosis Risk in Communities 
Study with median age of 57 years at baseline in 1990-1992.  Alcohol consumption was self-reported 
as usual drinks per week and categorized as never, former, light (≤3), moderate (4-17), and heavier 
(≥18) drinking.  Cognitive status was assessed thrice over follow-up using 3 tests of executive 
function, memory, and processing speed.  Linear regression with generalized estimating equations 
was used to estimate the difference in rates of decline according to alcohol intake.  In sensitivity 
analysis, we used multiple imputation methods to address informative attrition by imputing 
outcome and covariate data. 
Results:  Over 20 years of follow-up, light and moderate drinkers compared with abstainers had 
similar additional changes of 0.019 and -0.002 global z score units (95% CIs: -0.032 to 0.070 and -
0.066 to 0.061, respectively) while heavier and former drinkers had 0.041 and 0.035 more decline 
(95% CIs: -0.152 to 0.070 and -0.096 to 0.026).  Patterns were similar across specific tests, with some 
suggestion that light drinkers had slower cognitive changes in verbal fluency (DWRT and WFT). 
Conclusion: Self-reported light and moderate alcohol consumption at mid-life were not associated 
with additional 20-year cognitive changes compared with no drinking.  Heavier consumption as well 
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as former drinking, however, were associated with slightly accelerated declines. 
 
6.2 Introduction 
Cognitive aging is not uniform across the population; some individuals experience very little 
decline well into their 80s while others exhibit varying degrees of decline beginning in their 60s.59  
Slowing cognitive decline is important for increasing quality of life and for reducing the lifetime risk 
of developing dementia, currently estimated at 1 out of 5 to 6 adults.9  Alcohol consumption has 
been associated with cross-sectional differences in cognitive function,197 but its effect on cognitive 
aging trajectories is unknown.33  Estimating these effects may lead to additional avenues for 
preventing or delaying the onset of cognitive impairments and dementia.   
Seventy percent of U.S. adults report current drinking and more than one-quarter report 
excessive drinking (either heavy episodic or average consumption). 50, 67  Although heavier alcohol 
intake is known to damage the brain and may increase the risk of vascular disease, 72, 76 other studies 
have actually suggested that modest alcohol consumption might be protective against cognitive 
decline, although this concept remains controversial.1, 18, 20-26, 33  Hypothesized mechanisms include 
reduction in vascular disease risk as well as increases in cerebral blood flow and facilitation of 
memory.18, 44, 72, 98  A meta-analysis reported ~11% lower relative risk of dementia and Alzheimer’s 
disease, and to a lesser degree vascular dementia and ‘significant’ cognitive decline in light-to-
moderate drinkers compared with nondrinkers.230  Examining the effects of alcohol on rates of 
cognitive decline as opposed to risk of clinical endpoints has advantages; it does not rely on 
prevalent cases (minimizing survivor bias), can inform as to the etiology of small, pre-clinical 
changes in cognition, and is less influenced by confounding factors.231  Among studies with repeated 
cognitive measures, only one corrected for attrition,27 and there were the following additional 
limitations: combining never and former drinkers into a single referent group,19, 21, 22 21, 28, 29, 31, 32, 35 
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short (<5-year) follow-up periods,20, 21, 23, 25 1, 21, 27-32, 34 lack of confounder adjustment, 1, 19, 20, 24-26, 28-32, 
34-37and adjustment for mediators (e.g., HDL-C).1, 19, 21, 22, 24-27, 30-32, 34, 35 
In our study, we estimated the association between self-reported, usual mid-life alcohol 
consumption and 20-year cognitive decline in a biracial population-based cohort drawn from 4 US 
communities, the Atherosclerosis Risk in Communities (ARIC) study.  We use multiple imputation 
with chained equations (MICE) to correct for selection bias due to visit nonattendance and death. 
 
6.3 Methods 
 
Study Population 
The ARIC study is a 
population-based cohort recruited 
using probability sampling of 
adults aged 45-64 years from 4 US 
communities: Forsyth County, NC; 
Jackson, MS; the suburbs of 
Minneapolis, MN; and Washington 
County, MD.  The ARIC study 
design and rationale are described 
in detail elsewhere.204 The racial 
distribution of the sample from 
Minneapolis and Washington 
County is primarily White, whereas 
Blacks were oversampled in 
Figure 17. The ARIC study timeline and number of participants 
attending visits 1-5      
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Forsyth County and exclusively sampled in Jackson.  A total of 15,792 participants were enrolled at 
visit 1(1987-1989) and underwent an in-home interview and physical examination.  During annual 
telephone follow-up, ARIC investigators obtained information on hospitalizations and medical 
history over the preceding year.  Four additional study visits consisting of an interview and physical 
examination occurred over the subsequent 25 years (Figure 17).  The population for analysis 
included participants attending visit 2 (baseline for this analysis).  Exclusions included participants 
not classified as white or black (N=48); blacks from Minnesota or Washington County (N=55); 
prevalent stroke at visit 2 (N=272); missing data for alcohol consumption, baseline cognitive score, 
or covariates (total N=281).  After these exclusions, the analytic cohort totaled 13,704, 87% of the 
initial cohort. 
Alcohol Assessment 
Alcohol consumption was measured using an interviewer-administered dietary 
questionnaire developed in accordance with the validated Willett 66-item food frequency 
questionnaire (FFQ).208  Participants were asked at visit 2 to report whether they currently 
consumed alcoholic beverages and if so, their usual intake over the past 12 months in units of drinks 
per week.  Separate intake frequency questions were asked for standard drinks of wine (4-oz), beer 
(12-oz), and hard liquor (1.5-oz).  
Measurement of Cognition 
Cognitive function was measured at visits 2 (1990-1992), 4 (1996-1998), and 5 (2011-2013) 
using three tests: the Delayed Word Recall Test (DWRT), the Digit Symbol Substitution Task (DSST), 
and the Word Fluency Task (WFT).  These tests measured several cognitive domains including short-
term memory, verbal learning, processing speed, executive function, and expressive language.  Tests 
were administered by trained and certified staff in a quiet environment without distraction.  
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Administrators were re-certified annually, and both technique and protocol adherence were 
monitored over the study.  We generated z scores for each test at each study visit standardized to 
the population mean and standard deviation at visit 2.  A global score was calculated as the average 
of the three test-specific z scores and standardized to the global mean and standard deviation at the 
second study visit. 
Covariates 
Confounders were identified based on substantive knowledge of factors associated with 
alcohol129 and risk of cognitive decline.33, 203  Covariates to include in regression models were 
identified with directed acyclic graphs232: demographic characteristics (age, gender, race-center, 
education), lifestyle factors (smoking, physical activity, social support, diet), and medical history 
(diabetes mellitus, coronary artery disease [CAD]).  Apolipoprotein E ε4 alleles have been implicated 
in risk of cognitive decline and were included as an important predictor of the outcome. 
Age, sex, race, and education (<high school; high school or vocational school; some college 
or more) were self-reported at visit 1 as was usual dietary intake, measured with a FFQ.208  We 
calculated a diet score, as described elsewhere, based on quintile values for 6 dietary components: 
percent energy from trans-fatty acid,  percent energy from omega-3 fatty acid, fiber (g), folate (mg), 
glycemic load, and polyunsaturated:saturated fatty acid ratio.225  At visit 2, smoking status was self-
reported (never; current; former), physical activity was measured using the Baecke questionnaire,209 
and social support was measured with the 40-item Interpersonal Support Evaluation List and the 
Lubben Social Network Scale.233  Medical history at visit 2 included diabetes (self-reported physician 
diagnosis, fasting glucose >126 mg/dL, or self-reported pharmacologic treatment for diabetes) and 
CAD (electrocardiogram-adjudicated myocardial infarction [MI] or any of self-reported: MI, 
heart/arterial surgery, coronary bypass, or angioplasty).   
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Statistical Analysis 
Linear regression models fit with generalized estimating equations (GEE) were used to 
estimate rates of cognitive decline by category of alcohol consumption.219  Valid standard errors 
were obtained with the “sandwich” estimator and we assumed an unstructured correlation matrix.  
Time since visit 2, our study baseline, was modeled with linear splines (knot at 6 years) and all 
models were adjusted for the covariates listed above and their interactions with time.  Twenty-year 
declines at each level of alcohol intake were estimated for all covariates after centering to represent 
the ‘average’ ARIC participant and interactions between alcohol and time were used to estimate 
additional 20-year declines compared with lifetime abstainers.  Effect estimates represent changes 
in z score units and were scaled to represent additional years of aging by dividing the 20-year 
adjusted differences by the annual average population change.  In secondary analyses, we tested for 
differences in effect estimates by sex-race and APOE ε4 using stratified models and tests of 
interaction terms between sex-race or APOE and exposure by time.  We also estimated trends in 
additional changes in 20-year z scores across continuous alcohol drinks per week among current 
drinkers and lifetime abstainers.  Finally, we repeated analyses using the cumulative average alcohol 
consumption (from measurements at visits 1 and 2) and compared these results to those of primary 
analysis of baseline (visit 2) alcohol consumption. 
Sensitivity Analysis 
 Missing outcome data in GEE models are assumed to be missing completely at random, an 
assumption likely to be violated in our data as both visit attendance and death were associated with 
baseline cognition and alcohol consumption.  We accounted for this informative misingness using 
multiple imputation with chained equations (MICE).221, 222  Missing data at visits 4 and 5 were 
imputed with 25 iterations.  GEE analysis models were run on each of the 25 datasets and combined 
into a single estimate with variance calculated to account for the uncertainty in the imputation 
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process as well as the within-dataset variance.  Covariates used in the imputation models included 
all covariates in the analysis model, as well as predictors of missingness: self-reported outcomes on 
annual follow-up (stroke, CAD, diabetes, hypertension, lung disease); nursing home residence; proxy 
respondent on annual follow-up; functional status; hospitalizations; measured cognitive scores; 
clinical dementia rating score; Mini Mental State Exam (MMSE) and telephone interview for 
cognitive status (TICS) scores; and suspected dementia based on prior hospitalization with an ICD-9 
code for dementia or need for proxy interview on annual calls. 
 Additional sensitivity analyses were conducted to test for floor effects by dropping 
participants in the lowest 5% of the global z score distribution s at visit 2.  In addition, we assessed 
the sensitivity of our results to the selection of exposure cut-points by comparing our results with 
those obtained using alternative cut-points from other studies and in alcohol consumption 
guidelines.  We used Statistical Analysis Software Version 9.2 (SAS Inc) and STATA 13.0 (StataCorp) 
for analyses. 
 
6.4 Results 
Participant characteristics 
Over one-third of the ARIC participants were light drinkers, consuming 3 or fewer glasses of 
alcohol per week (Table 26).  Roughly one-fifth of participants each were moderate drinkers of 4 to 
17 drinks per week, lifetime abstainers, and former drinkers and only 4% consumed 18 or more 
drinks per week.  Women comprised the largest proportion of abstainers and light drinkers, and 
white men accounted for nearly three-quarters of heavier drinkers.  Light-to-moderate drinkers had 
higher educational attainment than heavier drinkers, abstainers and former drinkers.  High 
perceived social support and large social network size were less common for heavier and former 
drinkers.  Current smoking was reported by 42% of heavier drinkers but only 22% of light drinkers.  
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Diabetes was more than twice as prevalent in abstainers compared with current drinkers.  Finally, 
blood pressure and HDL-cholesterol increased across alcohol consumption level.   
 
Table 26. Characteristics of ARIC Participants at Visit 2 (1990-1992) According to Self-Reported Usual Mid-
Life Alcohol Consumption* 
 
Alcohol Consumption, usual drinks per week 
  Abstainers ≤3 4-17 ≥18 Former 
Number of participants 3073 4942 2335 510 2844 
Ethanol intake, g/week 0 0 (0-15) 98 (72-151) 318 (277-423)  
Drinks per week, median (IQR) 0 0 (0-1) 7 (5-11) 24 (20-31) 
 Age, years 57.6 (5.7) 56.6 (5.7) 56.6 (5.7) 57.2 (5.8) 57.3 (5.7) 
Sex-race group 
     White men 16.2 35.9 51.5 72.4 37.0 
White women 46.4 50.8 34.0 11.2 27.5 
Black men 5.5 5.4 9.9 14.5 14.2 
Black women 31.8 7.9 4.6 2.0 21.4 
Educational attainment 
     Less than high school 28.6 12.4 12.1 19.0 35.1 
High school or vocational 43.1 44.7 38.7 42.6 37.7 
College degree or higher 28.3 42.9 49.2 38.4 27.2 
Large social network 80.4 78.3 76.2 69.8 73.7 
High perceived social support 80.1 81.3 81.0 77.7 76.4 
Sports physical activity index 2.3 (0.7) 2.5 (0.8) 2.6 (0.8) 2.5 (0.9) 2.4 (0.8) 
Diet score 12.4 (3.8) 11.9 (3.9) 12.1 (3.8) 12.0 (3.7) 11.9 (3.9) 
Cigarette smoking status 
     Current 11.6 22.0 29.3 42.4 24.2 
Former 17.7 39.9 47.7 44.7 47.0 
Never 70.7 38.1 23.1 12.9 28.8 
Apolipoprotein E ε4 alleles      
0 68.8 70.1 69.1 71.8 68.2 
1 28.1 27.3 28.4 27.2 29.2 
2 3.1 2.6 2.5 1.0 2.6 
Coronary artery disease** 3.4 4.4 5.1 6.3 9.1 
Diabetes mellitus 17.6 8.8 7.2 6.9 20.4 
Systolic blood pressure, 
mmHg 123 (19) 119 (18) 122 (18) 128 (19) 122 (19) 
Visit 5 (2011-2013) status 
     Attended 44.4 50.7 48.0 35.1 37.2 
Died 30.4 28.0 31.4 48.4 41.5 
Alive, did not attend 25.2 21.3 20.6 16.5 21.3 
* Includes 13,704 white and black participants attending study visit 2 without history of stroke or missing 
exposure, covariates, or baseline cognitive score. Values indicate % of mean (SD) unless otherwise 
indicated 
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Univariate associations between alcohol and cognitive decline 
Baseline cognitive z scores were considerably lower for abstainers and former drinkers 
compared with current drinkers (Table 27).  Among current drinkers, there was a tendency for 
heavier drinkers to have lower cognitive scores on all tests, but differences were small.  Average 
unadjusted 20-year declines in global z scores were largest for heavier drinkers (-0.85) and smallest 
for abstainers (-0.76).  This trend was relatively consistent across the specific tests; however, light 
drinkers had the largest decline on the DSST and the least decline on the WFT of any group. 
 
Table 27. Mean Global and Test-Specific z Scores at Visits 2 (1990-1992), 4 (1996-1998), and 5 (2011-2013) by 
Alcohol Intake in the ARIC study 
 Alcohol Consumption, usual drinks per week 
  Abstainers ≤3 4-17 ≥18 Former 
Global z score 
     Visit 2 -0.22 0.23 0.23 0.00 -0.34 
Visit 4 -0.22 0.16 0.17 -0.07 -0.36 
Visit 5 -0.78 -0.43 -0.42 -0.69 -0.91 
20-year decline* -0.76 -0.80 -0.82 -0.85 -0.80 
Delayed word recall test 
     Visit 2 -0.07 0.12 0.08 -0.08 -0.17 
Visit 4 -0.07 0.07 0.02 -0.14 -0.22 
Visit 5 -0.98 -0.82 -0.91 -1.14 -1.14 
20-year decline* -0.94 -0.98 -1.02 -1.11 -1.02 
  Abstainers ≤3 4-17 ≥18 Former 
Digit symbol substitution task 
     Visit 2 -0.26 0.28 0.22 -0.06 -0.38 
Visit 4 -0.29 0.15 0.11 -0.16 -0.43 
Visit 5 -0.70 -0.31 -0.33 -0.57 -0.81 
20-year decline* -0.64 -0.73 -0.72 -0.66 -0.65 
Word fluency test 
     Visit 2 -0.19 0.14 0.24 0.15 -0.25 
Visit 4 -0.16 0.14 0.24 0.11 -0.21 
Visit 5 -0.27 0.09 0.19 0.01 -0.29 
20-year decline* -0.21 -0.16 -0.17 -0.22 -0.20 
* Mean 20-year declines in z scores were estimated from unadjusted linear models fit with GEE that included 
time splines and alcohol intake category 
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Effect of alcohol on additional adjusted 20-year changes in cognition 
After adjustment for covariates, compared to abstainers, light and moderate drinkers had 
similar 20-year rates of decline (0.019 z score units; 95% CI -0.032, 0.070 and -0.002; -0.066, 0.061; 
Table 28).  Both heavier (-0.041; 95% CI -0.152, 0.070) and former drinkers (-0.035; -0.096, 0.026) 
had somewhat steeper declines compared with abstainers.  To provide context for these z score 
changes, we estimated the population decline in z score and scaled the effect estimates to represent 
additional years of cognitive aging.  Light consumption was associated with approximately 0.5 years 
less aging over 20 years than the average ARIC participant (95% CI -1.8 to 0.8) and heavier and 
former drinking with 1 (-1.8 to 3.8) and 0.9 (-0.7 to 2.4) years, respectively, of additional aging 
compared with the overall population decline.  The trend in additional cognitive change across 
drinks per week mirrors the findings from categorical analysis; there was little additional change at 
lower levels of consumption and small, non-significant acceleration of decline roughly around 14 
drinks per week (Figure 18).
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Table 28. Estimated Average 20-Year Cognitive Decline and Additional Adjusted 20-Year Cognitive Change Associated with Alcohol Consumption Category 
in the ARIC study, Complete Case Analysis compared with MICE-Corrected Analysis 
 
Global z score Delayed Word Recall Test z score 
  Complete Case MICE Imputed Complete Case MICE Imputed 
20-Year Average Decline (SD)     
Abstainers (ref) -0.89 (-0.94, -0.85) -0.97 (-1.03, -0.91) -1.13 (-1.20, -1.05) -1.18 (-1.27, -1.08) 
Light (≤3 drinks/week) -0.88 (-0.91, -0.84) -0.93 (-0.98, -0.88) -1.09 (-1.15, -1.03) -1.13 (-1.20, -1.05) 
Moderate ( 4-17 drinks/week) -0.90 (-0.95, -0.85) -0.99 (-1.05, -0.92) -1.12 (-1.19, -1.04) -1.19 (-1.30, -1.09) 
Heavier (≥18 drinks/week) -0.94 (-1.04, -0.83) -1.01 (-1.13, -0.88) -1.19 (-1.35, -1.02) -1.26 (-1.44, -1.07) 
Former -0.93 (-0.98, -0.88) -0.99 (-1.06, -0.92) -1.17 (-1.25, -1.09) -1.21 (-1.30, -1.12) 
20-Year Additional Decline (SD) 
    Light vs. Abstainers 0.019 (-0.032, 0.070) 0.036 (-0.027, 0.099) 0.037 (-0.047, 0.121) 0.049 (-0.055, 0.153) 
Moderate vs. Abstainers -0.002 (-0.066, 0.061) -0.017 (-0.090, 0.056) 0.012 (-0.090, 0.114) -0.019 (-0.134, 0.097) 
Heavier vs. Abstainers -0.041 (-0.152, 0.070) -0.035 (-0.164, 0.093) -0.060 (-0.238, 0.119) -0.080 (-0.265, 0.105) 
Former vs. Abstainers -0.035 (-0.096, 0.026) -0.024 (-0.093, 0.046) -0.040 (-0.140, 0.059) -0.034 (-0.133, 0.066) 
  Digit Symbol Substitution Test z score Word Fluency Test z score 
20-Year Average Decline (SD) 
    Abstainers (ref) -0.74 (-0.77, -0.71) -0.77 (-0.81, -0.73) -0.26 (-0.30, -0.22) -0.29 (-0.34, -0.24) 
Light (≤3 drinks/week) -0.75 (-0.78, -0.73) -0.77 (-0.81, -0.74) -0.22 (-0.25, -0.19) -0.23 (-0.28, -0.19) 
Moderate ( 4-17 drinks/week) -0.77 (-0.81, -0.74) -0.81 (-0.86, -0.76) -0.23 (-0.27, -0.18) -0.26 (-0.32, -0.20) 
Heavier (≥18 drinks/week) -0.77 (-0.85, -0.70) -0.77 (-0.85, -0.69) -0.25 (-0.35, -0.16) -0.29 (-0.41, -0.17) 
Former -0.78 (-0.81, -0.75) -0.80 (-0.84, -0.76) -0.24 (-0.28, -0.20) -0.27 (-0.33, -0.21) 
20-Year Additional Decline (SD) 
    Light vs. Abstainers -0.013 (-0.049, 0.024) -0.005 (-0.049, 0.040) 0.041 (-0.005, 0.088) 0.056 (0.007, 0.105) 
Moderate vs. Abstainers -0.029 (-0.075, 0.016) -0.040 (-0.098, 0.019) 0.034 (-0.023, 0.091) 0.026 (-0.038, 0.090) 
Heavier vs. Abstainers -0.033 (-0.114, 0.048) -0.006 (-0.083, 0.072) 0.008 (-0.096, 0.111) -0.006 (-0.130, 0.118) 
Former vs. Abstainers -0.039 (-0.081, 0.003) -0.030 (-0.074, 0.015) 0.020 (-0.033, 0.072) 0.017 (-0.042, 0.076) 
Models are adjusted for age, age2, sex, race-center (whites in NC, MN, and MD; blacks in NC and MS), education (<high school; high school, GED, 
vocational school; college and above), smoking status (never; former; current), prevalent diabetes, prevalent CAD, physical activity (continuous), 
apolipoprotein E ε4 genotype allele number (0; 1; 2) social support (continuous), diet score (continuous), time since visit 2 as a linear spline with a knot at 
6 years, and all interactions between covariates and time.  Values are presented as z score, or change in z score, (95% confidence intervals) 
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Figure 18. Adjusted additional 20-year cognition change in global and test-specific z scores according to alcohol intake category 
 
Estimates were obtained from linear models fit with GEE on complete case data and were adjusted for covariates.  Data markers and error bars indicate 
categorical point estimates and 95% confidence intervals; lines represent curvilinear trend for drinks per week with corresponding 95% confidence intervals 
shown with dotted lines. A. Global z score; B. Delayed Word Recall Test (DWRT); C. Digit Symbol Substitution Test (DSST); D. Word Fluency Test (WFT) 
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Twenty-year changes in the DWRT and DSST z scores followed a roughly similar pattern by 
alcohol group as for the global z score, although effect estimates were small and confidence 
intervals overlapped the null (Table 28).  Both heavier and former drinkers compared with 
abstainers had steeper declines.  The largest difference was for heavier drinkers on the DWRT (-
0.060; -0.238, 0.119), which is equivalent to ~1.2 years additional aging.  Light drinking versus 
abstention was associated with small decreases in additional decline on the DWRT (0.037; -0.047, 
0.121) and little effect was seen on the DSST.  Moderate drinking was not strongly associated with 
additional change on the DWRT or DSST.  The largest test-specific effects for light and moderate 
drinking were observed for the WFT.  Light and moderate drinkers had slower declines, equivalent 
to 4.6 and 3.8 fewer years of aging, respectively (0.041; -0.0058, 0.088 and 0.034; -0.023, 0.091).  
Trend analysis complemented the results of categorical analysis; 20-year additional declines 
accelerated at higher numbers of drinks per week, and for DWRT and WFT, the trend suggests slight, 
non-significant inverse U-shapes (Figure 18). 
Analyses using MICE 
Missing cognitive scores were associated with alcohol intake; non-attendance at visit 5 
ranged from 17% among heavier drinkers to 25% among abstainers and mortality by visit 5 from 
28% among light drinkers to 48% among heavier drinkers (Table 26).  In models that included MICE-
imputed scores to correct for this informative missingness, the estimated average decline increased 
for all exposure groups, as expected.  Effect estimates for additional change were very small and 
moved away from the null for light and moderate drinking by approximately 0.016 global z score 
units and toward the null by ~0.01 z score unites for heavier and former drinkers.  Differences 
between MICE models and complete case analysis were similarly small for test-specific z score 
changes.  Overall, inferences were not changed by our sensitivity analysis. 
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Sensitivity analyses 
 Results were unchanged (not shown) in sensitivity analyses testing for “floor effects” of 
cognitive scores, which may occur if baseline scores are so low that additional decline is not 
measurable.  We also found no differences in results when testing for effect modification by sex-
race or when specifying alcohol intake as the cumulative average of visits 1 and 2.  Finally, we 
assessed the sensitivity of our results to choice of cut-points and found nearly identical results when 
compared with alternative cut-points for defining light, moderate, and heavier intake (e.g., ≤7; 8-14; 
≥15 drinks per week). 
 
6.5 Discussion 
 
We found no meaningful association between light-to-moderate alcohol consumption at 
mid-life and 20-year rates of global cognitive decline in this analysis of a bi-racial population-based 
cohort.  There was some evidence for slower declines in verbal fluency (DWRT and WFT z scores) 
with light drinking, but effects were small, roughly equivalent to 0.75 and 4.6 years of additional 
aging, respectively.  Heavier and former drinkers had slightly accelerated rates of decline compared 
with never drinkers in global cognition and the DWRT and DSST, equivalent to approximately 1 
additional year of aging.   
 We noted fairly large baseline differences in cognitive scores between abstainers and light-
to-moderate drinkers consistent with other reports.1, 21, 34  Longitudinal studies suggest that light 
drinking may also be associated with lower risk of dementia or cognitive decline,230, 234 but many are 
limited by short follow-up and survivor bias given the relatively older ages at baseline.  Moderate 
alcohol intake was associated with 11% reduced risk of cognitive decline (RR=0.89, 0.67-1.17) in 
meta-analysis results.230  Specifically, the Women’s Health Initiative and Nurses’ Health Study both 
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reported lower relative odds of ‘substantial’ cognitive decline among light-to-moderate drinkers 
compared with abstainers on measures of global cognition (the 3MSE and TICS, respectively).21  
These populations were older at baseline, follow-up was short (6 and 1.5 years, respectively), effect 
estimates were not corrected for attrition, and rates of decline were not estimated.  Our results 
build on these by estimating differences in the rate of cognitive decline over longer follow-up in a 
diverse population.  We also employed test-specific measures that are less subject to the ceiling 
effects of global measures.  Our results suggest that protective effects of light-to-moderate drinking 
on the rate of cognitive decline are small at most and that cognitive patterns in these persons may 
not differ substantially from never drinkers. These small effects may possibly reflect the timing of 
exposure measurement (mid-life in this study); earlier alcohol exposures may have larger effects on 
cognitive aging. 
Rates of change in global measures of cognition have been estimated in a small number of 
studies.  Declines in the MMSE were 0.05 points per year less for female low-to-moderate drinkers 
compared with women reporting non-drinking at baseline; no differences across alcohol intake 
levels were found for men.32  The average change in TICS-m over ~2.2 years of follow-up in the 
Northern Manhattan Stroke Study was higher for all levels of drinking compared with never 
drinkers; 0.9 (95% CI -1.2, 1.9) for light drinkers, 1.5 (0.6, 2.4) for moderate drinkers, and 2.4 (0.8-
4.0) for heavier drinkers.  Most recently, men consuming ~3 or more drinks per day compared with 
<1 had faster 10-year declines in cognition, equivalent to 1.5-5.7 additional years of aging in the 
Whitehall II cohort; no differences were observed between lower levels of drinking and 
abstention.235  For women, abstention was associated with faster decline than light drinking 
(additional decline in z-scores of -0.21(-0.37, -0.04) for global cognition and -0.17 (-0.32, -0.01) for 
executive function.  Overall, our effect sizes were smaller in magnitude than those in the Whitehall 
cohort, possibly because of differences in population characteristics and drinking habits, 
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measurement and specification of the exposure and outcomes, or selection factors.  In addition, 
light-to-moderate drinking may serve as a marker for better health that is not fully accounted for by 
covariates.  To provide additional context for the magnitude of our estimates, rates of decline for 
hypertension versus no hypertension in the ARIC study are reported to range from -0.008 on the 
DWRT to -0.079 on the DSST, with -0.056 for the global z score.236   
 Heavier drinking has been implicated in increased risk of dementia, significant cognitive 
declines, and faster rates of cognitive decline in several studies,230, 234 but others have found no 
association or even improved scores with heavier drinking.30, 34, 234  Our estimates were relatively 
small and overlapped the null, but are consistent with an increased rate of decline relative to 
abstainers among both heavier and former drinker, particularly in tasks requiring psychomotor 
speed.  Lack of associations with some measures of cognition in our and other studies may reflect 
the relatively small proportion of heavier drinkers in these studies (several reports do not estimate 
effects of heavy drinking), survivor biases, and attenuation of effect estimates from cohort attrition. 
Test-specific results suggested a possible reduced rate of decline for WFT, but not the DSST 
for light and moderate drinkers.  These tests measure different cognitive domains; verbal fluency 
and executive function versus processing speed and visuospatial ability, respectively, and suggest 
that light-to-moderate intake may have greater effects on executive functions, which are often the 
first to be impaired in vascular dementia.  Others have reported a specific effect of light drinking on 
verbal fluency compared with other tests of verbal memory, visuospatial ability, or global 
cognition,237, 238 while others report effects for memory and executive function.235 
Light-to-moderate alcohol consumption is hypothetically associated with reduced cognitive 
decline through its putative effects on vascular risk factors (i.e. chronic anti-thrombotic, anti-
inflammatory, and anti-atherogenic effects) that in turn preserve neurovasculature.72  For example, 
moderate alcohol consumption is associated with higher HDL-C, lower fibrinogen levels and 
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decreased platelet aggregation.13  In addition, there is evidence that alcohol increases acetylcholine 
and therefore may facilitate learning and memory.  Heavier consumption of alcohol has direct 
neurotoxic effects on the brain. 72, 76  Additional adverse effects include elevations in blood pressure, 
small-vessel disease, infarcts and bleeds, white matter lesions, and alcohol-related dementias. 
Our study results should be interpreted in light of several limitations.   First, alcohol was self-
reported and therefore may be under-reported.  We were unable to quantify measurement errors 
or calibrate effect estimates; however, construct and rank-order validity of our measure was 
supported by positive correlations of alcohol with both HDL-C and blood pressure and relative 
validity studies report high reliability of alcohol self-reports by FFQ (REF).  Second, residual 
confounding is possible, although the ARIC study collected data on myriad confounders including 
social support, physical activity, and diet quality.  Third, the prevalence of heavy drinking was low 
and limited our ability to estimate the impact of heavier drinking.  Furthermore, the heavier drinkers 
that participated in the ARIC study may not represent the larger population of heavy drinkers, 
limiting generalizability of study results.  Fourth, selection bias induced by informative 
nonattendance at study visits and deaths is likely, and would tend to attenuate our estimates as we 
hypothesize that non-attenders would have lower cognitive scores.  We attempted to mitigate this 
selection bias using MICE methods.  Fifth, there is potential for floor and practice effects in cognitive 
assessments; however, we conducted sensitivity analyses that suggested floor effects were minimal. 
  Strengths of our study include a prospective study design with over 20 years of follow-up, a 
bi-racial population, and repeated measures of 3 cognitive tests over time that are sensitive to 
changes at higher levels of cognition - unlike the MMSE - and allow differentiation of cognitive 
domains.  Alcohol consumption was assessed using a validated instrument with beverage-specific 
questions (thus reducing under-reporting) that differentiated never from former drinkers.   
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Our study results suggest that the putative beneficial effects of mid-life light-to-moderate drinking 
on cognitive decline are, at most, quite small, and may affect verbal fluency more than other 
domains.  Consumption of alcohol in moderation does not appear to adversely affect aging 
trajectories, consistent with other findings but neither should it be recommended for slowing 
cognitive aging based on these and other studies.  Consumption of 18 or more drinks per week was 
associated with accelerated decline on global function and delayed word recall in particular, though 
all estimates were imprecise.  The potential harmful effects of heavier intake on cognitive aging is 
consistent with public health recommendations to moderate alcohol consumption.47  Understanding 
the alcohol-cognitive decline association would be further advanced by continued development of 
methods to correct for cohort attrition, measurement of drinking patterns and consumption over 
the life course including in younger adulthood, and by estimating dose-dependent exposure 
measurement errors for effect estimate calibration. 
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CHAPTER 7. CONCLUSIONS AND PUBLIC HEALTH IMPLICATIONS 
Stroke and cognitive impairment represent a significant health burden.  The prevalence of 
these conditions is projected to increase dramatically as the population demographic shifts to a 
greater proportion of older adults.51, 52  Identifying modifiable risk factors to prevent or delay disease 
- such as the consumption of alcoholic beverages - is necessary to reduce disease burden, its high 
economic cost, care giver burden, and negative impact on quality of life.  This research is further 
motivated by the high prevalence of alcohol exposure (70% of adults report drinking alcohol), which 
could result in a large impact on disease in the population even with small effects on disease risk.  
Specific aims of this dissertation research were to 1) estimate the dose-response relationship 
between usual alcohol consumption and incidence of ischemic and hemorrhagic stroke; and 2) to 
estimate the additional change in 20-year cognitive decline according to alcohol intake. 
The literature on alcohol and stroke is expansive, has grown in methodologic rigor over the 
past few decades, and yet is inconsistent with regard to effects of light-to-moderate consumption.  
There is still debate as to whether light-to-moderate alcohol intake protects against cardiovascular 
disease, stroke in particular.  Biological mechanisms include changes in HDL-cholesterol, clotting and 
platelet aggregation, blood pressure, and insulin sensitivity that depend on alcohol dose and may 
have different impacts on ischemic and hemorrhagic stroke etiologies.  Meta-analyses report J-
shaped relationships between alcohol and ischemic stroke.2, 6, 14  The pooled hazards ratio comparing 
drinkers with nondrinkers for ischemic stroke were 0.92 (95% CI: 0.85-1.00) and 1.04 (1.02-1.06) and 
for hemorrhagic stroke was 1.14 (0.97-1.34); these results were largely similar for men and 
women.2, 14  Alcohol and cognitive decline research is comparatively much younger, less robust, and 
far from conclusive.  Studies report varying results from no differences across intake, to reduced 
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declines in global cognition for women but not men at low levels of drinking, faster decline for men 
consuming heavy alcohol but no differences at lower intakes, and slower declines at all levels of 
drinking compared with abstention.32, 34, 235  
Effect estimates for both outcomes are subject to several biases.  Primary among these are 
exposure measurement error, confounding by healthier lifestyles of light-to moderate drinkers, and 
selection bias from cohort attrition.  The ARIC study and our analytic approach were unique in their 
ability to address several of these important limitations.  While measurement error in our study is a 
possibility, we have comparatively strong measurement of beverage-specific alcohol consumption 
assessed with a validated FFQ.  Our data were obtained from a large, racially-diverse middle-aged 
population-based cohort with ~25 years of follow-up, robust stroke ascertainment, rich covariate 
data, and repeated assessment of cognitive function.  Our findings suggest little support for a 
protective effect of self-reported light-to-moderate drinking of 0.5 to 17 drinks per week compared 
with lifetime abstention and either stroke or cognitive decline.  Increased risk of ischemic stroke and 
faster rates of decline were found for consumption of 18 or more drinker per week compared with 
abstention, although confidence intervals were wide and overlapped the null.  Increased risk of 
hemorrhagic stroke was present for moderate drinking.   
The null association between light drinking and stroke and cognitive decline may reflect mis-
measurement of alcohol that attenuated effect estimates, attrition that was not captured in MICE 
models for cognitive decline, or imprecision in our estimates.  It may also reflect the true 
relationship between alcohol and these outcomes despite the underlying plausible biological 
mechanisms.  For example, HDL-C (a major pathway through which alcohol may influence disease 
risk) is a weaker predictor of stroke than heart disease.  Previously reported protective effects may 
have been confounded by lack of adjustment for socioeconomic status, smoking, or former drinking.  
Finally, additional characteristics of alcohol consumption such as drinking patterns, life-course 
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trajectories, and cumulative effects may modify results across studies, few of which are able to 
examine these factors. 
Our findings are consistent with the American Heart Association recommendations that 
adults moderate their alcohol consumption (≤2 drinks per day for men; ≤1 for women) and that 
individuals should not initiate drinking for the purposes of reducing cardiovascular disease risk.47  
These recommendations were made primarily based on cardioprotective effects observed in studies 
of coronary heart disease as well as the known risks of alcohol consumption even at lower doses 
including dependency, interactions with medications, and increased cancer risk.  Our study results 
suggest that there is no benefit from light drinking on vascular-related diseases of the brain and 
likely harm from higher intake.  The definition of moderate consumption in clinical guidelines may 
need continued scrutiny and modification as data from other cardiovascular disease outcomes – 
such as stroke and cognitive changes – becomes available.  
This dissertation research and its extensive review of the literature and limitations, has 
brought to attention areas for advancement in future research.  First, dose-dependent errors in self-
reported alcohol are largely unexplored.  Studies are needed that measure alcohol intake with 
multiple, independent measurement tools and that compare validity across intake levels.  This 
information will be useful not only in quantifying the magnitude of error across intake, but also for 
calibration to obtain bias-corrected effect estimates.  Furthermore, epidemiologic studies should 
include separate questions to assess the frequency and quantity of alcohol intake as well as the 
frequency of heavy-drinking episodes.  Identification of valid biomarkers for usual alcohol intake is 
needed to validate self-reported alcohol intake.  Second, additional research is needed that 
examines sex-race effects.  We noted no differences in associations by sex-race, but were limited by 
sample size.  Third, continued methodological development and refinement of existing methods for 
correcting attrition will be useful in estimating rates of cognitive decline in cohorts with a high 
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degree of death or drop-out.  These are essential for cognitive decline research because cognition 
must be repeatedly assessed through older age, a time at which mortality and non-attendance will 
be high and are likely associated with exposures of interest.  Fourth, large pooling studies that 
include only high-quality studies are needed to achieve Aim #2 in this dissertation of estimating the 
population impact of changes in alcohol consumption.  Quantifying the change in rates of disease is 
important for policy makers and public health researchers and should be done using precise and 
minimally biased effect estimates. 
The research herein has added data from a major U.S. cohort study with minimal bias in 
stroke measurement to the alcohol-stroke relationship and has added substantially to the cognitive 
decline literature as one of the first studies to correct for attrition and to have long follow-up 
beginning in mid-life.   Our study will contribute additional data for future meta-analyses and 
systematic reviews that in turn will be useful for population scientists and clinicians judging the risk-
benefit tradeoff of alcohol consumption for individual patients.  We found no support for a 
protective effect of light-to-moderate alcohol intake and risk of stroke or rate of cognitive decline.  
Consistent with existing knowledge, heavier intake likely increases the risk of these outcomes.  
Public health recommendations should continue to encourage reduction of excessive drinking and 
should not issue population-wide recommendations for initiation of light drinking.  Effective 
strategies for reducing excess drinking could involve pricing policies and brief interventions in high-
risk groups.   
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APPENDIX 1: NATIONAL SURVEY OF STROKE CLASSIFICATION SCHEME 
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APPENDIX 2: ALCOHOL AND STROKE LITERATURE REVIEW TABLES 
A. Part 1: Population, Study Design, and Measurement 
Author (Year) Population 
Baseline 
Calendar 
Year N 
Follow-
up (y) Stroke Ascertainment 
Stroke 
Events, 
N Alcohol Measurement 
Analysis 
Included 
Multiple 
Exposure 
Berger (1999) Physicians' Health 
Study 
Prospective cohort of 
male physicians, aged 
40-84 
1982 22,071 12.2 Medical record 
review, clinician 
adjudication 
  Frequency: Self-
reported number of 
drinks per unit time 
No 
Djousse (2002) Framingham Study 
Population-based 
cohort of adults aged 
28-62 
1948-
1952 
5209 3 pools of 
10-y 
Review of interim 
exams, surveillance of 
hospital admissions, 
medical record review 
and review 
441 In-person interview 
Average number of 
drinks per week; 
alcohol consumption 
in past 12 years 
Yes, follow-up 
divided into 3 
10-yr periods 
with alcohol re-
assessed at each 
starting point 
Djousse (2009) Framingham Study 
Population-based 
cohort of adults aged 
28-62 at baseline in 
1948 and Offspring 
cohort in 1971 
1948-
1952; 
1971 
7676 2 pools of 
8-yr 
Review of interim 
exams, surveillance of 
hospital admissions, 
medical record review 
and review 
222 In-person interview 
Average number of 
drinks per week; 
alcohol consumption 
in past 12 years 
Yes, follow-up 
divided into 2 8-
yr periods with 
alcohol re-
assessed at each 
starting point 
Chiuve (2008) Health Professionals 
Follow-up Study & 
Nurses' Health Study 
Prospective cohorts of 
men 40-75 and 
women 34-59, 
1986; 
1976 
43, 685 
men; 
71,243 
women 
18; 20 Self-reported with 
medical record 
review. Death 
certificates 
  FFQ-based QF ~ every 
2 years 
Yes, cumulative 
average 
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respectively 
Elkind (2006) The Northern 
Manhattan Study 
Prospective cohort of 
adults ≥40 years 
residing in northern 
Manhattan 
1993 3176 5.9 y Self-report with 
further evaluation, 
surveillance of area 
hospital admissions. 
Defined based on 
WHO criteria 
  Interviewer 
administered FFQ, 
quantity per day 
  
Bazzano 
(2007) 
China National 
Hypertensive Survey 
Prospective cohort of 
men aged ≥40 years 
1991 83533 9 Self-reported with 
verification by medical 
record review or 
death certificates.  
Diagnosis made by 
neurologist using 
criteria from ARIC 
study 
3434 Interviewer 
administered 
questionnaire asking 6 
questions on 
frequency, amount, 
and type 
  
Donahue 
(1986) 
Honolulu Heart 
Program 
Prospective study of 
men of Japanese 
ancestry aged 45-69 
residing in Oahu 
1965-8 8006 12 Surveillance of 
hospital discharges, 
death certificates, 
autopsy records. 
Neurologist diagnosis 
based on WHO 
definition, records, 
clinical findings 
190 In-person interview 
recording usual 
monthly intake of 
beer, wine, and liquor 
No 
Drogan (2012) Case cohort nested in 
the European 
Prospective 
Investigation into 
Cancer and Nutrition 
1994-8 2558 8.2 Self-report or death 
certificate 
246 Self-administered FFQ No 
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(EPIC)-Potsdam, a 
general population 
cohort of 27548 adults 
aged 35-65 year 
Gaziano (2000) Physicians' Health 
Study 
Prospective cohort of 
male physicians, aged 
40-84 
1982 89299 5.5 Death certificate 150 
deaths 
Brief diet 
questionnaire asking 
combined question of 
FQ 
No 
Goldberg 
(1994) 
Honolulu Heart 
Program 
Prospective study of 
men of Japanese 
ancestry aged 45-69 
residing in Oahu who 
survived to second 
examination in 1971 
1971-4 6069 12 Surveillance of 
hospital discharges, 
death certificates, 
autopsy records. 
Neurologist diagnosis 
based on WHO 
definition, records, 
clinical findings 
70 
deaths; 
# 
events 
NR 
In-person interview 
recording usual 
monthly intake of 
beer, wine, and liquor 
No 
Gorelick 
(1989) 
Case control study of 
ischemic stroke 
patients and general 
outpatient controls 
1984 615 NA   205 Frequency of usual 
weekday and 
weekend alcohol 
intake and usual 
amounts in the past yr  
No 
Hansagi (1995) Swedish Population-
based Twin Register 
National register of 
the Swedish 
population born 
between 1886 and 
1925 
1967-
1968 
15077 19 National death 
register, ICD-9 codes 
430-438. Authors cite 
validity of codes to be 
97% 
769 
deaths 
Self-administered 
questionnaire asking 
current and former 
intake, current QF and 
binge drinking 
 
No 
  
 
160 
Hart (1999) Prospective cohort 
study of employed 
men aged 35-64 
residing in Scotland 
1970-3 5766 21 Death certificates, ICD 
codes 430-438) 
133 
deaths 
Self-reported weekly 
alcohol consumption 
No 
Ikehara (2009) Japan Public Health 
Center-Based 
Prospective Study 
Cohort II 
Adults aged 40-69 
residing in 5 regions in 
Japan 
1993 19356 9.9 Self-reported stroke 
with medical record 
confirmation, 
surveillance of 
hospital records and 
death certificates. Dx 
based on criteria from 
National Survey of 
Stroke 
629 Self-administered 
questionnaire, QF 
No 
Iso (1995) Japan Public Health 
Center-Based 
Prospective Study 
Cohort I 
Adults aged 40-59 
residing in 4 regions in 
Japan 
1990 27063 11 Self-reported stroke 
with medical record 
confirmation, 
surveillance of 
hospital records and 
death certificates. Dx 
based on National 
Survey of Stroke 
694 Self-administered 
questionnaire asking 
frequency, amount, 
and type of alcohol 
Sensitivity 
analysis updated 
exposure 
Jakovljevic 
(2004) 
Cohort study of 
middle-aged residents 
of Serbia 
1974 500 20 Death certificate 7 
deaths 
Self-administered 
multiple choice 
questionnaire to 
assess drinks per day 
No 
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Jimenez (2012) Nurses’ Health Study 
Female nurses aged 
30-50 years in 11 US 
states 
1976 121700 26 Self-report on follow-
up questionnaires; 
stroke deaths through 
National Death Index 
searches and next of 
kin. Included 
adjudication with 
medical records, 
death certificates 
2171 Food frequency 
questionnaire every 4 
years assessed 
beverage specific QF 
Cumulative 
average alcohol 
in secondary 
analysis 
Jousilahti 
(2000) 
WHO MONICA 
Prospective study of 
adults aged 25-64 in 
Finland from 2 
samples 
1982, 
1987 
15658   Administrative data 
on hospital discharges 
and deaths. Diagnosis 
based on ICD-9 codes. 
470 Self-administered 
questionnaire 
assessing number of 
drinks per week 
 
 
No 
Kiyohara 
(1995) 
Hisayama Study 
Prospective study of 
Japanese adults aged 
40+ 
1961 1621 26 Self-report, confirmed 
with exam and record 
review, surveillance 
  Interview-
administered 
questionnaire asking 
usual weekly intake of 
alcohol 
No 
Klatsky (1989) Kaiser Permanente 
Adults <age 50 y 
receiving health 
examinations in 
prepaid health plan 
1978 101137 max 6 Hospital discharge 
records. Dx based on 
ICD-8 codes 
361 
 
Self-administered 
Questionnaire, details 
of administration 
unclear, asking for 
average amount per 
day 
No 
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Klatsky (2002) Kaiser Permanente 
Adults <age 50 y 
receiving health 
examinations in 
prepaid health plan 
1978 128934 8.5 Hospital discharge 
records. Dx based on 
ICD-8 codes 
2494 Health examination 
questionnaires 
assessing number of 
days per week and 
amount usually 
consumed 
No 
Kono (1986) Cohort of Japanese 
male physicians 
1965 5477 18 Death certificate 230 
deaths 
Self-administered 
questionnaire 
assessing past and 
current alcohol intake 
No 
Leppälä (1999) Alpha-Tocopherlo 
Beta-Carotene Cancer 
Prevention Study 
Male cigarette 
smokers aged 50-69 
residing in Finland 
enrolled in an RCT 
1985 26556 6.1 National hospital 
discharge and death 
registers. Diagnosis 
based on ICD 
diagnosis codes 
960 Self-administered diet 
history questionnaire 
including questions 
about amount and 
frequency of 
consumption 
No 
Maskarinec 
(1998) 
Population-based 
prospective cohort of 
Hawaiians older than 
30 years of age from 
one of 5 ethnicities 
1975-80 27678 15.3 Death from death 
certificate ICD-9 codes 
430-438 
  Questionnaire asking 
type and usual QF. 
Self-administered 
(maybe proxy?) 
No 
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Mukamal 
(2005a) 
Cardiovascular Health 
Study 
Prospective study of 
community-dwelling 
adults ≥65 years of 
age from 4 U.S. 
communities 
1989 5888 9.2 Surveillance of 
hospitalizations 
reported by 
participants at 6-
month interval 
telephone calls or 
clinic exams.  
Neurologist review of 
medical charts for 
hospitalizations and 
deaths.  Dx based on 
neurological deficit 
lasting 24 hours, 
typing based on 
imaging test results 
etc 
434 Questionnaire on 
usual frequency of 
consumption and 
number of drinks. Also 
asked about past 
exposure and 
episodes of heavy 
drinking (≥5 drinks/d) 
Yes 
Mukamal 
(2005b) 
Health Professionals 
Follow-up Study 
US male health 
professionals aged 40-
75 
1986 51529 14 Medical record review 
of self-reported stroke 
and deaths 
412 FFQ in previous 12 
months average 
frequency of drinking 
a specified amount of 
alcohol. 
Yes 
Romelsjo 
(2012) 
Cohort study of 
Swedish conscripts 
from 1969-1970 born 
from 1949-1951 
1969 49411 34 National Cause of 
Death Register (ICD-9 
430-438) 
72 Questionnaire on Q 
and F of alcohol; 
measure of binge 
drinking 
No 
Romelsjo 
(1999) 
Cohort study of 
Swedish conscripts 
from 1969-1970 born 
from 1949-1952 
1949 49618 25 Unclear, death 
register and inpatient 
care register 
233 Questionnaire on Q 
and F of alcohol 
No 
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Sacco (1999) Case control study 
embedded in 
Northern Manhattan 
Stroke Study 
Cases were >39 years 
of age and resident of 
Northern Manhattan 
1993 1816 - Self-report with 
further evaluation, 
surveillance of area 
hospital admissions. 
Defined based on 
WHO criteria 
677 In-person interview 
adapted from the 
National Cancer 
Institute Block FFQ 
No 
Sankai (2000) Prospective cohort of 
adults aged 40-69 
years in 6 
communities in Japan 
1975 12372 9.4 Insurance claims, local 
physician reporting, 
ambulance records, 
death certificates, CV 
risk surveys 
71 Interviewer 
questionnaire 
assessing usual weekly 
intake of alcohol in 
standard unit 
No 
Shaper (1991) British Regional Heart 
Study 
Cohort of men aged 
40-59 randomly 
selected from general 
practices in 24 English 
towns 
1978-80 7735 8 Death certificates, 
nonfatal events based 
on presence of 
neurological deficit for 
>=24 hours 
110 Nurse administered 
questionnaire on 
average intake 
No 
Stampfer 
(1988) 
Nurses’ Health Study 
Female nurses 34-59 
years 
1980 87526 4   120 Self-administered 
questionnaire 
No 
Truelson 
(1998) 
Copenhagen City 
Heart Study 
Adult residents of 
Denmark aged 45-84 
years 
1976 13329 16 Self-reported stroke 
ascertained upon 
examination, Danish 
National Patient 
register, and death 
register. Identification 
based on ICD codes 
with validation using 
833 Questionnaire on 
weekly intake of beer, 
wine, and spirits 
No 
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medical records 
Yuan (1997) Prospective study of 
men aged 45-64 in 
Shanghai 
1986-
1989 
18244 6.7 Death certificates 269 Interviewer-
administered 
questionnaire to 
assess drinks per week 
No 
Woo (1990) Cohort of Chinese 
adults aged 60 years 
and over living 
independently 
1986 427 2.5 Self-reported stroke 
with confirmation 
from medical record 
review 
7 Questionnaire No 
Yang (2012) Population-based 
cohort of 220,000 
men aged 40-79 years 
randomly selected 
from 45 regions in 
China 
1990-1 218189 15 Death certificate 4644 Questionnaire 
assessed amount 
consumed in a typical 
week of each beer, 
wine, and spirits 
No 
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B. Part 2: Analysis and Ischemic Stroke Results 
Author (Year) 
Operation Definition of 
Alcohol Consumption Covariates Ischemic Stroke 
Berger (1999) <1 drink/week vs. ≥1 
drink/week; more categories 
evaluated for total stroke 
Age, SBP, smoking, BMI, exercise, diabetes, current 
HTN tx, randomization assignment 
0.77 (0.63-0.94) 
Djousse (2002) Never, 0.1-11 g/d, 12-23 g/d, 
≥24 g/d, former drinker of 
0.1-11 g/day, former drinker 
of ≥12 g/d 
Age, diabetes, smoking, BMI, BP, left ventricular 
hypertrophy, AF, antihypertensive tx, CHD 
                                   Men                       Women 
Never                      1.00                         1.00 
0.1-11 g/d              1.0 (0.6-1.7)          0.9 (0.6-1.3) 
12-23 g/d                0.8 (0.4-1.6)         0.8 (0.5-1.4) 
≥24 g/d                    0.9 (0.5-1.6)         0.9 (0.5-1.5) 
Former (0.1-11)   0.8 (0.4-1.6)         1.0 (0.7-1.5) 
Former (≥12)         2.6 (1.3-5.1)         0.8 (0.4-1.7) 
Djousse (2009) None vs. any current drinking Age, sex, SBP, treatment for hypertension, 
cigarette smoking, diabetes, CHD 
                                   Apo E4 neg           Apo E4 pos 
Age < 65 years       
Never                      1.00                         1.00 
Any                           0.50 (0.24-1.07)   0.70 (0.24-2.05) 
Age 65+ 
Never                      1.00                         1.00 
Any                           0.88 (0.62-1.25)   1.40 (0.83-2.77) 
Chiuve (2008) Grams per day: 0, 0.1-4.9, 5-
14.9, 15-29.9, ≥30 
Age, calendar year, parental history of MI before 
age 60, aspirin use, vitamin E supplementation, 
HRT for women 
                           Men                          Women 
0 g/d                  1.00                          1.00 
0.1-4.9 g/d       0.84 (0.67-1.06)  0.77 (0.65-0.92) 
5-14.9 g/d        0.93 (0.74-1.17)   0.82 (0.68-1.00) 
15-29.9 g/d      0.81 (0.60-1.10)   0.86 (0.64-1.16) 
≥30 g/d              1.39 (1.08-1.79)   1.41 (1.07-1.88) 
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Elkind (2006) <1 drink per month, 1 drink 
per month - 2 drinks per day, 
>2 drinks/day - <5 per day, 5 
or more per day 
Age, sex, race-ethnicity, hypertension, diabetes, 
AF, HDL, smoking 
<1 drink/month                   1.0 
1 drink/m - 2 drinks/d       0.67 (0.46-0.99) 
>2 drinks/d                            1.30 (0.69-2.45) 
Bazzano 
(2007) 
Nondrinkers, 1-6 drinks/week, 
7-20, 21-34, >35. 
Age, BMI, physical activity, urban residence, 
geographic region, smoking, diabetes, education 
Nondrinkers    1.0 
1-6 drink/w      0.95 (0.77-1.16) 
7-20 dk/w         0.88 (0.76-1.01) 
21-34 dk/w      0.87 (0.73-1.05) 
>=35 dk/w        0.99 (0.83-1.19) 
Donahue 
(1986) 
Nondrinkers, light (1-14 
oz/m), moderate (15-39 
oz/m), heavy (40+ oz/m) 
Age, hypertension, cholesterol, BMI, smoking, uric 
acid, glucose, hematocrit 
Nondrinkers    1.0 
1-14 oz/m        1.0 (0.7-1.4) 
15-39 oz/m      1.2 (0.8-1.8) 
40+ oz/m          1.1 (0.7-1.7) 
Drogan (2012) Average grams per day: Non-
drinker, >0-6, >6-12, >12-24,  
>24-60, 60+ 
Age, BMI, waist circumference, smoking status, 
education, physical activity, non-alcohol energy 
intake, hypertension, diabetes, total cholesterol, 
past alcohol intake, ADH polymorphism 
                       Women                         Men 
0 g/d             
>0-6 g/d        1.00                               1.00 
>6-12 g/d      1.28 (0.71-2.31)       1.01 (0.47-2.17) 
>12-24 g/d    1.11 (0.53-2.30)       1.07 (0.51-2.25) 
>24-60 g/d    0.52 (0.14-1.87)       1.68 (0.85-3.32) 
60+                                                     1.01 (0.41-2.46)) 
Gaziano (2000) Rarely/never, 1-3/month, 
1/wk, 2-4/wk, 5-6/wk, 1/d, 
2+/d 
Age, smoking, diabetes, exercise, BMI  - 
Goldberg 
(1994) 
Nondrinkers, light (1-14 
mL/d), moderate (15-39 
mL/d), heavy (40+ mL/d) 
Age, SBP, serum cholesterol, triglycerides, uric acid, 
smoking, coffee intake, calorie intake 
Fatal + Nonfatal stroke 
                       50-64 years              65-75 years       
Abstainer      1.0                               1.0 
Light                0.84                             1.12 
Moderate      1.44                             1.64 
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Heavy              0.66                             0.70 
Gorelick 
(1989) 
Grams per week: 0, 1-99, 100-
299, 300+ 
Age, race, sex, hospital payment method, smoking, 
hypertension 
                               Men                          Women 
0                             1.00                            1.00 
1-99 g/wk           2.20 (0.95-5.13)     1.06 (0.23-4.86) 
100-299 g/w      1.86 (0.89-3.92)      2.70 (0.75-9.77) 
300+ g/w             1.68 (0.79-3.56)     1.77 (0.23-13.45) 
Hansagi (1995) Assessed average intake, 
quantity, frequency, and 
binge drinking 
Age, smoking                                    Men                          Women 
0 g/d                         1.00                          1.00 
0.01-4.99 g/d        1.3 (0.9-2.0)            0.6 (0.5-0.8) 
5.00-14.9 g/d        1.3 (0.8-2.0)            0.9 (0.5-1.8) 
15+ g/d                   1.1 (0.6-2.0)            1.7 (0.5-5.8) 
Hart (1999) Drinks per week (0, 1-7, 8-14, 
15-21, 22-34, 35+) 
Age, smoking, cholesterol, BMI, adjusted FEV, 
social class, father's social status, education, care 
use, siblings, deprivation, angina, ischemia on 
electrocardiogram, bronchitis  
 - 
Ikehara (2009)   Age, smoking, BMI, hypertension, diabetes, leisure 
time sports, mental stress level, flushing, 
employment, marital status, medical checkup, 
region 
Never                1.00 
Former              0.78 (0.47-1.28) 
Occasional       0.86 (0.52-1.42) 
1-149 g/wk      0.93 (0.68-1.26) 
150-299 g/w    1.07 (0.79-1.44) 
300-449 g/w    1.35 (0.97-1.88) 
450+ g/w            1.13 (0.76-1.68) 
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Iso (1995) Weekly intake in grams per 
week 
Age, smoking, BMI, diabetes, education, leisure 
time sports, dietary intake of fruits, vegetables, 
and fish. 
Nondrinker      0.72 (0.47-1.09) 
Occasional        1.00 
1-149 g/wk       0.61 (0.39-0.97) 
150-299 g/w    0.97 (0.65-1.47) 
300-449 g/w    1.00 (0.65-1.55) 
450+ g/w           1.12 (0.74-1.70) 
Jakovljevic 
(2004) 
Rare/never, moderate (1-2 
drinks/day), heavy (3+ drinks 
per day) 
Gender, smoking, BMI, BP  - 
Jimenez (2012) Grams per day (0, >0-4.9, 5-
14.9, 15-29.9, 30-45) 
Age, smoking, physical activity, BMI, family history 
of heart disease, history of heart disease, diabetes, 
hypertension, oophorectomy, post-menopausal 
status, hormone therapy, high cholesterol, 
multivitamin intake, aspirin, diet score, education 
level, husband's education level, marital status 
None      1.00 
>0-4.9      0.88 (0.76-1.02) 
5.0-14.9  0.86 (0.72-1.02) 
15-29.9   0.82 (0.63-1.07) 
30-45       1.17 (0.89-1.54) 
Jousilahti 
(2000) 
Drinks per week Age, study year, smoking, serum total cholesterol, 
SBP, DBP, BMI 
- 
Kiyohara 
(1995) 
Nondrinker, light (<34g/d), 
heavy (34+ g/d) 
Age, sex, BP, heart rate per minute, ECG 
abnormalities suggesting left ventricular 
abnormality or ischemic changes, glucose 
intolerance, serum cholesterol, BMI, smoking  
Figure only: No diff between 0 and light, heavy has 
higher risk 
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Klatsky (1989) Abstainers, former drinkers, 
<1 drink/d, 1-2 drinks/day, 3+ 
drinks per day 
Age, sex, race, coffee, smoking, Quetelet index, 
restricted to no history of CVD 
Abstainers    1.00 
Former           1.05 (0.49-2.24) 
<1/day            0.61 (0.37-1.00) 
1-2/day          0.73 (0.41-1.28) 
3+/day            0.62 (0.29-1.31) 
Klatsky (2002) Abstainers, former drinkers, 
<1 drink/d, 1-2 drinks/day, 3-
5 drinks per day, 6+ drinks per 
day 
Age, sex, race, BMI, education, smoking Abstainers    1.0 
Former           1.0 (0.8-1.3) 
<1/mo             0.9 (0.8-1.0) 
<1/d                0.8 (0.7-1.0) 
1-2/day          0.8 (0.6-0.9) 
3-5                   1.0 (0.8-1.2) 
6+/day            1.0 (0.7-1.5) 
Kono (1986) Non-drinker, ex-drinker, 
occasional drinker, daily 
drinker (<2/day and >=2 per 
day) 
Age, smoking Nondrinker   1.0 
Ex-drinker      3.2 (1.9-5.4) 
Occasional     1.0 (0.6-1.7)  
Daily, <2          1.4 (0.8-2.3) 
Daily, 2+          1.8 (1.0-3.2) 
Leppälä (1999) Mean daily alcohol intake. 
Nondrinkers, light (≤24 g/d), 
moderate (24.1-60.0 g/d), 
heavy (>60.0 g/d) 
Age, BMI, total cholesterol, smoking, education, 
leisure-time physical activity, diabetes, heart 
disease, randomization group 
None                  1.00 
Light                   0.91 (0.72-1.14) 
Moderate         1.17 (0.91-1.51) 
Heavy                1.54 (1.08-2.19) 
Maskarinec 
(1998) 
drinks per week Age, ethnicity, smoking, BMI, years of education  - 
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Mukamal 
(2005a) 
Average weekly consumption. 
None, former, <1 drink, 1-6 
drinks, 7-13 drinks, ≥14 drinks 
Age, sex, race, smoking, marital status, education, 
exercise intensity, diabetes, depression score, 
aspirin use, BMI 
None           1.00 
Former       0.87 (0.67-1.15) 
<1/wk         0.85 (0.63-1.13) 
1-6/wk       0.75 (0.53-1.06) 
7-13/wk     0.82 (0.51-1.30) 
≥14/wk       1.03 (0.68-1.57) 
Mukamal 
(2005b) 
Average grams per day of 
ethanol. Abstainer, light (0.1-
9.9), moderate (10-29.9), and 
heavier (≥30) 
Age, smoking, BMI, aspirin use, diabetes, 
hypercholesteroliemia, daily exertion, energy 
intake, parental history of MI before age 60, 
saturated fat, trans fat, folate, vitamin E, dietary 
fiber, geographic region, magnesium, potassium, 
omega-3 fatty acids 
0 g/d                     1.00 
0.1-9.9 g/d          0.99 (0.72-1.37) 
10.0-29.9 g/d     1.26 (0.90-1.76) 
30+ g/d                 1.42 (0.97-2.09) 
Romelsjo 
(2012) 
Average grams of ethanol per 
day (0, 0.1-10, 10-30, 30-
60,60+) 
None   
Romelsjo 
(1999) 
Average grams of ethanol per 
day (0, 0.1-14.9, 15-30, 30+) 
BP, BMI, father's social status, running away from 
home, poor school wellbeing, parental divorce, 
poor emotional control, few friends, 
unemployment, poor health, smoking 
 - 
Sacco (1999) Average daily consumption in 
past year 
Age, sex, race-ethnicity, hypertension, diabetes, 
cardiac disease, smoking, education, BMI 
None                                  1.00 
1 drink/y-2 drinks/d      0.55 (0.42-0.72) 
3-4 drinks/d                     0.77 (0.44-1.34) 
5+ drinks/d                       1.55 (0.70-3.43) 
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Sankai (2000) Lifetime abstainer, former, 
current drinker (<69g/d vs. 
69+ g/d) 
Age, smoking, blood pressure, total cholesterol, 
BMI, diabetes 
 - 
Shaper (1991) Never/occasional, light (1-20 
drinks/week), 21-42 
drinks/week), heavy >42 
drinks/week) 
Age, SBP  - 
Stampfer 
(1988) 
  Age, parental history of infarction before age 60, 
menopausal status, HRT in women, study period, 
smoking, hypertension, diabetes, cholesterol level, 
obesity, exercise, cholesterol intake, saturated fat 
intake, polyunsaturated fat intake 
0                              1.0 
<1.5 g/day             0.7 (0.4-1.6) 
1.5-4.9 g/d            0.4 (0.2-0.9) 
5-14.9  g/d            0.3 (0.1-0.7) 
≥15 g/d                  0.5 (0.2-1.1) 
Truelson 
(1998) 
Total weekly intake (# 
beverages) of alcohol: <1, 1-7, 
8-14, 15-21, 22-41, 42+ 
Age, sex, smoking, BMI, physical activity in leisure 
time, Cholesterol, antihypertensive treatment, 
triglycerides, education, diabetes 
<1  drink/d   1.17 (0.96-1.43) 
1-7                  1.0 
8-14                1.02 (0.82-1.26) 
15-21              1.02 (0.76-1.37) 
22-41              0.93 (0.68-1.26) 
42+                  1.35 (0.99-1.86) 
Yuan (1997) Non-drinker, drinks per 
week(<=7, 8-14, 15-21, 22-28, 
29-42, 43+) 
Age, smoking, education  - 
Woo (1990) Yes vs. no none  - 
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Yang (2012) Average grams per week Region, age, smoking, education  - 
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C. Part 3: Hemorrhagic and Total Stroke Results 
 
Author (Year) Hemorrhagic Stroke Total Stroke 
Berger (1999) 0.92 (0.55-1.54) <1 drink/wk       1.00 
1 drink/wk          0.78 (0.59-1.04) 
2-4 drinks/wk    0.75 (0.58-0.96) 
5-6 drinks/wk    0.83 (0.63-1.11) 
≥1 drink/day      0.80 (0.64-0.99) 
Djousse (2002) - - 
Djousse (2009)  - -  
Chiuve (2008)                            Men                             Women 
0 g/d                 1.00                              1.00 
0.1-4.9 g/d      0.65 (0.41-1.03)       0.83 (0.62-1.10) 
5-14.9 g/d        0.85 (0.55-1.30)      0.76 (0.54-1.06) 
15-29.9 g/d      1.29 (0.78-2.13)     0.69 (0.39-1.23) 
≥30 g/d             0.99 (0.58-1.71)     1.40 (0.86-2.28) 
                           Men                         Women 
0 g/d                 1.00                          1.00 
0.1-4.9 g/d      0.81 (0.68-0.97)   0.78 (0.68-0.88) 
5-14.9 g/d        0.86 (0.72-1.03)   0.77 (0.66-0.89) 
15-29.9 g/d      0.91 (0.73-1.15)   0.79 (0.63-0.99) 
≥30 g/d             1.21 (0.99-1.49)    1.30 (1.04-1.61) 
Elkind (2006) <1 drink/month                   1.0 
1 drink/m - 2 drinks/d       1.17 (1.46-2.97) 
>2 drinks/d                            2.27 (0.60-8.64) 
<1 drink/month                   1.0 
1 drink/m - 2 drinks/d       0.68 (0.47-0.98) 
>2 drinks/d                            1.28 (0.71-2.32) 
Bazzano (2007) Nondrinkers    1.0 
1-6 drink/w      0.76 (0.55-1.06) 
7-20 dk/w         1.06 (0.86-1.30) 
21-34 dk/w      0.90 (0.68-1.19) 
>=35 dk/w        1.23 (1.00-1.58) 
Nondrinkers    1.0 
1-6 drink/w      0.92 (0.80-1.06) 
7-20 dk/w         1.02 (0.93-1.13) 
21-34 dk/w      1.22 (1.07-1.38) 
>=35 dk/w        1.22 (1.08-1.37) 
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Donahue (1986) Nondrinkers    1.0 
1-14 oz/m        2.3 (1.2-4.3) 
15-39 oz/m      2.5 (1.2-4.2) 
40+ oz/m          2.9 (1.4-6.0) 
Nondrinkers    1.0 
1-14 oz/m        1.2 (0.9-1.6) 
15-39 oz/m      1.3 (0.9-1.9) 
40+ oz/m          1.5 (1.1-2.2) 
Drogan (2012)  -                        Women                         Men 
0 g/d              1.71 (0.67-4.38)        3.48 (1.10-10.95) 
>0-6 g/d        1.00                               1.00 
>6-12 g/d      1.24 (0.71-2.13)        0.94 (0.45-1.94) 
>12-24 g/d    1.00 (0.50-1.99)       1.54 (0.80-2.95) 
24+ g/d           1.03 (0.41-2.56)       1.46 (0.65-3.28) 
Gaziano (2000)  - Rarely/never      1.00 
1-3/month          0.95 (0.49-1.83) 
1/week                 0.62 (0.30-1.28) 
2-4/week             0.59 (0.30-1.15) 
5-6/week             1.10 (0.58-2.11) 
1/d                         1.21 (0.76-1.94) 
2+/d                       0.84 (0.34-2.04) 
Goldberg (1994) Fatal + Nonfatal stroke 
                          50-64 years              65-75 years       
Abstainer      1.0                               1.0 
Light                4.02                             1.70 
Moderate      1.86                             0.01 
Heavy              4.59                             3.86 
Fatal + Nonfatal stroke 
                          50-64 years              65-75 years       
Abstainer      1.0                               1.0 
Light                1.17 (0.71-1.91)      1.27 (0.71-2.25) 
Moderate      1.43 (0.72-2.86)      1.19 (0.45-3.18) 
Heavy              1.35 (0.71-2.55)      1.00 (0.37-2.75)   
Gorelick (1989)  - -  
Hansagi (1995)                                    Men                          Women 
0 g/d                         1.00                          1.00 
0.01-4.99 g/d        0.8 (0.4-1.5)            0.7 (0.5-1.1) 
5.00-14.9 g/d        0.8 (0.4-1.7)            0.8 (0.3-2.2) 
                                   Men                          Women 
0 g/d                         1.00                          1.00 
0.01-4.99 g/d        1.2 (0.8-1.6)            0.6 (0.5-0.8) 
5.00-14.9 g/d        1.1 (0.8-1.7)            0.9 (0.5-1.5) 
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15+ g/d                   1.1 (0.5-2.7)            1.2 (0.2-9.6) 15+ g/d                   1.1 (0.7-1.9)            1.6 (0.5-4.6) 
Hart (1999)  - None                  1.00 
1-7 units/wk    0.98 (0.57-1.69) 
8-14                     1.08 (0.63-1.85) 
15-21                   1.53 (0.87-2.68) 
22-34                   1.59 (0.89-2.82) 
35+                       1.98 (1.09-3.59) 
Ikehara (2009) Never                1.00 
Former              1.26 (0.64-2.50) 
Occasional       1.41 (0.79-2.54) 
1-149 g/wk       0.68 (0.41-1.12) 
150-299 g/w    0.93 (0.58-1.48) 
300-449 g/w    1.39 (0.86-2.26) 
450+ g/w            1.80 (1.10-2.97)  
Never                1.00 
Former              0.90 (0.60-1.34) 
Occasional       1.04 (0.72-1.52) 
1-149 g/wk      0.83 (0.64-1.08) 
150-299 g/w    1.02 (0.79-1.31) 
300-449 g/w    1.37 (1.04-1.79) 
450+ g/w            1.36 (1.01-1.85)  
Iso (1995) Nondrinker      1.49 (0.85-2.63) 
Occasional        1.00 
1-149 g/wk       1.83 (1.03-3.24) 
150-299 g/w    2.52 (1.45-4.36) 
300-449 g/w    2.09 (1.17-3.73) 
450+ g/w           2.51 (1.43-4.41) 
Nondrinker      1.09 (0.80-1.49) 
Occasional        1.00 
1-149 g/wk       1.04 (0.75-1.44) 
150-299 g/w    1.46 (1.08-1.99) 
300-449 g/w    1.31 (0.94-1.81) 
450+ g/w           1.64 (1.20-2.24) 
Jakovljevic 
(2004) 
 - RR=1.138 (0.207-6.268) for moderate vs. rare/never 
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Jimenez (2012) None      1.00 
>0-4.9      0.82 (0.63-1.06) 
5.0-14.9  0.76 (0.56-1.03) 
15-29.9   0.88 (0.58-1.35) 
30-45       0.97 (0.58-1.60) 
None      1.00 
>0-4.9      0.83 (0.75-0.92) 
5.0-14.9  0.79 (0.70-0.90) 
15-29.9   0.87 (0.72-1.05) 
30-45       1.06 (0.86-1.30) 
Jousilahti (2000) -                     Women                                     Men 
Abstainer  1.00                                         1.00 
1-3/wk     0.64 (0.39-1.06)  1-5/wk  0.96 (0.71-1.30)   
4-6/wk     0.93 (0.49-1.80)   5-10      0.94 (0.65-1.37) 
7+/wk       1.22 (0.57-2.64)   10+       0.96 (0.67-1.40) 
Kiyohara (1995) Figure only: ~ linear increase in RR  - 
Klatsky (1989) Abstainers    1.00 
Former           1.47 (0.28-7.83) 
<1/day            1.02 (0.39-2.65) 
1-2/day          0.94 (0.28-3.17) 
3+/day            3.85 (1.19-12.41) 
 - 
Klatsky (2002)  -  - 
Kono (1986) Nondrinker   1.0 
Ex-drinker      1.0 (0.4-2.4) 
Occasional     1.2 (0.7-2.2)  
Daily, <2          0.9 (0.5-1.8) 
Daily, 2+          1.6 (1.0-3.2) 
Nondrinker   1.0 
Ex-drinker      2.3 (1.5-3.5) 
Occasional     1.1 (0.7-1.6)  
Daily, <2          1.2 (0.8-1.8) 
Daily, 2+          1.7 (1.1-2.6) 
Leppälä (1999)                             SAH                              ICH 
None                  1.00                             1.00 
Light                   1.00 (0.47-2.13)       0.83 (0.46-1.50) 
Moderate         1.33 (0.59-2.99)       0.64 (0.31-1.35) 
Heavy                1.58 (0.54-4.63)       1.77 (0.73-4.31) 
None                  1.00 
Light                   0.90 (0.74-1.10) 
Moderate         1.12 (0.89-1.39) 
Heavy                1.52 (1.12-2.08) 
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Maskarinec 
(1998) 
 -                    Men                         Women 
0                1.00                           1.00 
1-7            0.89 (0.58-1.36)     1.04 (0.59-1.83) 
8-14         1.03 (0.60-1.78)      0.83 (0.30-2.29) 
15-28       1.12 (0.86-1.47) 
15-35                                           2.38 (1.07-5.30) 
29-42       1.00 (0.40-2.47) 
43-70       0.54 (0.07-3.88) 
70+           0.65 (0.09-4.71) 
Mukamal 
(2005a) 
 - -  
Mukamal 
(2005b) 
 - -  
Romelsjo (2012)  - 0 g/d          1.00 
0.1-10       1.32 (0.41-4.27) 
10-30         1.91 (0.58-6.34) 
30-60         2.10 (0.42-10.40) 
60+             3.62 (0.61-21.68) 
Romelsjo (1999)  - 0 g/d          1.00 
0.1-14.9     1.59 (0.64-3.92) 
15-30          1.52 (0.57-4.00) 
30+              2.30 (0.81-6.43) 
Sacco (1999)  - -  
Sankai (2000)                                             SAH 
Lifetime abstainer          1.00 
Former drinker                - 
<69 g/d                              1.0 (0.5-2.3) 
69+ g/d                             3.9 (1.4-10.6)  
 - 
Shaper (1991)  -  Age, BP, smoking adjusted incidence per 100 PY 
None/occasional : 1.9 
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Light: 1.9 
Moderate: 1.7 
Heavy: 2.4 
Stampfer (1988) 0                              1.0 
<1.5 g/day             2.4 (0.5-12.1) 
1.5-4.9 g/d            2.9 (0.7-11.5) 
5-14.9  g/d            3.7 (1.0-13.8) 
≥15 g/d                  2.6 (0.7-10.3) 
 - 
Truelson (1998)  -  - 
Yuan (1997)  - Nondrinker          1.00 
1-28 drinks/w      1.02 
20+ drinks/w       1.65 (1.12-2.44) 
Woo (1990)  - RR=1.9 (0.01-11.6) 
Yang (2012)  - Non-drinker         1.00 (0.96-1.05) 
<140 g/wk             0.99 (0.88-1.12) 
140-279 g/wk      1.12 (1.01-1.24) 
280-419 g/wk      1.14 (1.03-1.26) 
420-699 g/wk      1.21 (1.07-1.37) 
700+ g/wk             1.55 (1.37-1.75) 
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APPENDIX 3: ALCOHOL AND COGNITIVE DECLINE LITERATURE REVIEW TABLES 
A. Part 1: Population, Study Design, and Measurement 
Author (Year) Population 
Baseline 
Calendar 
Year N 
Follow-
up (y) Attrition (%) 
Alcohol 
Measurement 
Analysis 
Included 
Multiple 
Exposure 
Frequency 
of cognitive 
assessments 
Assessment of 
Cognitive Status 
Bond (2004) Pooled 
prospective 
cohort of The 
Kame Project, 
population-
based study of 
community-
dwelling 
Japanese 
Americans 65+ 
years of age and 
The Adult 
Changes in 
Thought (ACT) 
study 
1994 4,191 Max 4 NR, at least 
11% 
Structured 
interview asking 
about alcohol 
consumption 
ever, formerly or 
currently (within 
the last year) 
No 3 total, 
every 2 
years 
CASI (assessment of 
9 cognitive domains) 
Dufouil 
(2000) 
Epidemiology of 
Vascular Aging 
(EVA) Study 
Population-
based 
prospective 
study of adults 
aged 59-71 y in 
western France. 
1991 1,389 4 21.0% Self-reported, 
beverage-
specific number 
of glasses of 
alcohol 
consumed at 6 
different times 
throughout the 
day. 
No Twice, 4 
years apart 
Global cognition: 
MMSE 
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Espeland 
(2005) 
Women's Health 
Initiative 
Memory Study 
(WHIMS) 
Randomized 
controlled trial 
of estrogen and 
progestin in 
postmenopausal 
women aged 50-
79 years 
1996 4,461 4.2 2% missing 
any follow-
up visit.  
Participation 
at V1-6 
were 96%, 
92, 91, 83, 
39, and 2% 
Beverage-
specific FFQ 
assessing past 3 
months of intake 
No Annually Global cognitive 
function: Modified 
Mini-Mental State 
Examination (3MSE) 
Ganguli 
(2005) 
Monongahela 
Valley 
Independent 
Elders Survey 
(MoVIES) 
Prospective 
cohort of rural-
dwelling blue 
collar workers in 
PA aged 65+ 
1987-9 1,681 7.3 Not 
reported 
Baseline QF 
measure, with F 
over follow-up 
Yes, 
trajectory of 
frequency 
Every 2 
years 
MMSE, Trailmaking 
Test, Word List 
Learning and 
Delayed Recall, Story 
Immediate and 
Delay Recall, Boston 
Naming Test, Clock 
Drawing, etc 
Herbert 
(1993) 
Established 
Populations for 
Epidemiologic 
Studies of the 
Elderly,  non-
institutionalized 
persons aged 
65+ in East 
Boston, MA 
1982 3,809 3 15.0% Interview-
administered 
questionnaire 
assessing alcohol 
consumption in 
past year (yes or 
no) and amount 
consumed in 
past month (# of 
No 2 total, 3 
years apart 
Memory test (story 
recall), digit span 
test, and orientation 
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drinks) 
Leroi (2002) Baltimore arm 
of Epidemiologic 
Catchment Area 
program 
prospective 
study of adults 
18+ from 5 sites 
1981 3,481 12.5 57.3% QF of alcohol 
consumption at 
3 waves 
No, subject to 
immortal 
person-time 
2; 1 and 11 
years 
MMSE 
Lobo (2010) ZARADEMP 
Project 
Prospective, 
population-
based study of 
adults 55 and 
older in Spain 
1994 4,803 4.5 41.0% Beverage-
specific usual 
daily intake (Q 
only) 
No 2; ~2 years 
apart 
MMSE 
Peters (2009) The 
Hypertension in 
the Very Elderly 
Trial (HYVET) 
Randomized trial 
of 
antihypertensive 
treatment 
among older 
adults aged 80 
and over from 
Europe, China, 
2005 3,336 2 NR Consumption of 
alcohol at 
baseline 
No Annually MMSE 
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and Australia 
Stampfer 
(2005) 
Nurses’ Health 
Study 
Female nurses 
aged 30-55 years 
in 11 US states 
1995 12,480 1.8 11% (~3% 
died, 7% LTF 
or declined) 
Food frequency 
questionnaire 
every 4 years 
beginning in 
1980 assessed 
beverage specific 
QF 
No, restricted 
to women 
with stable 
drinking over 
time and 
used 
measurement 
immediately 
prior to 
cognitive 
assessment 
1.8 years 
apart 
Baseline: Telephone 
Interview of 
Cognitive Status 
(TICS) 
Follow-up: TICS, East 
Boston Memory 
Test, 10-Word List, 
verbal fluency, digit 
span backward test 
Stott (2008) Prospective 
Study of 
Pravastatin in 
the Elderly RISK 
(PROSPER) 
RCT of adults 
aged 70-82 years 
with vascular 
risk factors or 
disease in 
Ireland, the 
Netherlands, 
and Scotland 
~1998 5,804 3.2 20.8% Self-reported 
usual intake 
during previous 
month 
No 5; baseline 
and 9, 18, 
30 months, 
final visit 
MMSE, Stroop Color-
Word test, Letter-
Digit Coding Test 
(LDCT), Picture Word 
Recall Test (PWRT) 
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Wright (2006) The Northern 
Manhattan 
Stroke Study 
Residents of 
Northern 
Manhattan >39 
years of age with 
no history of 
stroke at 
baseline 
2001 2,631 2.2 46.0% In-person 
interview 
adapted from 
the National 
Cancer Institute 
Block FFQ to 
assess beverage-
specific average 
consumption in 
past 6 months 
No Annually TICS-m 
Yaffe (2009) Health, Aging, 
and Body 
Composition 
(Health ABC) 
study 
Prospective 
cohort of 
community-
swelling 
residents of 
Memphis, TN 
and Pittsburgh, 
PA aged 70-79 
1997 3,075 Max 7 
years 
NR, at least 
20% 
Interviewer 
administered 
questionnaire to 
assess usual 
weekly 
consumption 
over 12-month 
period 
No Years 1, 3, 5, 
8 
3MS 
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B. Part 2: Analysis and Results 
Author 
(Year) 
Operation 
Definition of 
Alcohol 
Consumption 
Operation 
Definition of 
Cognitive 
Status Covariates 
Statistical 
Analysis Results 
Bond 
(2004) 
Current (5+ drinks 
per year) 
Former (drinking 
but not in past 
year) 
Abstainer 
Mean CASI 
score as a 
function of 
time 
Age, BMI, 
education, income, 
smoking, stroke 
history, HTN, CHD, 
depression, DM 
Mixed-effects 
hierarchical 
linear models 
with multiple 
imputation for 
missing data 
generated 
through death, 
LTF, refusals 
Alcohol             Intercept, B(SE);p        Slope, B(SE);p 
Current             1.36 (0.26); <0.001          0.17 (0.08); <0.05 
Not current     0.89 (0.33); <0.01            0.02 (0.11); NS           
Dufouil 
(2000) 
Usual daily intake 
in drinks per day. 
Never, <2, 2-5, 5+ 
Categorized 
MMSE change 
score as 1) 
Deterioration 
(3+ point drop) 
or 2) No 
deterioration 
(drop less than 
3 points) 
None Logistic 
regression 
Daily Alcohol            RR (95% CI)                   RR (95% CI) 
                                        APOE e4+                      APOE e4-  
0                                     1.0                                     1.0 
<2 glasses                    1.9 (0.7-5.0)                   0.7 (0.5-1.1) 
2-5 glasses                   2.7 (0.9-8.4)                   0.6 (0.4-1.1) 
5+ glasses                    8.3 (1.0-66.00                0.3 (0.1-1.3) 
Espeland 
(2005) 
Drinks per day: 
none, <1, 1+ 
Baseline 3MSE, 
continuous 
Decline of 8+ 
points vs not 
Age, years since 
menopause, 
education, family 
income, use of 
tobacco, BMI, 
HTN, CVD, DM, 
statin therapy, 
Analysis of 
variance (cross-
sectional 
analysis), logistic 
regression (drop 
in score of 8 or 
more points vs. 
                          Baseline score       OR (8pt drop) 
No alcohol         95.28                      1.0 
<1 drink/d          95.63                      0.69 (0.49-0.97) 
1+ drink/d          96.00                      0.53 (0.28-0.99) 
p-value               <0.001 
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aspirin use, HRT, 
intervention 
assignment 
not) 
Ganguli 
(2005) 
Drinking frequency 
trajectory 
PROC TRAJ 
identified 1) no 
drinking, 2) 
minimal drinking 
(1/mo or less), 3) 
moderate drinking 
(>1/mo) 
Global (MMSE 
score) and 
domain specific 
(learning, 
memory, 
visuospatial, 
fluency, 
trailmaking, 
naming) 
Age, sex, 
education level, 
smoking, 
depressive 
symptoms, self-
reported HD, DM, 
stroke, neurologic 
disease, peptic 
ulcer disease, 
nervous/emotional 
conditions, 
baseline MMSE 
score, incident 
dementia 
Latent class 
analysis 
Baseline scores were higher and declines were slower 
among minimal and moderate drinkers compared with 
nondrinkers. When models were compared with 
nondrinkers broken out as quitters and abstainers, find most 
of the effect is due to quitters 
Herbert 
(1993) 
Average ounces 
per day 
1) None in 
previous year 
2) V. light < 0.5 oz 
per day 
3) Light 0.1-1 oz 
per day 
4) Moderate 1+ oz  
Normal score 
transformation 
within strata of 
baseline scores 
Age, sex, 
education, income, 
presence of any 
chronic condition 
(self-reported 
stroke, MI, cancer, 
DM, or HTN), 
baseline score. 
Linear regression                       Normal Score Change (95% CI) 
Alcohol        Orientation      Digit-span           Memory 
None            0                        0                            0 
V. light   0.10 (-0.03, 0.23)  0.09 (0.02,0.16)  0.03 (-0.10, 0.16) 
Light      0.17 (-0.03, 0.37)  0.06 (-0.05,0.17) 0.05 (-0.16, 0.25) 
Mod.  -0.001 (-0.20, 0.19)  0.07 (-0.04,0.18) 0.18 (-0.02, 0.38) 
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Leroi 
(2002) 
Categorized as the 
highest reported 
intake over the 3 
waves 
1) Nonuser            
2) Mild/Moderate: 
<5 drinks/day on 
<20 d/m 
3) Habitual: <5 
drinks/day on 
20+d/m 
4) Heavy 
infrequent: >4 
drinks/d on <20 
d/m 
5) Heavy frequent: 
>4 drinks/d on 20= 
d/m 
Mean change 
in MMSE 
between 
waves 2 and 3 
Age, sex, race, 
education 
Analysis of 
covariance 
                                               Men                 Women* 
Nonusers                            -1.25                 -1.75 
Social users                         -1.23                -1.50 
Habitual users                    -1.34                -1.10 
Binge users                         -1.06                 -1.56 
Heavy, frequent users    -1.29                  -0.86 
* F-test significant differences, p<0.0001 
Lobo 
(2010) 
Abstainers, former 
drinkers, 
grams/day: <12, 
12-24, >24 for 
women and <12, 
12-24, 24-40, and 
>40 for men 
Annual change 
in MMSE from 
the first and 
last 
measurements.  
Age, marital 
status, education, 
smoking (yes, no), 
HTN, depression, 
use of 
psychotropic 
drugs, disability 
index 
Simple linear 
regression 
                             Men                      Women 
Abstainer         0                                  0 
<12 g/day        -0.09 (-0.23,-0.05)   -0.55 (-0.25,-0.14) 
12-24 g/day     0.09 (-0.07,0.25)      0.29 (-0.02,0.61) 
24-40 g/day     -0.06 (-0.23,0.11) 
40+ g/day        -0.01 (-0.21,0.20) 
Former              0.04 (-0.09,0.18)      -0.06 (-0.30, 0.19) 
Peters 
(2009) 
Consumption of 
alcohol (yes vs. no) 
Mean annual 
change in 
MMSE score 
Age, sex, current 
smoking, lives 
alone, BMI 
(underwt, overwt, 
obese), education, 
Simple linear 
regression 
Alcohol (yes vs. no)      -0.01 (-0.25,0.23) 
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use of piraetam, 
treatment arm. 
Hypertension, by 
design 
Stampfer 
(2005) 
Grams per day: 0, 
1.0-14.9, 15.0-30.0 
Global 
cognition: 
average of z 
scores from all 
tests 
Mean scores 
on individual 
tests 
Change: 
substantial 
decline 
(bottom 10t 
percent of 
decline) vs. not 
Age, highest 
educational 
degree, HTN, 
cholesterol, DM, 
heart disease, 
physical activity, 
age at menopause, 
HRT, vitamin E, 
BMI, smoking 
status (former, 
never, current), 
aspirin use, mental 
health index, 
energy-fatigue 
index, SF36, social 
integration, 
baseline cognitive 
score 
Cross-sectional: 
linear regression, 
logistic 
regression 
Longitudinal: 
Logistic 
regression 
OR for Substantial Decline 
                         TICS                            Global Cog Score 
No alcohol      1.00                           1.0 
1.0-14.9          0.85 (0.74-0.98)     0.89 (0.77-1.03) 
15.0-30.0      1.04 (0.77-1.41)       0.82 (0.58-1.16) 
Stott 
(2008) 
Units per week. 
Women 
categorized as 0,  
<3 units per week, 
3+; men 0, <7 units 
per week, 7+ 
Mean test 
score 
Age, country, edu. 
level, baseline 
cognitive status, 
smoking, BMI, 
weight, incident 
stroke, history of 
vascular disease, 
test version 
Linear mixed 
models 
estimating rate 
of decline and 
mean decline 
Mean differences were smaller for female drinkers 
compared with nondrinkers for all tests except PWLT. No 
differences for men. 
Rate of decline similar for all cognitive domains. 
MMSE decline was less in female drinkers vs. nondrinkers 
(0.05 points per year, p=0.001) 
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Wright 
(2006) 
Average daily 
consumption in 
past year 
categorized as: 
never, past, <1 
drink/wk, 1-14 
drinks/wk, >14 
drinks/week 
Mean change 
in TICS-m 
Age, education, 
sex, race, 
insurance status, 
HDL-C, BMI, HTN, 
DM, cardiac 
disease, current 
smoking, 
depression, 
physical inactivity, 
time between 
TICS-m 
administration 
Generalized 
estimating 
equations. 
Accounts for 
correlation 
among change 
scores 
Alcohol Intake                 Change in TICS-m over referent 
category 
Never                                  1.00 
Former                                 0.4 (-0.4, 1.2) 
0-7 drink/wk                      0.9 (-1.2, 1.9) 
7-14 drinks/w                    1.5 (0.6, 2.4) 
>14+ drinks/w                   2.4 (0.8, 4.0) 
Yaffe 
(2009) 
Current drinking 
(>1 drink/day vs. ≤ 
1 drink/day) 
Trajectory of 
cognitive 
decline 
categorized 
based on 
participant-
specific slopes: 
1) Maintainers, 
slope ≥0; 2) 
Minor 
decliners, slope 
<0 and > (mean 
decline - 1SD); 
3) Major 
decliners, slope 
> 1SD below 
mean decline 
Age, race, 
education, 
employed, social 
support, lives 
alone, self-rated 
health, exercise, 
current smoking, 
CED-D, BMI, HTN, 
DM, stroke history, 
APOE, CRP, IL-6, 
TG, fasting glucose 
Linear mixed 
model with 
random 
intercepts and 
slope to 
categorize 
outcome. Logistic 
regression to 
estimate 
association of 
alcohol with 
cognitive 
trajectory. 
                                 Maintainer vs.             Major vs. 
                                 minor decline          minor decline 
≤1 drink/day       1.0                                  1.0 
>1 drink/day       1.33 (0.91-1.93)         0.67 (0.36-1.27) 
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